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Androgen receptor (AR) signalling is essential for the development and function of 
the male reproductive system. Conditional gene ablation using the Cre-loxP system 
has previously assisted in the elucidation of the rol of AR in different cell types. 
The aim of this study was to examine the effects of the ablation of AR in previously 
untargeted cell types, with the hypothesis that this will have significant and novel 
effects on reproductive development and function that ave not been previously 
documented by current models of androgen disruption.  
 
In these studies, three Cre recombinase lines were empirically validated for action in 
the male reproductive system, before being used to ablate AR and the phenotypes of 
the resulting lines were characterised. Endothelial-specific receptor tyrosine kinase 
(Tie2)-Cre was shown to target the vascular and endothelial cells of the testis, and 
used to ablate AR in these cells. The testes of the resulting Tie2-ARKO line were 
morphologically similar to controls, with normal spermatogenesis and mature 
spermatozoa present in the cauda epididymis. Aquaporin 2 (Aqp2)-Cre was shown to 
target the post-meiotic germ cells of the testis, and was used to ablate AR in these 
cells. The testes of the resulting Aqp2-ARKO line wre morphologically similar to 
controls, with normal spermatogenesis and mature spermatozoa present in the cauda 
epididymis. It was concluded that the Ar gene was dispensable in the endothelial 
cells and post-meiotic germ cells of the testis for n rmal spermatogenesis.  
 
Forkhead box protein G1 (FoxG1)-Cre was shown to targe  the caput epididymal 
epithelium and pituitary, and used to ablate AR in these cells. d100 FoxG1-ARKO 
mice had a severe testicular phenotype, with sloughing of the seminiferous 
epithelium, atrophy of some seminiferous tubules and distension of the rete testis 
with spermatozoa. Despite the severe testis phenotype, ablation in the testis was 
incomplete and restricted to a small percentage of Leydig cells, with no ablation in 
Sertoli cells. Ablation of AR in the embryonic pituitary did not cause adult serum 
testosterone or LH concentrations to change, nor did it cause changes in other 
    
 
iv 
pituitary hormone transcripts. Mosaic ablation of AR in the caput epididymal 
epithelium was shown to impair epididymal development, with failure of initial 
segment (segment I) development and a significant decrease in epithelial cell height 
and lumen diameter in the remaining proximal caput epididymis (segment II).  
Dysfunction of the caput epididymis resulted in thefailure of spermatozoa to transit 
the efferent ducts into the epididymis correctly: instead they were found to stall in 
the efferent ducts and produce a block. The testicular phenotype could be explained 
as the result of fluid backpressure effects resulting from the efferent duct block. 
Consequently, low concentration of spermatozoa in the cauda epididymis resulted in 
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1. Literature review 
1.1 The mouse as a model organism for reproductive biology 
1.1.1 The mouse as a model organism 
 
The use of the house mouse, Mus musculus as a mammalian model organism for 
human disease has been growing in popularity since the beginning of the 20th century 
(Paigen, 2003a). The striking similarity between the anatomy and physiology of 
humans and mice was recognised long before the sequencing of the mouse genome 
discovered that there are mouse homologues of around 99% of human genes 
(Waterston et al., 2002). Mice and humans are estimated to have diverged from a 
common ancestor around 75 million years ago, comparatively recently in 
evolutionary terms (Paigen, 2003b). The advantages of using the mouse as a model 
organism are numerous. Its small size, basic needs (food, water, bedding, controlled 
temperature and light regimens and a small amount of environmental enrichment), 
short generation time (approximately 10 weeks from being born to giving birth) and 
a large litter number (an average of 5-10 pups) allows for rapid generation of large 
numbers of experimental animals (Silver, 1995). This makes them advantageous 
when compared to model organisms such as sheep and cows, which, although 
phylogenetically closer to humans, are expensive to maintain as experimental 
animals (Gama Sosa et al., 2010). Another advantage is the availability of congenic 
inbred strains generated from at least 20 generations of sibling inter-crosses (Beck et 
al., 2000) which are essentially genetically identical and homozygous at all loci, 
limiting any influence of genetic variation on experimental outcome. More recently, 
the generation of transgenic mice by oocyte pro-nuclear microinjection and gene 
targeting in embryonic stem (ES) cells has proven highly successful in mice but less 
adaptable in other species (Gama Sosa et al., 2010), resulting in an exponential 
increase in the number of transgenic mouse lines. The International Knockout Mouse 
Consortium aims to mutate all protein-encoding genes in the mouse using a 
combination of gene trapping and gene targeting in mouse ES cells (Collins et al., 
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2007). As of December 2010 it has generated mutant ES cell lines for 15526 out of 
24646 protein coding genes (http://www.knockoutmouse.org). 
 
1.1.2 The Cre- loxP system 
The Cre-loxP system is a genetic tool based on a method of site-specific 
recombination occurring in P1 bacteriophage (Nagy, 2000). Cre recombinase is an 
enzyme that catalyses the recombination of DNA betwe n two loxP sites. The 34 bp 
loxP site consists of a directional element surrounded by palindromic binding sites 
for Cre. The directionality of the loxP sites affects the result of recombination: 
recombination between two inverted loxP sites will cause inversion of the DNA 
between them and recombination between two repeated loxP sites will cause deletion 
of the DNA between them. If loxP sites are on different chromosomes, a 
chromosomal translocation can occur.  
 
Transgenes consisting of Cre recombinase driven by cell specific promoters allow 
cell-specific expression of Cre. These can be either ‘knock-in’ lines where Cre has 
been targeted to the endogenous locus of the promoter of interest, or ‘random 
insertion’ lines where both Cre and the cloned promoter that will drive it are inserted 
at a random locus in the genome. Both methods have problems associated with them 
(Matthaei, 2007). Knock-ins can produce an insertional deletion of the gene 
controlled by the promoter to be used which may result in a haploinsufficiency 
phenotype. However, the insertional deletion can be avoided if the construct uses an 
internal ribosome entry site (IRES) followed by the transgene placed between the 
stop codon and the polyadenylation signal of the target gene resulting in production 
of a bicistronic transcript. Random insertions may be significantly influenced by the 
local environment at the integration site which canlead to the ectopic expression or 
silencing of the transgene due to modification of the specificity of the promoter, or a 
more severe phenotype due to disruption of an unknown gene by insertion of the 
transgene (insertional mutagenesis). A further level of control can be introduced by 
fusing Cre to a ligand-inducible nuclear translocation signal such as that found in the 
nuclear hormone receptor family. Under the control of a cell-specific promoter Cre is 
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generated, but will not be transported to the nucleus to execute recombination unless 
a ligand to the hormone receptor of choice is applied (Garcia and Mills, 2002).  
 
The corresponding ‘floxed’ line is created so that the sequence to be recombined is 
surrounded with direct loxP repeats. If cell-specific ablation of a gene of interest is 
required, this sequence can be a gene, or part of a gene such as an exon that is critical 
to the gene’s action. This strategy can also be utilised for activation of a gene of 
interest, for example, a ‘reporter gene’ such as which results in a chromogenic (e.g. 
E. coli β-galactosidase) or fluorescent (e.g. A. victoria green fluorescent protein, 
GFP) product. Reporter genes can be part of a transgenic construct inserted into a 
ubiquitously expressed locus with an upstream stop codon flanked by loxP sites. 
Recombination between the loxP sites by Cre results in excision of the stop codon 
and expression of the reporter gene. Mating of a ‘Cre’ line with a ‘floxed’ line results 
in offspring with a cell-specific knock-out or activation of the gene of interest, as 
illustrated in Figure 1-1. 
 
Figure 1-1: Mating of a mouse line expressing Cre under a tissue specific promoter 
with a mouse line containing a floxed gene of interest generates mice with the gene of 
interest conditionally ablated in the target tissue.  
Image obtained through Wikimedia Commons (http://commons.wikimedia.org, author: 
Matthias Zepper) 
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1.1.3 The mouse reproductive system 
The reproductive system of the male mouse (summarised in Figure 1-2) is located in 
the posterior abdomen and exists to produce and deliver haploid male gametes into 
the female tract for fertilisation. The testes are th male organs of gametogenesis. 
The testes produce spermatozoa (the male haploid gametes) and testosterone that is 
vital for correct development and function of the male reproductive system. In mice, 
the testes are retractable, and can either be found in the posterior abdominal cavity on 
either side of the urinary bladder, or in the scrotum which is an extension of the body 
cavity located between the penis and the anus, by travelling through the inguinal 
canal. Position of the testes is controlled by the cremaster muscle reflex in response 
to temperature or perineal pressure stimulus (Kojima and Ohe, 1986). Also found 
inside the scrotum are the excurrent ducts: the effrent ducts, epididymis and vas 
deferens. Spermatozoa exit the testis and are transported into the efferent ducts 
(involved in concentration of sperm) and into the epididymis (pl. epididymides), 
which is a single, highly coiled tubule located on the dorsal side of each testis. The 
epididymis provides a place for maturation and storage of spermatozoa in the mouse. 
Up until the point of ejaculation, spermatozoa are stored in the epididymis, and 
during ejaculation they pass into the vas deferens (pl. vasa deferentia). This is 
straight tubule that exits the epididymis on the posterior side of the testis and travels 
through the inguinal canal to connect with the urethra near the neck of the bladder. 
The vas deferens is surrounded with layers of contractile smooth muscle that force 
the sperm towards the urethra during ejaculation. The neck of the bladder and the 
anterior end of the urethra are surrounded by accessory glands and their ducts: the 
seminal vesicles, coagulating glands, ampullary glands, and the dorsal and ventral 
lobes of the prostate. These glands and ducts provide secretions to bathe and activate 
the spermatozoa on ejaculation. In mice, the secretions of these glands also cause the 
formation of a copulatory plug. During ejaculation, spermatozoa are released from 
the cauda epididymis, combine with secretions from these glands and enter the 
urethra. The urethra is the common outlet for urine a d semen and extends from the 
urinary bladder to an opening on the top of the penis. The penis is the male 
intromittent organ that is used to transmit sperm into the male reproductive tract. In 
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mice, it contains a small bone: the os penis, as well as corpus cavernosum tissues. 
The bulbourethral glands secrete a fluid that lubricates the urethra and removes any 
traces of urine so the urethral environment facilitates the transit of the spermatozoa. 
In the final stages of ejaculation during mating, sperm pass down the urethra, through 




Figure 1-2: Lateral and ventral views of the male mouse reproductive system 
Adapted from R. Rugh (1964) Vertebrate Embryology 




Steroid hormones are vital for normal reproductive development and function in both 
males and females (Johnson and Everitt, 2000). The web of enzymatic conversions 




Figure 1-3: Synthesis of steroid hormones from cholesterol 
Indicating the classes of hormones, enzymes involved and cellular locations (from 
http://commons.wikimedia.org/, author: Mikael Häggström). 
 
Although it is possible for all steroid hormones to be synthesised from pregnenolone, 
the hormones produced by a steroidogenic cell largely d pend on which of the 
steroidogenic enzymes it expresses. Synthesis of all steroid hormones begins with the 
Chapter 1: Literature review          
 
7 
shuttling of cholesterol from the outer to the inner mitochondrial membrane by 
steroidogenic acute regulatory protein (StAR), this is the rate-limiting step of 
steroidogenesis (Stocco, 2001). Cholesterol is then co verted to pregnenolone, 
catalysed by the enzyme cytochrome P450, family 11, subfamily a, polypeptide 1 
(commonly known as P450scc, encoded by the Cyp11a1 gene) (Porter and Coon, 
1991). Pregnenolone then exits the mitochondria andcan be converted into 
progestogens, estrogens, androgens, mineralocorticoids and glucocorticoids in the 
smooth endoplasmic reticulum. 
1.2.1 Testicular testosterone biosynthesis 
Androgens are the class of steroid hormones responsible for masculinisation and 
function of the adult reproductive tract. The Leydig cells are the source of androgens 
in the testes. Due to the web of potential steroid c nversions mediated by enzymes 
that can catalyse multiple steps in the web, production of testosterone by the testis is 
a dynamic process involving multiple substrates anddynamic equilibria established 
between intermediate products of the reaction. In the mouse Leydig cell, 
pregnenolone is converted to progesterone by the action of hydroxy-∆5-steroid 
dehydrogenase, 3β- and steroid ∆-isomerase (commonly known as 3β-HSD), types I 
(encoded by the Hsd3b1 gene) and VI (encoded by the Hsd3b6 gene)(Baker et al., 
1999). 17α-hydroxylase/17,20 lyase/17,20 desmolase (commonly k own as 17α-
hydroxylase, encoded by the Cyp17a1 gene) then catalyses first the hydroxylation of 
progesterone at C17 followed by the cleavage of the two-carbon side-chain to yield 
the C19 steroid, androstenedione, the immediate precursor of testosterone (Nakajin 
and Hall, 1981). The final reaction is the reduction f the 17-ketone of 
androstenedione by 17β-hydroxysteroid dehydrogenase (commonly known as 17β-
HSD) type III (encoded by the Hsd17b3 gene)(Geissler et al., 1994). Leydig cells 
also express cytochrome P450, family 19, subfamily A, polypeptide 1 (commonly 
known as aromatase, encoded by the Cyp19a1 gene), which catalyzes the 
aromatisation of testosterone to 17β-estradiol. Testosterone biosynthesis begins 
around e13 in the mouse and 6-7 week of pregnancy in the human and is secreted at 
high levels by fetal Leydig cells during embryonic life to enable masculinisation of 
the male reproductive tract during development (section 1.3)(O'Shaughnessy et al., 
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2006). There is then a reduction of testosterone secretion after birth before adult 
Leydig cells begin to secrete testosterone around pberty (section 1.5).  
 
Testosterone can act as an autocrine, paracrine or endocrine hormone after binding 
its receptor, androgen receptor (AR, encoded by the Ar gene, see section 1.2.2). As 
well as having local effects in the testis, testosterone can diffuse into the blood and 
lymph vessels in the testicular interstitium and be transported around the body in the 
systemic circulation to reach other endocrine target tissues. It can also diffuse into 
the seminiferous tubules of the testis, where it may enter Sertoli cells or be carried to 
the excurrent ducts in seminiferous tubule fluid.  During transport in the blood or 
testicular fluid, testosterone is bound to androgen binding protein (ABP) in rodents, 
or sex-hormone binding globulin (SHBG) in humans (Joseph, 1994). 
 
1.2.1.1 Conversion of testosterone to DHT 
Testosterone can also be converted to dihydrotestost rone (DHT) by the action of  
steroid 5α-reductase. DHT also binds to the AR and is considered a more ‘potent’ 
AR agonist because it has a higher binding affinity for the AR but a lower 
dissociation rate, making it ideal to stimulate a response at low concentrations (Grino 
et al., 1990). Conversion occurs locally in tissue-p cific sites, and is thought to 
facilitate the action of testosterone in tissues receiving low concentrations. Two 
isoforms of steroid 5α-reductase transcribed from separate genes were identif ed in 
humans and termed type 1 (encoded by the Srd5a1 gene) and type 2 (encoded by the 
Srd5a2 gene)(Andersson et al., 1991; Andersson and Russell, 1990; Labrie et al., 
1992). Mice also have two isoforms (Jenkins et al., 1991). Type 1 is present in non-
genital skin, liver and brain and type 2 is present in fetal and adult genitals and adult 
liver. Males with mutations in the 5α-reductase type 2 gene are born with female 
external genitalia, and often (but not invariably) with undescended inguinal testicles 
(Imperato-McGinley and Zhu, 2002). Despite this, the Wolffian duct differentiates 
normally, with distinct epididymis, vas deferens and seminal vesicles. At puberty 
patients often undergo a slight virilisation with growth of the phallus and scrotum, 
and occasionally descent of the testicles due to an increase in circulating testosterone 
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levels. However the prostate is reduced in size, and lthough ejaculation is often 
possible, semen is very viscous. Despite this, normal sperm concentrations and 
motility are possible, and intra-uterine insemination has been performed successfully 
with sperm from men with 5α-reductase type 2 (Katz et al., 1997). The phenotype of 
these males implies that DHT is vital for external genitalia differentiation in humans, 
as well as growth and function of the prostate, but tha  it does not seem to have a 
vital role in sperm production or maturation. In contrast, mice with a knock-out of 
both 5α-reductase type 1 and type 2 genes have normal external and WD virilisation 
but with smaller seminal vesicles and prostate (Mahendroo et al., 2001). They are 
fertile, albeit with a slight decrease compared to controls, and have normal sperm 
morphology and movement. The relatively mild phenotype in these mice suggests 
that testosterone is the only androgen required for the differentiation of the male 
urogenital tract in mice and that the synthesis of DHT serves largely as a signal 
amplification mechanism.  
 
1.2.1.2 Conversion of testosterone to 17 β-estradiol 
Testosterone can also be converted to 17β-estradiol in the male mouse reproductive 
system by the action of aromatase in the Leydig cells and round and elongating 
spermatids of the testis (Nitta et al., 1993), and epididymal sperm (Janulis et al., 
1996). 17β-estradiol acts by binding to its receptors, estrogen receptor α (ERα, 
encoded by the  Esr1 gene) and estrogen receptor β (ERβ, encoded by the Esr2 gene) 
(Heldring et al., 2007). The actions of estrogens in the male reproductive system will 
be referred to in more detail in sections 1.4 and 1.6. 
 
1.2.2 The androgen receptor (AR) 
Steroid hormones can enter almost all cells in the body by diffusing through the lipid 
bilayer of the cell membrane. Once inside, they bind to receptors that are members of 
the ligand-activated transcription factor super-family. These intracellular receptors 
can become activated upon ligand binding allowing iteraction with regulatory 
regions in the genome specific to that receptor (section 1.2.3.1). They can also act in 
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the absence of a ligand through a non-classical pathway (section 1.2.3.2). All steroid 
hormone receptors share a similar structure made up of 4 main functional domains 
(from N to C terminal): the variable domain, DNA-bind ng domain, hinge region and 
ligand-binding domain (Ribeiro et al., 1995).  
 
Androgen receptor (NR3C4; nuclear receptor subfamily 3, group C, gene 4) is a 
single copy gene present on the X chromosome in mice and men (Brown et al., 
1989). The length of the ORF is 2697 nucleotides over eight coding exons, which 




Figure 1-4: Structure of the androgen receptor 
Note its four functional domains and three transcriptional activation regions (AF-1, AF-2 and 
AF-5) 
 
The DNA, hinge and ligand binding domains of the mouse AR are virtually identical 
to the human AR, but there is approximately 15% variation in the N-terminal 
variable region (Gaspar et al., 1990). Despite this, m ce with a transgenic knock-in of 
human AR show normal development and fertility (Albertelli et al., 2006). AR and 
both the ligand binding and DNA binding domains areid ntical between the two 
species. The N-terminal variable region of the AR comprises over half of the 
receptor protein. This region is poorly conserved both in length and sequence 
similarity among the members of the steroid receptor family (Faber et al., 1989). 
Within this domain are two transcription activation regions (AF-1 and AF-5) which 
can bind co-regulator proteins to increase or decrease transcription of downstream 
genes (Jenster et al., 1995; McEwan, 2004). It also contains a variable polyglutamine 
stretch that may be important in transcriptional regulation (Lieberman et al., 2002). 
The AR DNA-binding domain has the greatest sequence similarity with other steroid 
receptors (Brinkmann, 2009). It is composed of two zinc finger motifs: the first is 
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responsible for recognition of the target DNA sequence while the second stabilises 
DNA-receptor interaction by contact with the DNA phosphate backbone (Berg, 
1989; Freedman, 1992). Between the two zinc fingers is an amino acid sequence that 
can recognise specific DNA response elements thus making this domain vital for 
transcription of downstream genes (Beato et al., 1996). At the overlap between the 
between the DNA binding and hinge regions is a nuclear targeting sequence that is 
responsible for androgen dependent translocation frm the cytosol to the nucleus 
(Jenster et al., 1993). The hinge region is responsible for androgen dependent 
conformational changes of the AR. The ligand binding domain (LBD) is at the C-
terminus of the AR. Its sequence is less conserved between other steroid hormone 
receptors to ensure specific, high affinity binding of androgens (Mangelsdorf et al., 
1995). The LBD contains another transcription activation region (AF-2) which can 
bind coregulator proteins to increase or decrease transcription (Beato et al., 1996). 
The LBD also contains a binding region for heat-shock protein 90 (HSP90) that is 
common to all steroid hormone receptors: HSP90 and other HSPs are thought to be 
involved in maintaining the structure of the receptor in the absence of ligand and 
preventing the receptor from associating with AREs on DNA in the absence of ligand 
(Jenster et al., 1993; Picard et al., 1990). 
 
1.2.3 Mechanisms of AR action 
1.2.3.1 Classical mechanism of AR action 
The current model for genomic androgen action involves a multi-step mechanism 
(see Figure 1-5). Upon entry of testosterone into the androgen target cell, binding 
occurs to the androgen receptor either directly or after its conversion to DHT. 
Binding of the androgen ligand to the receptor is followed by dissociation of the 3’-
bound heat shock proteins in the cytoplasm (Jenster et al., 1993). HSP release 
unmasks the DNA binding motifs and the nuclear localisation signal (Kuil and 
Mulder, 1995). Androgen binding promotes AR hyper-phosphorylation which 
induces coactivator recruitment and transcriptional activation (Gioeli et al., 2002; 
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Kuiper and Brinkmann, 1995). The complex then translocates to the nucleus 




Figure 1-5: The classical mechanism of AR action  
Testosterone enters the cell. It can bind to the ligand binding domain (LBD) of cytoplasmic 
AR either as testosterone or after conversion to DHT. Loss of bound heat-shock proteins 
(HSP) occurs, along with phosphorylation of the receptor, dimerisation and translocation to 
the nucleus.The DNA binding domain (DBD) binds to androgen response elements (ARE) in 
the genome, and cofactors and RNA polymerase (RNAP) II bind to the receptor complex, 
resulting in expression of androgen dependent genes.(Gobinet et al., 2002) 
 
It is widely accepted that the receptor/ligand complex requires dimerisation to bind 
to androgen response elements (AREs) located in the regulatory regions of androgen 
responsive genes (Jones, 1990). Classical AREs are 15 bp sequences with two 
imperfect 6 bp repeats that are almost identical to glucocorticoid response elements 
so will also bind glucocorticoids (Roche et al., 1992). More recently, androgen-
specific response elements have been discovered that will only bind activated AR. 
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Reproductive homeobox on the X chromosome 5 (Rhox5) is a well-characterised 
androgen-responsive gene with two androgen-specific AREs in its promoter 
(Barbulescu et al., 2001). Rhox5 itself is a transcription factor found in Sertoli cells 
that is thought to direct some of the actions of AR in the testes (Hu et al.). In order to 
modify transcription of genes with AREs, the AR/ligand homodimer complex further 
recruits additional proteins that form a transcription activation/repression complex at 
discrete sites on the chromatin (McKenna et al., 1999). Cofactors are thought to be 
cell specific so AR signalling can elicit particular responses in a wide variety of 
different tissues. 
 
1.2.3.2 Non-classical and ligand independent action s of androgens and AR 
Androgens and AR can act in a rapid non-classical way ithout binding to genomic 
AREs. Non-classical effects of testosterone have now been demonstrated 
convincingly in several tissues, in particular in the reproductive, cardiovascular, 
immune and musculoskeletal systems (Rahman and Christian, 2007). It is thought 
that non-classical signalling may explain the relative lack of genes discovered that 
contain AREs compared to the wide range of effects that testosterone can produce 
within a cell (Walker, 2010). In the reproductive system, evidence from both Sertoli 
cells and the  prostate cancer LNCaP cell line show that testosterone can produce 
intracellular calcium influx via membrane depolarisation, leading to cytoskeletal 
rearrangement (Kampa et al., 2002; Lyng et al., 2000). It can also activate the 
mitogen-activated protein kinase (MAPK) pathway to regulate numerous 
transcription factors including cAMP response element binding protein (CREB), 
independently of AR binding to DNA. This is thought to occur by binding of 
testosterone-activated AR to Src tyrosine kinase, which subsequently activates the 
MAPK pathway through the EGF receptor (Cheng et al., 2007; Fix et al., 2004).  
 
AR can also act ligand-independently. A set of constitutively-active AR splice 
variants that lack the ligand-binding domain have been discovered in hormone-
refractory prostate cancer cells (Hu et al., 2009). In the absence of ligand or in the 
presence of low androgenic concentrations, AR can also be stimulated by growth 
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factors or proinflammatory cytokines including interleukin-6 and insulin-like growth 
factor 1 (Kim and Lee, 2009; Malinowska et al., 2009). 
1.2.4 Disruption of AR action 
1.2.4.1 Clinical mutations 
Androgen insensitivity syndrome (AIS) consists of a spectrum of masculinisation 
disorders in XY individuals from a fully female xternal phenotype (complete 
(C)AIS) to an undervirilised male phenotype (partial (P)AIS). In most cases, AIS is 
caused by a mutation of the Ar gene (Quigley et al., 1995). CAIS (historically known 
as testicular feminisation or Tfm) individuals have inguinal undescended testes with
incomplete spermatogenesis: embryonic testicular development is not affected by 
lack of androgens but testicular descent and adult function is dependent on it (section 
1.3). Due to lack of AR signalling during development, they have female external 
genitalia, a blind ending vagina and no Wolffian duct-derived structures (Quigley et 
al., 1995). Because the Sertoli cells of the testes ill produce AMH they have no 
uterus or oviducts. PAIS is a spectrum of undervirilisation, and  testicular maturation 
of seminiferous tubules and Sertoli cells tends to be more advanced in patients with 
PAIS than ones with CAIS (Muller, 1984).  
 
As of November 2010, more than 1000 mutations in human AR have been identified 
(http://www.mcgill.ca/androgendb/). Many of these mutations lead to androgen 
insensitivity via different mechanisms: incomplete synthesis of the AR protein, 
inability of androgen binding by the AR or abnormalities in binding of the androgen–
AR complex to AREs (Gottlieb et al., 2004). Some of them are ‘silent’ and do not 
have a phenotypic effect, others are implicated in prostate cancer (Marcelli et al., 
2000) and Kennedy’s disease (X-linked spinal and bulbar muscular atrophy) 
(Lumbroso et al., 1997). Kennedy’s disease results in an expansion of the 
polyglutamine tract in the N-terminal variable region of the AR. Symptoms include 
progressive flaccid proximal paralysis and muscle atrophy as well as endocrine 
disturbances including gynaecomastia and progressiv infertility (La Spada et al., 
1991). A number of mutations in the AR have also been reported that result in 
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patients that present with oligozoospermia or azoospermia despite an otherwise 
normal male phenotype (Hiort and Holterhus, 2003). For example, in one patient, the 
mutation prevented interaction of the AR with a TIF2, Sertoli-cell specific co-
activator, thus impeding the genomic actions of AR in Sertoli cells only (Ghadessy et 
al., 1999). 
1.2.4.2 Transgenic animal models 
The first animal model of androgen insensitivity was described in 1970 by Lyon and 
Hawkes, who reported an X-linked gene for Tfm in the mouse (Lyon and Hawkes, 
1970). It was subsequently discovered that male Tfm mice carry a single nucleotide 
deletion in exon 1 of their Ar gene, the resulting frameshift introduces a premature 
termination codon (Charest et al., 1991; Gaspar et l., 1991). With the advent of Cre-
loxP technology (section 1.1.2), mice with a total androgen receptor knock-out 
(ARKO) genotype have been produced by four groups. By mating a mouse line with 
floxed region of the Ar gene to one expressing Cre recombinase under the control of 
a constitutively active gene, genetic ablation of part of the AR resulting in loss of 
functional protein was achieved in all cells of theresulting offspring (De Gendt et al., 
2004; Notini et al., 2005; Sato et al., 2004; Yeh et al., 2002). Both ARKO and Tfm 
mice have a phenotype similar to that of CAIS, with small, inguinal testes, lack of 
Wolffian duct structures and external feminisation. Testicular histology consists of 
some tubules with Sertoli cells only and the others containing a few spermatogonia, 
but no post-meiotic germ cells. Normal spermatogenesis does not occur. This is 
analogous to testicular histology in CAIS patients (Hannema et al., 2006; Yeh et al., 
2002). 
 
Studies of global androgen receptor ablation mice have been vital in gaining 
information on the function of androgens during development, but since adult 
spermatogenesis is incomplete and Wolffian duct-derived structures (epididymis, vas 
deferens and seminal vesicles) are absent, little knowledge can be gained about the 
post-natal role of androgens in these tissues. Cre-loxP transgenic mice are ideal for 
studying the post-natal actions of androgens and also for elucidating the specific 
roles of androgens in different cell types, as the promoter that drives Cre can be 
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selected to be active post-natally, or in specific cell types. Mouse lines with cell-
specific knock-outs of AR in Sertoli cells (Chang et al., 2004; De Gendt et al., 2004; 
Holdcraft and Braun, 2004), peri-tubular myoid cells (Welsh et al., 2009a; Zhang et 
al., 2006), Leydig cells (Xu et al., 2007), germ cells (Tsai et al., 2006), vascular 
smooth muscle (Welsh et al., 2010b), prostate epithlium (Simanainen et al., 2008; 
Wu et al., 2007), seminal vesicle smooth muscle (Welsh t al., 2010a) and nervous 
system (Raskin et al., 2009) have been characterised.  
 
 
1.3 Androgens and reproductive development 
1.3.1 Formation of the fetal testis and initiation of androgen production 
Sex determination in mammals results from the action of the Sex-determining region 
Y (Sry) gene (Sinclair et al., 1990). Sry is normally found on the Y chromosome but 
translocations may occur that cause individuals with an XX genotype to develop into 
males (Koopman et al., 1991). Prior to action of Sry at e10.5 embryos develop 
‘bipotential’ gonads independent of chromosomal sex, but expression of Sry causes 
the gonads to form into testes and begin production of androgens, which act to 
masculinise the male reproductive tract.  
 
The intermediate mesoderm thickens to form a pair of ur genital ridges first 
identifiable at e10 either side of the aorta. Three s gments emerge from each ridge, 
the transient pronephros, the mesonephros and the metanephros, which later develops 
into the kidney (Kuure et al., 2000). The gonads begin to form on the ventromedial 
side of the mesonephros beneath the coelomic epithelium at e10.5 and grow quickly 
over the next 48 hours through recruitment of somatic and germ cells. The primordial 
germ cell gamete precursors move from the allantois to the hindgut and then actively 
migrate to the developing urogenital ridges via the dorsal mesentery, where they 
continue to proliferate. Germ cell migration completes between e10-11.5 (Bendel-
Stenzel et al., 1998). The somatic supporting cell population of the bipotential gonad 
at this stage is recruited from the coelomic epithelium (Karl and Capel, 1998). 
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Several genes have been identified that are necessary for development of the 
bipotential gonad. Mutations in genes encoding steroidogenic factor 1 (Sf-1), Wilms' 
tumour suppressor 1(WT-1), Lim homeobox gene 9 (Lhx9) and empty-spiracles 
homeobox gene 2 (Emx2) result in regression of both XX and XY gonads befor  
differentiation (Wilhelm et al., 2007). 
 
The first stage of testis differentiation involves the expression of the transcription 
factor Sry at e10.5 in a sub-population of cells that have migrated from the coelomic 
epithelium to the gonad. At e11.5 the gonad is undifferentiated and only 6 cells thick, 
but by e12.5 the testis is easily discernable on the ventro-medial side of the 
mesonephros and the newly-formed seminiferous cords can be identified (Smith and 
Mackay, 1991). Early stages of testis formation include complex positive and 
negative feedback loops resulting in proliferation and recruitment of the supporting 
cell lineage of the testis (Sekido and Lovell-Badge, 2009). Cells expressing Sry 
differentiate into Sertoli cells (Palmer and Burgoyne, 1991). Sry combines with SF-1 
to upregulate expression of Sry-like HMG box 9 (Sox9) in pre-Sertoli cells almost 
immediately after Sry expression (Kent et al., 1996; Morais da Silva et l., 1996).  
 
Sry initiates a feed-forward loop between Sox9 and fibroblast growth factor 9 (Fgf9), 
which represses two independent signalling pathways, one involving the R-spondin1 
(Rspo1)/ wingless-type MMTV integration site family, member 4 (Wnt4)/β-catenin 
pathway and the other involving Foxl2. This results in differentiation of more Sertoli 
cells and commitment to a testis-specific fate (Kim et al., 2006). In females, the 
absence of the Sry stimulus prevents the feed-forward loop between Sox9 and Fgf9, 
and thus allows the Rspo1/Wnt4/β-catenin pathway and Foxl2 to block further Fgf9 
transcription, initiating the female-specific pathway. Thus, gonadal fate is dependent 
on which way the balance is tipped between the mutual antagonism of the male and 
female pathways. The ‘tipping point’ is the expression of Sry (Nef and Vassalli, 
2009). 
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Figure 1-6: A genetic model of sex determination 
The mutual antagonism of Sox9/Fgf9 and Foxl2/Rspo1/Wnt4 acts as a ‘balance’ that can tip 
the bipotential gonad towards either a testicular or ovarian fate. Arrows indicate stimulation; 
T bars indicate inhibition (Nef and Vassalli, 2009). 
 
The next stage of testis development involves the polarisation and aggregation of 
pre-Sertoli cells around the newly-migrated germ cells to form the seminiferous 
cords.  Peri-tubular myoid (PTM) cells are induced to differentiate and surround the 
cords, depositing the basal lamina (Frojdman et al., 1992). PTM differentiation, 
formation of the testis-specific vasculature and differentiation of fetal Leydig cells 
are all developmentally intertwined, and disruption of one of these processes often 
results in disruption of the other. For example, disruption in PTM cell differentiation 
resulting from a knockout of the desert hedgehog (Dhh) gene causes impairment of 
testis cord formation and fetal Leydig cell differentiation (Yao and Capel, 2002). 
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Migration of cells from the mesonephros induces cord formation (Tilmann and 
Capel, 1999) and differentiation of PTM cells from the interstitial cells derived from 
the coelomic epithelium (Cool et al., 2008). Inhibition of the development of the 
testis-specific coelomic vessel results in the absence of testis cords (Combes et al., 
2009). Fetal Leydig cells (FLCs) first appear in the mouse at around e12.5 as an 
inter-cord population expressing p450scc (Greco and Payne, 1994). There are several 
theories that FLCs arise from cells migrating from the neural crest, adreno-gonadal 
primordium, coelomic epithelium or mesonephros, or that they are present in the 
bipotential gonad but induced to differentiate by an unknown signal upon male sex 
determination. Currently none of these putative migratory populations, nor a resident 
gonadal population have been demonstrated to be an xclusive source of FLCs 
(Griswold and Behringer, 2009). Differentiation and development of FLCs is known 
to depend on a number of factors including the Sertoli cell products Dhh (Yao et al., 
2002) and platelet derived growth factor A (PdgfA) (Brennan et al., 2003), the 
PTM/endothelial product aristaless related homeobox gene (Arx) (Kitamura et al., 
2002) and steroidogenic factor 1 (SF-1) which is specifically required for induction 
of steroidogenic enzyme expression in FLCs (Jeyasuri  et al., 2004). Onset of 
expression of the necessary steroidogenic enzymes from e12.5 onwards (Greco and 
Payne, 1994) results in secretion of testosterone from e13 (Pointis et al., 2010). 
 
1.3.2 Masculinisation of the Wolffian duct by andro gens 
The internal genitalia develop from the paired Wolffian ducts in the male and 
Müllerian ducts in the female. Initial formation ofthese ducts is common to both 
male and female embryos. The Wolffian ducts initially develop from the transient 
embryonic pronephroi at e9.5 (Smith and Mackay, 1991). From e9 to e10.5, each 
Wolffian duct extends caudally through the mesonephros by the process of 
mesenchymal to epithelial transition, connecting with the cloaca (later the urogenital 
sinus) at its posterior end. Extension of the Wolffian duct induces condensation of 
surrounding mesenchyme into mesonephric tubules that lie perpendicular to the duct 
and elongating towards the coelomic epithelium. Meson phric tubules form along the 
whole length of the Wolffian duct, but whilst cranil tubules are attached to the duct, 
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the more caudal tubules are unattached (Sainio et al., 1997). Caudal tubules 
degenerate by apoptosis between e11 and e12, leaving cra ial tubules attached to the 
Wolffian duct at one end and terminating close to the lateral edge of the developing 
gonad. The Müllerian (paramesonephric) ducts form alongside the Wolffian ducts at 
e12 from invaginations of the mesonephric surface epith lium (Smith and Mackay, 
1991). Müllerian ducts grow in a cranial-caudal direction. At the cranial pole of the 
gonad they are lateral to the Wolffian ducts, but cross over as they reach the caudal 
mesonephros to appear on the medial side of the Wolffian ducts before termination in 
the urogenital sinus (Staack et al., 2003). The two ducts and mesonephric tubules 
persist alongside each other until the developing testes start to produce anti-




Figure 1-7: Development of the bipotential gonad, ducts and urogenital sinus into 
either a female-specific or male-specific physiology 
 
The male-specific fate of the bipotential duct system is regression of the Müllerian 
ducts and stabilisation and differentiation of the Wolffian ducts (Figure 1-7). The 
Wolffian duct is morphologically similar in male and female mice until e13-e14 
(Staack et al., 2003). Around this time, the fetal Leydig cells of the testes begin to 
produce testosterone and the Wolffian duct in male embryos starts to increase in size 
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compared to that of female embryos (Smith and Mackay, 1991). Wolffian duct 
growth is due to testosterone prevention of programmed cell death (Welsh et al., 
2009b). Around e12.5 the Sertoli cells of the fetal testis begin to produce AMH 
(Munsterberg and Lovell-Badge, 1991), which causes regression of the Müllerian 
duct in a cranial-caudal direction between e13 and e14 (Kobayashi and Behringer, 
2003). Regression occurs due to a combination of apoptosis and subsequent 
basement membrane disruption and epithelial-mesenchymal transition (Allard et al., 
2000). AMH receptor (Amhr2) is expressed in the peri-Müllerian mesenchyme, but 
not in the duct epithelium itself, implying that the regression is mediated by 
mesenchymal-epithelial signalling (Baarends et al., 1994) .  
 
Stabilisation of the male Wolffian duct is also due to mesenchymal-epithelial 
signalling, in this case by androgen signalling via androgen receptor (AR). Adult 
ARKO mice lack any Wolffian duct-derived structures due to the failure of the WD 
to stabilise (Welsh et al., 2009b; Yeh et al., 2002). Since both humans and mice with 
knock-out mutations in 5α-reductase develop a fully differentiated Wolffian duct, it 
is thought that testosterone rather than DHT is the androgen involved in Wolffian 
duct stabilisation and differentiation (Imperato-McGinley and Zhu, 2002; Mahendroo 
et al., 2001). AR mRNA is first identified in the mesonephric mesenchyme at e12.5 
(Crocoll et al., 1998), with functional protein identified at e13.5 (Cooke et al., 1991). 
AR mRNA has been identified in the Wolffian duct epithelium from e15.5 (Crocoll et 
al., 1998) but onset of significant levels of functional epididymal AR protein 
expression occurs in stages in a cranio-caudal direction from epididymis and vas 
deferens at e19.5, and seminal vesicles at post-natal d y 2 (Cooke et al., 1991). This 
pattern of AR protein expression onset is also seen in rats (Bentvelsen et al., 1995). 
Since onset of AR protein production in the epithelum of the WD occurs after its 
stabilisation at e15.5 (Welsh et al., 2009b) it hasbeen theorised that AR signalling 
within the mesenchyme is sufficient for initial stabilisation of the WD in fetal life. 
AR protein is not present in the mesenchyme or epith lium of the Müllerian duct 
(Drews et al., 2001). The expression of AR during development is thought to be 
induced by the presence of androgens (Bentvelsen et al., 1995). 
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Once the Wolffian duct has stabilised it then begins to differentiate into its three 
terminal organs: the epididymis, the vas deferens ad the seminal vesicles. 
Differentiation proceeds in a cranial-caudal direction. At e16, the cranial Wolffian 
duct begins the process of coiling and elongation that will result in the differentiation 
of the highly convoluted epididymis (Joseph et al.,2009; Welsh et al., 2009b). 
Three-dimensional coiling of the caput epididymis begins at e18. The straight tubule 
of the vas deferens arises from the medial region of the Wolffian and is surrounded 
by three layers of smooth muscle. At around e17 the caudal segment of the WD 
begins to distend and elongate in the initial stages of seminal vesicle formation 
(Staack et al., 2003). Initial differentiation of the three organs of the WD also occurs 
before onset of epithelial AR protein expression, implying that epithelial androgen 
receptor is also not required for these early patterning events. Tissue recombination 
experiments by Cunha and colleagues have provided insight into the relationship 
between the Wolffian duct epithelium and mesenchyme during this critical period of 
development. When epithelium from the anterior portion of the Wolffian ducts 
(which will form the epididymides), was grafted ont mesenchyme from the 
posterior Wolffian ducts (which will form the seminal vesicles), the epithelium was 
transformed to a seminal vesicle-like phenotype (Higgins et al., 1989). Grafting 
experiments have also confirmed the importance of mesenchymal AR by 
recombining Wolffian duct epithelium from androgen-insensitive Tfm embryos onto 
wild-type urogenital sinus mesenchyme. The Tfm epithelium of these recombinants, 
still underwent ductal and cellular differentiation resembling that of the prostate 
(Sugimura et al., 1986).  
 
AR signalling is vital for the early differentiation events of the three WD organs: 
male rats given the AR antagonist flutamide during development undergo WD 
stabilisation (possibly due to the dose of flutamide not being high enough to abolish 
all AR action) but the epididymal part of the Wolffian duct does not undergo its 
distinctive coiling (Welsh et al., 2006). Other genes that have been shown to be 
involved in patterning of the WD are inhibin beta A (Inhba) and some homeobox 
(Hox) genes. Inhba protein is present in a cranial to caudal gradient in the WD 
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mesenchyme, and epididymides of Inhba knockout mice do not undergo coiling, so it 
is possible that Inhba is induced to activate epididymal coiling by AR signalling in 
the mesenchyme (Tomaszewski et al., 2007). Both Hoxa10 and Hoxa11 mutant mice 
have a partial homeotic transformation of vas deferens to epididymis (Benson et al., 
1996; Hsieh-Li et al., 1995).  
 
The epithelium of the mesonephric tubules expresses AR protein at e16.5, three days 
before the Wolffian duct epithelium (Cooke et al., 1991). However, testosterone is 
not required to stabilise the mesonephric tubules, as they are often seen as peri-
ovarian remnants (also known as the paroophron) in female mice (Rosenfeld et al., 
2000). 
 
The female specific pathway of duct differentiation in the absence of testosterone 
and AMH results in the regression of the Wolffian duct and persistence of the 
Müllerian duct, which develops into the oviduct, uterine horns, cervical canal, and 
upper vagina (Kobayashi and Behringer, 2003).    
 
1.3.3 Masculinisation of the prostate and external genitalia by androgens 
Masculinisation of the remainder of the reproductive organs is also dependent on the 
action of testosterone. The prostate begins to develop from budding of the epithelium 
lining the UGS and cloaca at around e17 (Staack et al., 2003). The buds become 
tubular, branch and fuse behind the urethra forming its lobed structure (Thomson and 
Marker, 2006). The mesenchyme of the UGS expresses AR protein from e13.5, but it 
is not seen in the prostate epithelium until d4, implying that the prostate 
morphogenesis, like WD patterning, is dependent on mesenchymal not epithelial AR 
signalling (Cooke et al., 1991). In females, absence of androgen signalling results in 
the UGS developing into the lower portion of the vagin  (Marker et al., 2003). This 
is also seen in the ARKO mouse model (Yeh et al., 2002).  
 





Figure 1-8: Development of the bipotential external genitalia into either a female-
specific or male-specific physiology 
 
The male and female external genitalia develop from the same anlagen, namely the 
genital tubercle, genital swellings and urethral fods, all of which express 
mesenchymal AR (Drews et al., 2001). Under the influence of androgens the genital 
tubercle elongates to form the body of the penis, the urethral folds elongate and fuse 
to form the penile urethra and the urogenital swellings fuse to form the scrotum 
(Johnson and Everitt, 2000). In females, absence of androgen signalling results in the 
genital tubercle becoming the clitoris, urethral folds become the labia minora and the 
urogenital swellings form the labia majora. A female pattern of external genitalia 
development is also seen in the ARKO mouse model (Yh et al., 2002). Hypospadias 
(the incomplete fusion of the urethral folds resulting in incorrect placement of the 
urethral meatus) is present in rats treated with the AR-antagonist flutamide (Welsh et 
al., 2008). DHT is thought to be the androgen that m sculinises both the prostate and 
external genitalia during embryonic development in humans, as both are under-
developed in men with 5α-reductase type 2 mutations (Imperato-McGinley and Zhu, 
2002). However, mice with genetic ablation of both 5α-reductase isoforms have an 
under-developed prostate, but normally virilised external genitalia, suggesting that 
testosterone is sufficient for external genitalia msculinisation in mice (Mahendroo et 
al., 2001).  
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1.3.4 Descent of the testes under the influence of androgens 
Testis descent occurs in two phases: the trans-abdominal phase when testes migrate 
from the urogenital ridge to above the inguinal ring occurs from e16 until just before 
birth, and the inguinoscrotal phase when testes migrate through the inguinal canal 
into the scrotum, occurs at around d21 (Hughes and Acerini, 2008). The trans-
abdominal phase requires the action of the Leydig cell-derived insulin-like 3 (Insl3) 
which promotes thickening of the gubernaculum, the ligament that connects the testis 
to the inguinal canal (Nef and Parada, 1999; Zimmermann et al., 1999). This results 
in the testis being drawn towards the inguinal ring. Androgens are also known to play 
a role in trans-abdominal descent preventing the outgr wth of the cranial suspensory 
ligament and so allowing the embryonic testis to move caudally from the diaphragm 
(Emmen et al., 1998; van der Schoot and Elger, 1992). The inguinoscrotal phase of 
descent is predominantly controlled by androgens, occurring just after birth at the 
same time as the neonatal surge in testosterone levels. ARKO mice are cryptorchid 
with testes found in the low abdominal area close t the internal inguinal ring (Yeh et 
al., 2002). The gubernaculum contracts and relaxes in response to a concentration 
gradient of calcitonin gene-related peptide (CGRP) released from the sensory 
neurons of the genital branch of the genitor-femoral nerve (GFN) (Park and Hutson, 
1991). Androgens are thought to mediate a sex-dimorphic differentiation of the GFN 
as prenatal administration of an AR-antagonist in rats inhibited the development of 
the GFN nucleus in the spinal cord and resulted in cryptorchidism (Shono et al., 
2004). 
 
1.4 Actions of androgens in the adult testis 
1.4.1 Testicular histology: an overview 
 
The testes of mammals are paired organs that perform two functions: the production 
of spermatozoa (spermatogenesis) and synthesis of steroid hormones 
(steroidogenesis). The testis consists of numerous u-shaped seminiferous tubules that 
begin and end in the rete testis, a network of anastomotic channels lined with 
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cuboidal epithelium located at the vascular pole of the testis through which sperm 
pass as they exit the testis into the efferent ducts. The seminiferous tubules are 
embedded in a vascularised interstitial stroma and the structure is encased by a 
connective tissue capsule: the tunica albuginia. Spermatogenesis takes place in the 
seminiferous epithelium lining the seminiferous tubules, and is supported by 
intratubular somatic Sertoli cells (Figure 1-9). The seminiferous epithelium 
interfaces with a lumen into which spermatozoa are rel ased. Seminiferous tubules 
are surrounded by a basement membrane and a layer of contractile peri-tubular 
myoid (PTM) cells that cause peristalsis to move th luminal spermatozoa towards 
the rete testis. The interstitium consists of steroidogenic Leydig cells, mesenchymal 
cells, macrophages and blood and lymphatic vessels. Communication between the 
interstitium and the tubules is possible via release of paracrine factors that are 
transported between the compartments. Blood vessels ar  not found inside the 
seminiferous tubules and the tubule is divided intophysiologically distinct adluminal 
and basal layers separated by the ‘blood-testis barrier’: junction complexes between 
Sertoli cells that act to keep maturing haploid germ cells separate from the rest of the 
testis. This helps avoid an adverse immune response t  permatozoal antigens, and to 
regulate the conditions specific to the germ cells.  





Figure 1-9: Architecture of the testis 
(a): haematoxylin and eosin stained thin-section of the testis, showing the arrangement of 
the seminiferous tubules (scale 100µm) (b): schematic diagram showing the cell types of the 









After puberty begins, quiescent pro-spermatogonial germ cells undergo a process of 
mitotic proliferation followed by meiotic division to produce spermatozoa: the 
mature sperm cells. Spermatogenesis in mice can be summarised as three distinct 
phases:  
• Mitosis of one spermatogonia to form many spermatocytes  
• Meiosis of each spermatocyte to form 4 haploid spermatids 
• Metamorphosis of round spermatids into elongated spermatids and then 
spermatozoa involving a process of cellular remodelling.  
 
1.4.2.1 Mitosis: spermatogonia to spermatocytes 
The mitotic phase of spermatogenesis (also known as spermatocytogenesis) takes 
place in the basal compartment of the seminiferous tubule. There are three different 
types of spermatogonia, the undifferentiated stem cell spermatogonia, dividing 
spermatogonia and differentiating spermatogonia (Hermo et al., 2010). Type A single 
(As) spermatogonia are the diploid spermatogonial stem c lls found proximal to the 
basement membrane in the seminiferous epithelium. When an As spermatogonia 
undergoes mitosis it forms a pair of daughter cells connected by an intracellular 
cytoplasmic bridge. These cells either separate to become two As cells (and thus 
renew the As stem cell population), or continue to remain connected as A paired (Apr) 
spermatogonia. Apr spermatogonia both undergo mitosis to form 4 A aligned (Aal) 
spermatogonia, arranged side by side.  These undergo two further mitoses to form a 
string of 16 Aal spermatogonia, and a further mitosis differentiates them into a clone 
of 32 A1 spermatogonia. Further mitoses form A2, 3, A4, Intermediate (I) and type 
B spermatogonia. In mice, A, I and B-type spermatogonia can be identified in thin 
section, with type A having a pale nucleus, type I a ‘speckled’ nucleus and type B a 
dark nucleus. B spermatogonia further divide to give primary spermatocytes in the 
last mitotic division of spermatogenesis. Through the process of these mitotic 
divisions one spermatogonium should theoretically yield 2048 spermatocytes. The 
actual number of spermatocytes generated by one spermatogonium is estimated to be 
much lower due to apoptosis (Billig et al., 1995). Points of this theory are contested 
Chapter 1: Literature review          
 
29 
between research groups. It is still debated whether As cell division is symmetrical 
(forming two daughter cells committed to renewal or differentiation) or asymmetrical 
(producing one daughter cell committed to renewal and one committed to 
differentiation) (Oatley and Brinster, 2008) and whether or not Apr and Aal 
spermatogonia, in case of cell loss, for example because of irradiation or the 
administration of a cytostatic drug, can ‘de-differentiate’ and become stem cells 
again (Nakagawa et al., 2007).  
 
The microenvironment of spermatogonial stem cells is called their ‘niche’, and is 
formed by the contributions of surrounding cells. Of particular note are the 
contributions of Sertoli cells, which produce glial cell line derived neurotrophic 
factor (GDNF) which stimulates spermatogonial self-r newal and proliferation, and 
stem cell factor (SCF) which promotes spermatogonial differentiation (de Rooij, 
2009). Retinoic acid is essential for male fertility and deficiency leads to 
degeneration of spermatogenesis through arrest of nrmal spermatogonial 




Figure 1-10: Stages of spermatogenesis in the mouse 
Note the number of germ cells present after each step (Ehmcke et al., 2006). 
 
1.4.2.2 Meiosis: spermatocytes to spermatids 
The primary spermatocytes migrate from the basal compartment of the seminiferous 
tubule and enter the adluminal compartment, where each undergoes a round of 
meiosis to form four haploid spermatids. Meiosis is a process unique to germ cells 
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that involves one round of DNA replication followed by two consecutive cell 
divisions, allowing diploid germ cells to form haploid germ cells (Kerr et al., 2006). 
The two cell divisions are known as meiosis I and meiosis II (Figure 1-11).  
 
Primary spermatocytes undergo meiosis I. The prophase of meiosis I takes up 90% of 
the time of meiosis. It is at this stage that DNA synthesis takes pace to replicate 
chromosomes, and that the chromosomes of the diploi cell undergo crossing over 
(recombination of portions of DNA between homologous chromosome pairs). 
During prophase chromosomes condense (leptotene), come together in their 
homologous pairs (zygotene) via a protein complex called the synaptonemal complex 
(Zickler and Kleckner, 1999), undergo crossing over at chiasmata (pachytene) and 
begin to separate (diplotene). During the diakinesis phase of meiosis the nuclear 
membrane begins to disintegrate and the spindle beings to form. Recombination 
during crossing over introduces genetic variation into the population of sperm. 
Pachytene spermatocytes are particularly obvious in testicular thin sections because 
they appear very large after a period of sudden cytoplasmic and nuclear growth in 
this phase. Next, during metaphase I, homologous chromosomes align along an 
equatorial plane that bisects the spindle. Alignment is random, which adds more 
genetic variation to the population of sperm. During anaphase I, the microtubules 
that make up the spindles shorten, pulling the homol gous chromosomes apart 
towards opposing poles of the cell. During telophase I, the chromosomes arrive at the 
cell poles, the spindle disappears and new nuclear membranes form around each 
haploid set of chromosomes. Cytokinesis is the process of the division of the cell 
cytoplasm into two separate daughter cells, each containing a haploid set of 
chromosomes, still present as sister chromatids.  
 




Figure 1-11: Schematic of meiosis, showing the different stages of meiosis I and meiosis II 
Figure  
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After a period of rest (interphase) in which the chromosomes are present as 
decondensed chromatin, the cell enters meiosis II, which is similar to mitosis. Cells 
that are undergoing meiosis II are known as secondary spermatocytes, but this cell 
type is rarely seen in testicular thin sections because of the fast progression of 
meiosis II.  In prophase II the nuclear envelope again breaks down and the 
chromatids begin to condense. In metaphase II, the individual chromosomes (still 
consisting of two chromatids) line up on the spindle in the same orientation. In 
anaphase II the two sister chromatids of each chromos e are pulled apart to 
opposite poles of the cell. The process ends with telophase II, which is similar to 
telophase I, and is marked by uncoiling and lengthening of the chromosomes and the 
disappearance of the spindle. Nuclear envelopes reform and cleavage or cell wall 
formation eventually produces a total of four haploid daughter cells, known as 
spermatids. 
1.4.2.3 Metamorphosis: spermatids to spermatozoa 
The metamorphic stage of spermatogenesis (also known as spermiogenesis) is where 
spermatids undergo a profound morphological change from radially symmetrical 
cells with large nuclei to elongated polar cells with tails and highly condensed 
heterochromatin before being released into the lumen of the seminiferous tubules and 
into the reproductive tract (Figure 1-12).   
 
 
Figure 1-12 Morphological changes of the spermatid during spermiogenesis  
(http//www.embryology.ch) 1= axonemal primordium, 2= Golgi apparatus 3=Golgi vesicles, 
4= pair of centrioles 5= mitochondrion, 6= nucleus, 7= developing axoneme, 8=manchette 
microtubules, 9=tail piece, 10= acrosome 
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During spermiogenesis, the size of the spermatid head decreases to  approximately 
5% of the size of a somatic cell nucleus (Brewer et al., 1999). This occurs through 
replacement of the major nuclear proteins: the histones, with transition proteins, and 
finally protamines. Protamines are small, basic proteins that are thought to allow 
denser DNA packaging than histones and maintain the majority of the DNA in a 
highly condensed transcriptionally-inactive state (Braun, 2001). Despite this, 
between 2 and 15% of the genome essential for early embyronic development 
remains bound to histones (Ward, 2010).  
 
The acrosome is a membrane bound lysosomal organelle that contains digestive 
enzymes including hyaluronidase and acrosin to allow a mature spermatozoa to break 
through the zona pellucida of the ovum (Abou-Haila and Tulsiani, 2000). The 
acrosome begins to form in the round spermatid when vesicles produced by the Golgi 
apparatus accumulate and fuse at one pole of the spermatid. The acrosome is closely 
associated with the nuclear membrane, and as the head elongates it stretches it to 
form a ‘cap’. In the mouse, head elongation occurs in the latter half of 
spermiogenesis (from step 9) and gives rise to elongati g spermatids. Head 
elongation occurs at the same time as the formation of the manchette, a perinuclear 
ring linked to bundles of microtubules that is thought to be involved in head 
elongation and tail formation (Toshimori and Ito, 2003). In mice and rats the head of 
the spermatozoa containing the acrosome is shaped lik  a hook (Breed, 2004).  
Abnormalities in sperm head shaping result in teratozoospermia, including the 
specific disorder globozoospermia, which occurs when the sperm does not develop 
an acrosome (Borg et al., 2010). 
 
 
Figure 1-13: Variations in acrosome morphology in rat, mouse and man  





The distinctive flagellum (tail) of the sperm originates from a pair of centrioles 
(proximal and distal). The motile core of the flagellum, called the axoneme 
(Kierszenbaum, 2002), originates from extension of the distal centriole, assisted by a 
structure called the manchette. The axoneme consists of a bundle of nine peripheral 
double microtubules with two single ones in the centre. During its development, 
through the rotation of the nucleus and acrosomal vesicle, the flagellum primordium 
comes to lie on the opposite side of the acrosome. Th  mature flagellum consists of a 
neckpiece closest to the nucleus, which contains the centriole, a midpiece which 
consists of a sheath of mitochondria surrounding the axoneme to provide energy for 
movement, a principal piece consisting of ring fibres around the axoneme and an 
endpiece which consists only of the axoneme (Borg et al., 2010). Spermatozoa 
orientate so that their tails point towards the centre of the lumen, away from the 
epithelium.  
 
During spermiogenesis the spermatid cytoplasm is displaced to the caudal end of the 
elongating nucleus. Just before spermiation (releas of sperm into the lumen of the 
seminiferous tubule) the majority is sloughed off as the residual body, though some 
remains attached as the cytoplasmic droplet. The cytoplasmic droplet contains 
aromatase (Janulis et al., 1996), and is retained i rodents until it is lost during 
epididymal transit, coinciding with maturation (Hermo et al., 1988). The residual 
body is phagocytosed by Sertoli cells under the influence of androgens (Beardsley 
and O'Donnell, 2003). They can be clearly seen in stage IX seminiferous tubule 
sections as basophilic vesicles being drawn down towards the basement membrane 
by Sertoli cells (Borg et al., 2010). Also thought to be involved in cytoplasmic 
reduction are tubulobulbar complexes (TBCs): long tubular projections of the 
spermatid plasma membrane that end in a bulbous swelling in the apical process of 
the supporting Sertoli cell (Russell, 1979). Spermiation involves complex 
remodelling of the Sertoli-germ cell junctional complexes (Mruk and Cheng, 2004). 
These spermatozoa are morphologically mature but lack motility.  
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1.4.2.4 The cycle of the seminiferous epithelium an d the spermatogenic wave 
The mechanism and duration of spermatogenesis shows differences between species.  
It takes a mouse 35 days to produce a mature clone of spermatozoa from one type A 
spermatogonia and 64 days for a human (Johnson and Everitt, 2000; Oakberg, 1956). 
In mice, a transverse section through a seminiferous tubule reveals that germ cells at 
specific maturational stages are always found together. These ‘sets’ of germ cells can 
be classed into one of 12 different stages in mice. A seminiferous tubule cross 
section can always be designated at one of these stag s because spermatozoa in that 
vicinity initiate a new round of spermatogenesis at the same time: known as the cycle 
of the seminiferous epithelium. If an individual seminiferous tubule is dissected and 
laid out longitudinally, it appears that adjacent tubule segments have entered the 
spermatogenic process slightly out of phase with each other. For example, a segment 
of the seminiferous tubule that can be classified at st ge V will have a segment at 
stage IV on one side and VI on the other. This is known as the spermatogenic wave.  
These levels of organisation allow a constant supply of mature spermatozoa to be 
available for fertilisation. In humans it is slightly different, a cross section through a 
seminiferous tubule will show ‘wedges’ of delinearis tion containing similar cell 
associations in the same way as the mouse seminiferous tubule, but several different 
sets of cell associations could be present in the same tubule cross section (Johnson 
and Everitt, 2000) .  
 
 




Figure 1-14: The cycle of the seminiferous epithelium in mice 
Stages are indicated by roman numerals (In= intermediate spermatogonium, B= type B 
spermatogonium, Pl= preleptotene spermatocyte, L= leptotene spermatocyte, P= pachytene 
spermatocyte, D= diplotene spermatocyte, 1-16= stages of spermatid morphogenesis) From 
(Russell et al., 1990). 
 
Figure 1-15: The spermatogenic wave 
Note that whole segments of the tubule are at the same stage of the cycle of the 
seminiferous epithelium, and that adjacent segments tend to be either just advanced or just 
retarded (Johnson and Everitt, 2000). 
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1.4.3 Somatic cell types of the adult testis and th eir control by androgens 
 
Dependence of spermatogenesis on the action of androgens has been documented in 
models of hypophysectomy (Russell and Clermont, 1977), interference with 
gonadotropin action (Russell et al., 1981) and Leydig cell ablation by administration 
of ethane dimethanesulfonate (EDS) cells (Bartlett et al., 1986). Local testicular 
testosterone levels are much higher those found in serum (Maddocks et al., 1993). 
Despite their dependence on androgens for their survival and maturation, the germ 
cells of the murine testis do not express androgen receptors (O'Donnell et al., 2006) 
and germ cell specific androgen receptor expression i  not required for their normal 
maturation (Johnston et al., 2001; Tsai et al., 2006). However, the somatic Sertoli, 
peri-tubular myoid (PTM) and Leydig cells of the mature testis do express androgen 
receptor (Zhou et al., 2002), and it is likely that the requirement of testosterone for 
germ cell maturation is mediated by these cell types. Global models of androgen 
disruption can describe what processes in the testis rely on AR signalling, but they 
cannot elucidate which cell type(s) mediate these processes. It must also be noted 
that aromatisation of androgens to estradiol also occur in the testis, and reduction of 
androgen levels also results in changes in estradiol levels. Cell-specific ablation of 
AR in the testis using the Cre-loxP system is an ideal technique to elucidate both the 
cell and AR-specific actions of androgens in the testis, and information gained using 
this technique is described here. 
 
1.4.3.1 Sertoli cells 
Sertoli cells are known as the ‘nurse’ cells of spermatogenesis, as they are 
mesoepithelial somatic cells that coordinate and structurally support the maturing 
germ cells. Each Sertoli cells spans the tubule from the basement membrane to the 
tubule lumen, and is tightly linked to a set of germ cells at specific stages by different 
types of junction protein complexes (Mruk and Cheng, 2004). Sertoli cells have a 
very large surface area, but their cytoskeleton is well-developed and assists in 
maintaining their shape (Vogl et al., 1993) as well as providing a scaffold for the 
movement of germ cells (Lie et al., 2010). The leve of organisation of 
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spermatogenesis implies temporal and spatial organisation among the maturing germ 
cells that is likely to be controlled by Sertoli cells. Adjacent Sertoli cells are in 
continuity via connexin gap junction complexes so communication v a exchange of 
small molecules and ions could synchronise adjacent Ser oli cells (Pointis et al., 
2010). 
 
Tight junctions between adjacent Sertoli cells above the level of leptotene 
spermatocytes form the blood-testis barrier (BTB), a structure that partitions the 
adluminal compartment of the seminiferous tubule from the basal compartment so 
haploid germ cells can mature in an immunologically privileged site with a 
specialised environment (Dym and Fawcett, 1970). Maturing sperm move apically 
along the Sertoli cell, traversing the BTB during meiosis, then elongating spermatids 
appear to be drawn back down towards the basement membrane in Sertoli cell crypts 
before being released into the lumen during spermiation. Cell movement across the 
BTB is thought to be controlled by transforming growth factor β (TGFβ) and tumour 
necrosis factor α (TNFα) mediated perturbation, and testosterone-promoted 
reformation of the BTB junctions (Li et al., 2006; Lui et al., 2003; Wang et al., 
2006). Movement of elongating spermatids across the seminiferous epithelium is 
largely assisted by ectoplasmic specialisations (‘ES’, a type of adherens junction 
unique to the testis) between the spermatids and their supporting Sertoli cell (Wong 
et al., 2008). It has been postulated that spermatids can use their ES junctions to 
move along the microtubules of their supporting Sertoli cell like a train on a track 
(Guttman et al., 2000). Release of the sperm from the seminiferous epithelium during 
spermiation involves the replacement of the apical ES by TBCs: it has been 
hypothesised that TBCs function to internalise compnents from disassembled apical 
ES junctions in preparation for the release of spermatids (Guttman et al., 2004). 
Evidence is accumulating that fragments of laminin chains produced during 
spermiation induce remodelling of the BTB, thus intimately coordinating these two 
processes (Cheng and Mruk, 2009). 
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Mature Sertoli cells are also highly active synthetic and secretory cells. Sertoli cells 
synthesise and secrete the endocrine hormones inhibins and activins which work 
together to regulate FSH secretion. They are requird to synthesise and secrete 
products that are essential for growth and differentiation of developing germ cells: 
due to the BTB the post-meiotic germ cells cannot obtain these from the systemic 
circulation. An example is transferrin, a protein required for iron delivery (Sylvester 
and Griswold, 1994). At puberty the Sertoli cells begin to secrete fluid that opens and 
maintains the lumen of the seminiferous tubules (Rato et al., 2010). Sertoli cells also 
produce androgen binding protein (ABP) which binds to testosterone to sequester it 
at high concentrations in Sertoli cells and can also be exocytosed into luminal fluid 
and carried to the epididymis (Munell et al., 2002). Sertoli cells also influence their 
neighbouring spermatogonia by producing growth factors that stimulate stem-cell 
self-renewal (including GDNF) and differentiation (de Rooij, 2009).  
 
Androgen receptors are not present in the Sertoli cells of the mouse until d4-6 of 
postnatal life (Willems et al., 2009). After maturation, the expression of AR in 
Sertoli cells fluctuates in a seminiferous tubule stage-specific manner (Zhou et al., 
2002), appearing strongest at in stages VI–VII weakest at stages I–III and VIII–XII. 
The Sertoli-cell specific AR knockout (SCARKO) mouse line was created by two 
groups using an inserted Cre recombinase coding sequence driven by an anti-
Müllerian hormone promoter (Chang et al., 2004; De Gendt et al., 2004). Until the 
advent of the SCARKO mouse it was difficult to pinpoint how androgens acted via 
Sertoli cells to promote normal spermatogenesis without having to resort to in vitro 
models and their unavoidable limitations with regard to physiological relevance. The 
SCARKO mouse demonstrated that action of androgens in Sertoli cells is vital for 
progression of germ cells through meiosis.  
 
The testes of SCARKO mice develop normally with an external phenotype and 
weight similar to their control male littermates, with fully descended testes and intact 
Wolffian duct-derived structures, unlike the ARKO model where they are absent 
(Yeh et al., 2002). However at post-natal day 50 their testes were approximately a 
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third of the weight of their wild type littermates’ and were found to contain few post-
meiotic germ cells more advanced than pachytene primary spermatocytes indicating 
a meiotic block. A subsequent study suggested that tight junctions in the SCARKO 
can form, but BTB formation is delayed and incomplete (Willems et al., 2010). A 
decrease in levels of cytoskeletal and junctional proteins was also seen in a study of 
the Chang SCARKO (Wang et al., 2006). Gene expression comparison studies have 
also indicated that genes related to cytoskeletal dynamics and junction formation are 
differentially expressed between SCARKO and control animals (Denolet et al., 2006; 
Eacker et al., 2007). Changes in cytoskeletal genes ar  also seen in the Tfm mouse 
(O'Shaughnessy et al., 2007). Data suggest that abltion of AR in Sertoli cells results 
in early changes in gene expression (Denolet et al., 2006; Willems et al., 2009) so it 
is likely that transcriptional changes soon after the onset of AR expression induce 
maturational changes.  
It is important to note that mice with a Sertoli cell-specific ablation of the second 
zinc finger domain (vital for DNA binding) display a similar post-meiotic block 
phenotype, indicating that progression of spermatocytes through meiosis is an event 
dependent on classical genomic signalling of androgens (Lim et al., 2009). The two 
groups differed in analysis of the levels of testosterone and LH in their SCARKO 
models; where De Gendt and colleagues found these two hormones to be normal in 
adult mice, the Chang group found LH to be high and testosterone to be low. 
Spermatogonia (De Gendt et al., 2004) and Sertoli cel  numbers do not differ 
between SCARKOs and controls (Tan et al., 2005) but Leydig cell numbers in this 
model are lower than controls (De Gendt et al., 2005). Another study created a 
‘hypomorphic’ SCARKO with Sertoli cell-specific ablation of AR action, but also a 
general reduction in levels of AR protein throughout the whole body due to a 
phenotypic effect from the placing of the loxP sites in the transgenic AR (Holdcraft 
and Braun, 2004). The germ cells of these mice do go through meiosis but have a 
block at the round spermatid stage, which is surprising as this is a less severe 
phenotype than mice with SCARKO which do not have a r duction in AR protein in 
the remainder of the testis and other organs of the reproductive system. 
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Because of the presence of the post-meiotic block in SCARKO mice it is impossible 
to pinpoint the contribution of Sertoli cell AR signalling to subsequent stages of 
spermatogenesis. Rats with implants containing low-d se testosterone and estradiol 
reduce testicular T levels to 3% of control via suppression of LH (McLachlan et al., 
2002). ‘TE implanted’ rats have been used to determine that both spermatid 
maturation and spermiation are dependent on androgens. TE implantation results in a 
complete block in conversion of round spermatids into elongating spermatids 
(O'Donnell et al., 1994). Large numbers of round spermatids accumulate in cauda 
epididymis indicating that they are detaching from the seminiferous epithelium 
(O'Donnell et al., 1996). Despite this, ES in these mice are normal so it is likely to be 
defects in adhesion molecules that are causing detachment (O'Donnell et al., 2000). 
Spermiation is very sensitive to testosterone or FSH withdrawal in rats (Matthiesson 
et al., 2006). Spermiation failure is noted in TE rats, characterised by spermatid 
retention with subsequent phagocytosis by Sertoli cells (Saito et al., 2000). 
Tubulobulbar complexes and removal of ES are not affected by hormone withdrawal, 
but final disengagement is affected (Beardsley and O'Donnell, 2003). A similar 
phenotype is seen in the ‘hypomorphic’ AR mice with a reduction in AR protein 
throughout the body, with a reduction in numbers of round and elongating spermatids 
and evidence of spermiation failure (Holdcraft and Braun, 2004). Although defects in 
spermatid adhesion and spermiation cannot be definitively assigned to AR signalling 
in the Sertoli cell (because AR signalling is reduced in all testicular cell types), it is 
likely that the Sertoli cell is responsible due to the isolated environment in which 
post-meiotic germ cells develop due to the BTB. 
 
1.4.3.2 PTM cells 
Seminiferous tubules are surrounded by a layer of peri-tubular myoid (PTM) cells. 
PTM cells are contractile: this is thought to produce peristaltic waves in the 
seminiferous tubules that propel mature spermatozoa tow rds the rete testis (Farr and 
Ellis, 1980). Contractility is stimulated by endothelin-1 and inhibited by 
adrenomedullin, both of which are produced by the Sertoli cells (Romano et al., 
2005; Tripiciano et al., 1996). PTM cells also synthesise the basement membrane 
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components laminin, collagen and fibronectin in co-operation with Sertoli cells 
(Richardson et al., 1995; Skinner et al., 1985). These functions illustrate that, like 
other tissues in the reproductive system, a reciproal relationship exists between the 
mesenchymal (PTM) and epithelial (Sertoli) cells of the testis, which is vital for the 
structure and function of both cell types. Like thedeveloping reproductive tract, the 
mesenchymal PTM cells are the first cell in the testis to express AR: at or before 
e16.5 in the mouse (Drews et al., 2001) and at e18.5 in the rat (Majdic et al., 1995; 
You and Sar, 1998). Cell-specific ablation of AR in the PTM cells has been achieved 
using Cre/loxP transgenic mice (PTM-ARKO), and has shown that AR in PTM cells 
is essential for male fertility (Welsh et al., 2009a). PTM-ARKO testes are 70% 
smaller than controls because of a reduction in numbers of all germ cell stages 
including the spermatogonia, so it is likely that spermatogonia number may be 
regulated by AR signalling in PTM cells, which are in intimate proximity to the 
spermatogonia. The decrease in germ cells is not due to a decrease in Sertoli cell 
number, as SC is not reduced in PTM-ARKO mice. However, levels of Sertoli cell-
specific gene products including Rhox5, eppin (Epp) and β-tubulin (tubb3) are 
reduced in PTM-ARKO testes, implying that AR signalli g in PTM cells has an 
effect on the neighbouring Sertoli cells. Since PTM cells in the PTM-ARKO also 
demonstrate a progressive loss of desmin and SMA it is l kely that loss of AR is 
affecting the smooth muscle phenotype in PTM cells, and a disruption of laminin 
indicates problems with the basement membrane of the seminiferous tubules.  
In vitro evidence has demonstrated that androgens can stimulate PTM cells to secrete 
a factor dubbed P-mod-S (Skinner and Fritz, 1985) that modulates Sertoli cell 
function (Norton and Skinner, 1989). Attempts have be n made to purify (Skinner et 
al., 1988) and classify (Norton et al., 1994) P-mod-S but it remains as yet 
unidentified, and is disputed by some investigators (Verhoeven et al., 2000).  
 
1.4.3.3 Leydig cells 
The Leydig cells are the steroidogenic cells of the testis (section 1.2). In rodents 
there are two phases of Leydig cell development: fetal Leydig cells (FLCs) and adult 
Leydig cells (ALCs) (Lording and De Kretser, 1972). Both populations are 
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steroidogenic and synthesise and secrete androgens, although there is variation in 
nature of steroids secreted and control mechanisms regulating cell function. FLC 
development is discussed in section 1.3.1. FLCs produce testosterone during 
embryogenesis to masculinise the reproductive tract. FLCs do not express AR 
(Drews et al., 2001) so it is unlikely that fetal steroidogenesis is influenced by 
androgen signalling. Testosterone output of fetal Leydig cells drops sharply around 
birth (O'Shaughnessy et al., 2009) but they appear to persist in the adult testis (Kerr 
and Knell, 1988). The adult population of Leydig cells begins to differentiate at pnd7 
in the mouse (Baker et al., 1999; Nef and Parada, 1999).  
 
Experiments in rats have led to the characterisation of several stages of ALC 
maturation: progression from stem Leydig cells (SLCs) to progenitor Leydig cells 
(PLCs) to immature Leydig cells (ILCs) then finally to ALCs (Chen et al., 2009a). 
Each stage of maturation involves morphological andtranscriptional changes. There 
is conflicting evidence for the location of the SLC population: although some 
evidence is present for vascular smooth muscle cells/p ricytes (Davidoff et al., 2004) 
it is commonly accepted that SLC population is present in peritubular mesenchymal 
cells (O'Shaughnessy et al., 2008; Siril Ariyaratne et al., 2000). PLCs are cells that 
have committed to the ALC lineage. They are still spindle-shaped but express low 
levels of Leydig cell markers including p450scc 3βHSD and 17α-hydroxylase. They 
also begin to express luteinising hormone receptor (LHR) and AR, expression of 
which then persists into the adult stage. Morphological and functional maturation of 
the adult Leydig cell population is dependent on LHstimulation: mice lacking 
gonadotropin signalling only develop 10% of the contr l ALC number (Baker and 
O'Shaughnessy, 2001). PLCs secrete mainly androsterone (Shan et al., 1995). Their 
transformation to ILCs involves a morphological change with an increase in smooth 
ER and levels of steroidogenic enzymes (Dupont et al., 1993; Shan et al., 1995). But 
ILCs also express high levels of androgen metabolising enzymes, so their primary 
steroid product is the androgen metabolite androstanediol rather than testosterone 
(Ge and Hardy, 1998). The adult Leydig cell population results from a decrease in 
androgen metabolising enzymes and continued increase in teroidogenic enzymes, 
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resulting in predominance of testosterone biosynthesis. These stages have been 
characterised in vitro in mice (Wu et al., 2010). Mouse ALC precursors do not begin 
to proliferate extensively until p11 (Vergouwen et al., 1991) and do not express 
steroidogenic genes until around d30, corresponding with an increase in circulating 
LH levels (O'Shaughnessy et al., 2000; O'Shaughnessy and Sheffield, 1991; 
O'Shaughnessy et al., 2002b).  
 
It is difficult to identify the age of onset of AR expression in the post-natal Leydig 
cells populations due to changes in morphology and gene expression of the 
differentiating Leydig cell types. Interstitial cells AR staining is evident throughout 
fetal (Drews et al., 2001) and early postnatal life (Willems et al., 2009), but since 
SLCs and PLCs share their spindle-shaped cell morphology with mesenchymal 
stromal cells it is difficult to differentiate between the two cell populations. Obvious 
ILC staining is present from d21 onwards (Zhou et al., 1996). Intensity of its 
expression is variable (Zhou et al., 2002). An attempt to create a Leydig cell-specific 
AR knock-out mouse using the Cre/loxP system used AMHR2-Cre as the promoter 
for Cre (Xu et al., 2007). LC-ARKOs demonstrated a reduction in testosterone 
secretion and testicular size and a block at the round spermatid stage which led to 
infertility. However, since AMHR2 is also present i Sertoli cells the contribution of 
AR ablation in this cell type complicates the phenotype (Jeyasuria et al., 2004). 
Because of this, most current knowledge about the role of AR in Leydig cells has 
been gained from the Tfm mouse.  
 
Leydig cell number in Tfm mice is 60% of controls (O'Shaughnessy et al., 2002a) 
and serum testosterone levels are severely decreased despite high levels of LH 
(Goldstein and Wilson, 1972; Murphy and O'Shaughnessy, 1991). Levels of 
steroidogenic enzyme mRNAs (Murphy et al., 1994; O'Shaughnessy et al., 2002b)  
and protein activities (Blackburn et al., 1973; Murphy and O'Shaughnessy, 1991) are 
severely reduced in the Tfm testis, Since there is no defect of testosterone sy thesis in 
the fetal Tfm testis, it is likely that AR is required for maturation of adult Leydig cells 
and the increase in steroidogenic enzyme expression that this brings (Blackburn et 
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al., 1973), further backed up by the positive effect of testosterone on maturation of 
rat Leydig cells in vitro (Hardy et al., 1990). It is currently thought that LH and 
androgens work together to support pubertal maturation of PLCs to steroidogenically 
active ILCs (Hardy et al., 1990; Murphy et al., 1994).  
 
There is also evidence for paracrine regulation of Leydig cells by AR signalling in 
other testicular cell types. In SCARKO mice there is a reduction in Leydig cell 
number but LH and testosterone levels are identical to controls, explained by the fact 
that steroidogenic genes are upregulated in SCARKO Leydig cells (De Gendt et al., 
2005). The mechanism of how Sertoli cells regulate Leydig cell number is unclear at 
this time. PTM-ARKO mice have normal levels of serum testosterone but elevated 
levels of serum LH, suggesting that there is compensatory Leydig cell failure (Welsh 
et al., 2009a). Further work indicated that this was due to the presence of two 
populations of Leydig cells in the adult PTM-ARKO tes is, both normal ALCs and 
‘abnormal’ Leydig cells which are potentially arrest d in their development at a less 
mature stage (Welsh et al., 2011). This evidence points towards a role for AR 
signalling in PTM (or vascular smooth muscle) cells in Leydig cell maturation. 
 
1.4.4 Role of estrogens in spermatogenesis 
Testosterone can also be converted to 17β-estradiol in the male mouse reproductive 
system by the action of aromatase in the Leydig cells and round and elongating 
spermatids of the testis (Nitta et al., 1993), and epididymal sperm (Janulis et al., 
1996). 17β-estradiol acts by binding to its receptors, ERα and ERβ (Heldring et al., 
2007). In the mouse, ERα is found in the Leydig cells, some peri-tubular cells and 
the epithelium of the efferent ducts and epididymis, whereas ERβ is found in Leydig, 
Sertoli, some peritubular cells and pre-meiotic germ cells (Zhou et al., 2002). 
Evidence for cell-specific localisation of estrogen receptors varies between species 
and even between studies in a particular species, mo t likely due to differences in the 
antibodies used in these studies (Carreau and Hess,2010).  ERβ knock-out mice have 
no significant disruption of spermatogenesis (Dupont et al., 2000; Krege et al., 1998). 
ERα or ERα/ ERβ double knock-out mice have degeneration of the seminiferous 
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epithelium with ageing (Dupont et al., 2000; Eddy et al., 1996), though this was later 
shown to be a result of the failure of the efferent ducts to absorb testicular fluid, 
resulting in atrophy of the seminiferous tubules due to back-pressure of the fluid 
(Hess et al., 1997).  
 
Interestingly, a knockout of the aromatase gene (cyp19) did not display fluid-related 
seminiferous tubule atrophy (Fisher et al., 1998a) and maintained normal efferent 
duct morphology (Toda et al., 2008), suggesting that ERα signals in a ligand-
independent manner in the efferent ducts to control fluid reabsorbtion. However, the 
testes of aromatase knock-out animals displayed a heterogeneous failure of 
spermiogenesis from 18 weeks of age, with germ cells arresting and undergoing 
apoptosis at early spermiogenic stages, often concurrent with abnormalities in 
acrosome development (Robertson et al., 1999). Thisp enotype also occurs in a 
mouse with an inactivating mutation in the ligand binding domain of ERα 
(ENERKI), implying that the tropic effects of estrogens on spermiogenesis are 
dependent on estrogens binding to ERα (Sinkevicius et al., 2009). Interestingly, 
ablation of ERα signalling increases Leydig cell steroidogenesis (Akingbemi et al., 
2003) increases in plasma testosterone levels are seen in ERα knock-out, aromatase 
knock-out and ENERKI mice (Akingbemi et al., 2003; Fisher et al., 1998a; 
Sinkevicius et al., 2009). Lack of estrogen feedback at the pituitary also results in a 
slightly increased serum LH level in these three models. The change in levels of LH 
and testosterone may be contributing to the disruption in spermatogenesis.  
 
More studies are clearly needed to clarify the distinct roles of estrogens and 
androgens in the testis and the Cre/loxP system is an ideal tool to answer these 
questions. The function of AR in Leydig cells is still not fully elucidated. Floxed 
ERα mice have just become available to examine the action of estrogens in 
individual cell populations (Chen et al., 2009c). More information will provide a 
fuller picture of how these two hormones act in balance to control spermatogenesis.  
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1.5 Control of testicular function by the hypothala mus-pituitary-
gonad (HPG) axis 
 
The hypothalamus and pituitary, located in the brain, secrete the gonadotropin 
endocrine hormones: luteinising hormone (LH) and follicle stimulating hormone 
(FSH), that are vital for male reproductive function, and are in turn regulated by 
hormones produced by the testes in a feedback loop that is known as the 




Figure 1-16: Diagram summarising the regulatory pathways of the HPG axis 
 (Ge et al., 2008) 
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1.5.1 The pituitary and hypothalamus  
The pituitary gland (also known as the hypophysis) makes LH and FSH under the 
control of the hypothalamus. The pituitary is located in the hypophyseal fossa of the 
sphenoid bone of the skull (Page, 2006). It lies beneath the hypothalamus and is 
connected to it by the infundibulum (pituitary stalk). The mammalian pituitary gland 
has three lobes. The anterior pituitary (adenohypophysis) is glandular tissue that 
contains several different cell types, each of which secrete a different endocrine 
hormone. Gonadotrophs produce LH and FSH, lactotrophs roduce prolactin, 
somatotrophs produce growth hormone, corticotrophs roduce adrenocorticotropic 
hormone (ACTH) and thyroid-stimulating hormone (TSH) is produced by 
thyrotrophs (Savage et al., 2003). FSH, TSH and LH consist of two subunits, the α 
subunit is common to all three hormones, and the β subunit specific to each hormone 
(Ryan et al., 1988). The posterior pituitary lobe (n urohypophysis) is derived from 
neuroectoderm and extends to the infundibulum; it store  arginine vasopressin 
(antidiuretic hormone, ADH) and oxytocin. The intermediate lobe produces 
melanocyte stimulating hormone (MSH). 
 
The hypothalamus consists of many small nuclei which control functions such as 
sexual and ingestive behaviours, control of temperature and integration of 
cardiovascular and hormonal responses to stress (Page, 2006). The hypothalamus has 
both neural and vascular links to the pituitary. Magnocellular secretory neurons 
traverse the infundibulum to connect the paraventricular nucleus of the hypothalamus 
to the posterior pituitary. Oxytocin and arginine vasopressin are synthesised in these 
neurons then stored in the posterior pituitary before release into the blood stream.  
Conversely, there are no neural connections between th  hypothalamus and the 
anterior pituitary and communication between these two compartments is by vascular 
transport of neurohormones. 
 
1.5.2 GnRH regulates gonadotropin secretion  
Parvocellular secretory neurons in the hypothalamus synthesise neurohormones that 
are released into the portal vessels in the median emi ence that pass down into the 
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anterior pituitary (Herbison, 2006). These hormones act upon trophic cells to regulate 
synthesis and release of their hormones. Gonadotropin- eleasing hormone (GnRH) is 
the hormone released from the hypothalamus and acts on its receptor (GnRHR) 
found on pituitary gonadotrophs to stimulate LH and FSH biosynthesis and release 
(Millar, 2005). Destruction of GnRH synthesising neurons results in gonadal atrophy, 
which is reversed by intravenous doses of synthetic GnRH. The hypogonadal (hpg) 
mouse model has a naturally occurring mutation that results in undetectable 
gonadotropin secretion (Cattanach et al., 1977). The mutation was later found to be a 
truncation of the gene for the biosynthetic precursor of GnRH (Mason et al., 1986). 
GnRH and LH are secreted in a pulsatile manner, with a high degree of concordance 
between GnRH and LH pulses. The synthesis of FSH is clearly stimulated by GnRH 
but the extent to which its secretion depends on pulses of GnRH is less clear, as a 
relationship between GnRH pulses and FSH secretion is not always found (Tilbrook 
and Clarke, 2001).  Initiation of pulsatile GnRH secretion by a ligand called 
kisspeptin in the hypothalamus is concurrent with pubertal maturation of the HPG 
axis (d'Anglemont de Tassigny and Colledge, 2010). Loss-of-function mutations in 
the kisspeptin receptor (GPR54) cause hypogonadotropic hypogonadism and failure 
to progress through puberty.  
 
1.5.3 Feedback loop of LH and testosterone 
LH binds to specific, high-affinity receptors (LHR) on the surface of testicular 
Leydig cells (Dufau, 1988). Knock-out mice have been created for both the β subunit 
of LH (Ma et al., 2004) and the LHR (Lei et al., 2001; Zhang et al., 2001) and 
display a similar phenotype, with normal pre-natal masculinisation of the 
reproductive tract, but a decrease in testis size, Leydig cell hypoplasia, and 
spermatogenesis blocked at the round spermatid stage in adults. Expression levels of 
testicular steroidogenic genes, StAR and Insl3 were r duced in LHR knock-out 
(LuRKO) mouse testis (Zhang et al., 2004). Binding of LH has been shown to 
rapidly induce the synthesis of testosterone by increasing the phosphorylation of 
StAR and therefore its translocation across the mitochondrial membrane (Evaul and 
Hammes, 2008). Binding of LH also results in transcriptional upregulation of StAR, 
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Hsd3b and the Cyp11a1 gene that codes for p450scc (Lavoie and King, 2009). In 
humans, androgen production by fetal Leydig cells is under the control of LH: 
humans with a completely inactivating LHR mutation do not undergo 
masculinisation but humans with an inactivating mutation of LHβ undergo 
masculinisation of the male reproductive tract due to the presence of placental human 
chorionic gonadotropin (HCG) which can also activate the LHR receptor 
(O'Shaughnessy et al., 2009).  
 
Testicular factors are known to negatively regulate th  release of LH from the 
pituitary. Immunisation of male rhesus monkeys against testosterone results in 
consistently high plasma LH levels (Wickings and Nieschlag, 1978), and 
administration of exogenous testosterone causes a decrease in circulating LH and a 
decrease in Leydig cell synthesis of testosterone (Keeney et al., 1988). AR is found 
in both the hypothalamus and pituitary in the mouse (Miyamoto et al., 2007). 
Attempts to elicit the site of action of feedback by testosterone in rams and rhesus 
monkeys has led to the conclusion that it acts by decreasing the pulse rate of GnRH 
at the level of the hypothalamus and has negligible pituitary effects (Tilbrook and 
Clarke, 2001). A study in men with hypogonadotropic hypogonadism (GnRH-
deficiency) revealed that both testosterone and estradiol can act at the hypothalamus 
to suppress LH release, but only estradiol can act at the pituitary (Pitteloud et al., 
2008). However, AR colocalises with FSHβ and LHβ in rat and monkey 
gonadotrophs (Okada et al., 2003), testosterone has been shown to suppress LH 
secretion in rat gonadotroph cultures (Kotsuji et al., 1988; Starzec et al., 1996) and 
AR can suppress transcription of the LHβ subunit by interacting with SF-1 
(Jorgensen and Nilson, 2001): all evidence that AR potentially has a role in 
controlling pituitary gonadotropin release. Mouse models of global or specific AR 
ablation do add little to clarification of how testo erone feedback acts on the HPG 
axis. In Tfm mice, levels of serum LH and FSH are increased (Amador et al., 1986) 
due to a failure of testosterone to limit LH expression and an excess of LH then 
stimulating more testosterone production. Despite this, pituitaries of ARKO mice 
have apparently normal pituitary expression of LHβ and FSHβ at both the mRNA 
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and protein levels (Miyamoto et al., 2007), but this was recorded qualitatively not 
quantitatively. Mice with cell-specific inactivation of AR in the nervous system (but 
not pituitary) also have increased LH and testostern  levels and a slight decline in 
fertility mainly thought to be due to reduction in male-specific mating behaviours 
(Raskin et al., 2009). GnRH releasing neurons do not express AR, but hypothalamic 
KiSS-1 neurons which send projections to GnRH neurons are AR+ so feedback 
could be acting at this site (Raskin et al., 2009). Aromatisation to estradiol has been 
postulated to play a part in the feedback (Tilbrook and Clarke, 2001), but ERα and 
ERβ knockout mice do not appear to have defects in their HPG axis (Eddy et al., 
1996; Temple et al., 2003). More work is clearly required to elucidate the site and 
mechanism of regulation of LH release by testosteron . 
 
1.5.4 Feedback loop of FSH and inhibin B 
FSH acts via a specific G protein coupled receptor (FSHR) present in the testis 
exclusively in Sertoli cells (Heckert and Griswold, 1991; Vannier et al., 1996). 
Knock-out mice have been created both for the FSHβ subunit (Dierich et al., 1998; 
Kumar et al., 1997), and the FSHR (Abel et al., 2000; Dierich et al., 1998). Both 
types have a decrease in testicular size with reduced germ cell numbers but show 
complete spermatogenesis. Despite this, fertility is either normal (Abel et al., 2000) 
or slightly reduced (Dierich et al., 1998). In FSHβKO mice testosterone production 
and Leydig cell numbers are normal (Wreford et al., 2001) but aged FSHRKO mice 
have reduced testosterone production (Krishnamurthy et al., 2001) Leydig cell 
numbers and steroidogenic enzyme expression (Baker et al., 2003). These results 
show that FSHR signalling in Sertoli cells has a paracrine affect on Leydig cells and 
that binding to FSH is not required for these actions (Haywood et al., 2002). The 
decrease in testis size and germ cell number in FSHR and FSHβ mice is thought to 
be due to a decrease in testicular Sertoli cell number (Wreford et al., 2001). FSH has 
a tropic effect on Sertoli cell numbers that is independent of LH actions (Allan et al., 
2004). Transgenic FSH expression can restore Sertoli cell number in hpg mice (Allan 
et al., 2001) and neonatal FSH treatment is sufficient to increase Sertoli cell number 
in hpg mice, as long as it is given within the normal perinatal window of Sertoli cell 
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proliferation (Singh and Handelsman, 1996a, b). Examin tion of double 
hpg/SCARKO mice has confirmed that stimulation of spermatogonial number by 
FSH is due to direct effects of FSH on the Sertoli cells, and not due to any increase in 
testosterone production by the Leydig cells acting on Sertoli cell ARs 
(O’Shaughnessy et al., 2010). FSH also stimulates th  production of GDNF by 
Sertoli cells, thus promoting the renewal and proliferation of spermatogonial stem 
cells (Tadokoro et al., 2002).  
 
Based on current evidence, it is thought that althoug  testosterone is sufficient to 
induce initiation and maintenance of spermatogenesis in the absence of FSH (Singh 
et al., 1995), FSH is needed for quantitatively normal spermatogenesis and the two 
hormones act synergistically (Abel et al., 2008; Haywood et al., 2003). In contrast to 
mice, men with a deletion of the FSHβ gene are azoospermic and infertile (Layman 
et al., 2002; Phillip et al., 1998), but those with an inactivating mutation in the FSHR 
are oligozoospermic: their fertility is severely reduced but some have managed to 
sire children (Tapanainen et al., 1997). FSH appears to work via different 
mechanisms in mice and men. 
 
Inhibin B is a glycoprotein produced by the testes that was originally identified from 
its ability to inhibit FSH secretion by the pituitary (Burger, 1988). Although it is 
produced by the testis, the location of its production is disputed: most evidence 
points towards the Sertoli cells but there is some evidence for the Leydig and germ 
cells (Meachem et al., 2001). It is putatively thought to act via betaglycan as a 
receptor in the pituitary to reduce FSH secretion (Wiater et al., 2009). In some 
species with seasonal breeding, testosterone is thought to interact with inhibin to 
negatively regulate FSH secretion (Tilbrook and Clarke, 2001).  
 
1.5.5 Establishment of fetal Leydig cell testostero ne production is 
independent of the HPG axis  
It is currently believed that, although fetal rat and mouse Leydig cells do express a 
functional LHR (Zhang et al., 1994), their function is not intimately dependent on 
this stimulus. Evidence for this includes the fact that gonadotroph development and 
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secretion has not occurred at the time of induction of fetal Leydig cell testosterone 
production (Savage et al., 2003) and the fact that normal masculinisation of the 
reproductive system occurs in mice with a total faiure of pituitary development 
(Pakarinen et al., 2002), genetic ablation of LHβ (Ma et al., 2004) and LHR (Lei et 
al., 2001; Zhang et al., 2001). Despite normal reproductive tract masculinisation, 
mice with a failure in pituitary development have dcreased testicular androgen 
levels in fetus implying that a pituitary hormone other than LH is involved in 
regulation of fetal Leydig cell function. This hormone is postulated to be 
adrenocorticotropic hormone (ACTH), which can stimulate FLC function through 
the melanocortin type-2 receptor, however mice lacking ACTH have normal FLC 
development, so it is likely that FLCs, whilst responsive to ACTH, are not dependent 
on it (O'Shaughnessy et al., 2003). In contrast to rodents, humans are dependent on 
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1.6 Structure and function of the adult efferent du cts and epididymis 
and influence of steroid hormones 
1.6.1 Anatomy and physiology of the efferent ducts 
1.6.1.1 Structure of the efferent ducts 
The efferent ducts (also referred to in the literature as the ductuli efferetes, vasa 
efferentia or efferent ductules) are a series of tubules that conduct sperm from the 
rete testis to the epididymis. They develop from the mesonephric tubules (Rosenfeld 
et al., 2000). They number between 3 and 5 in the mouse (Guttroff et al., 1992). The 
proximal zone comprises the efferent ducts where they exit the rete testis and are 
slightly convoluted. They become more and more convoluted towards the epididymis 
in the region called the conus vasculosi, which is marked by a widening of the 
connective tissue capsule bundle. The efferent ducts anastomose in this region, with 
fusion points randomly spaced along the length of the ducts. This results in one 
common duct called the terminus, which is moderately coiled, and continues into the 
most proximal lobe of the epididymal capsule. The ducts are lined with a 
pseudostratified epithelium consisting of ciliated and non-ciliated (secretory) cells. 
They are surrounded by a thin layer of smooth muscle and connective tissue stroma 
(Ilio and Hess, 1994). 
  




Figure 1-17: Anatomy of the efferent ducts 
(a) The efferent ducts connect the testis to the epididymis. Modified from Joseph et al., 
2010b. (b) Four efferent ducts exit the testis and anastomose into one duct in the ‘conus 
vasculosa’ region before entering the epididymis. Modified from Guttroff et al., 1992. 
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1.6.1.2 Function of the efferent ducts 
The main function of the efferent ducts is to concentrate post-testicular spermatozoa 
by absorption of testicular fluid secretions. The effer nt ducts reabsorb more than 
90% of the fluid coming from the testis (Clulow et al., 1994). Several ion 
transporters (Hansen et al., 1999; Ilio and Hess, 1992; Lee et al., 2001; Leung et al., 
2001; Zhou et al., 2001) and aquaporin (AQP) water channels (Badran and Hermo, 
2002; Fisher et al., 1998b; Hermo et al., 2004; Pastor-Soler et al., 2001), are also 
found in the efferent duct epithelium and may participate in the transcellular 
movement of water, in addition to passive diffusion f water by paracellular 
pathways. ERα knock-out mice have impaired fluid reabsorbtion in their efferent 
ducts and several of these proteins have been shown to be regulated by estrogen or 
impaired in the ERα knock-out (Joseph et al., 2010a; Ruz et al., 2006). It has been 
proposed that the ciliated cells of the efferent duct epithelium assist in the movement 
of spermatozoa towards the epididymis, but this has been contradicted by evidence 
that suggests the cilia do not beat in one direction, and in fact exist to ‘stir’ the 
testicular fluids to allow for more homogeneous reabsorbtion. Movement of 
testicular sperm is now thought to occur due to pressure from testicular fluid and 
contraction of the PTM cells surrounding the seminiferous tubules (Ilio and Hess, 
1994). The efferent ducts appear particularly sensitive to environmental toxicants 
which have been reported to result in the formation of occlusions of the ducts and 
obstructive azoospermia (Hess, 1998). 
 
1.6.2 Anatomy and physiology of the epididymis 
1.6.2.1 Structure of the epididymis 
The epididymis is the organ distal to the efferent ducts and proximal to the vas 
deferens in the male excurrent duct system. It consists of a single, highly convoluted, 
tightly packed duct lined with pseudostratified columnar epithelium, embedded in 
vascularised stroma and surrounded by a connective tissue capsule (Robaire et al., 
2006). In rodents, it appears to have three sections when viewed macroscopically: a 
lobular head at the apical pole of the testis which receives the efferent ducts, a 
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delicate, thin body that follows the dorsal side of the testis and a lobular tail at the 
basal pole of the testis which takes a sharp convex curve into the vas deferens.  
Commonly, these sections are called the caput, corpus and cauda epididymis 
respectively. The duct and its epithelium vary in morphology between these sections 
and when viewed in thin-section it is obvious that the caput can be further subdivided 
into an ‘initial segment’ most proximal to the efferent ducts and the caput proper 
(Nicander and Glover, 1973; Soler et al., 2005). Each of these 4 regions is divided 
into segmental lobes by the presence of stromal connective tissue septa. The lobes of 
the initial segment and caput are the most well characterised, with general agreement 
that the initial segment is one lobe, designated segment I, the proximal caput consists 
of two lobes, designated segments II and III, and the distal caput also consists of two 
lobes, designated segments IV and V (Abou-Haila and Fain-Maurel, 1984; Avram 
and Cooper, 2004). Each segment is defined by distinct features such as epithelial 
height and chemical or immunostaining patterns. Theconnective tissue septa are 
thought to act as physical barriers between these sgments limiting the expression of 
genes to particular segments of the epididymis (Turner et al., 2003).  
 
 




Figure 1-18: Anatomy of the epididymis 
The epididymis is commonly divided into 4 regions, the initial segment (which receives the 
efferent ducts), the caput, the corpus and the cauda. Modified from (Joseph et al., 2010b) 
 
 
Six different cell types are seen in the epididymal epithelium, some are common to 
all segments and some are specific, or found in higher numbers in specific segments.  
 
Figure 1-19: Cell types of the epididymal epithelium 
Modified from (Joseph et al., 2010b) 





Principal cells are found in all epididymal regions and are the most numerous cell 
type, contributing between 65% and 80% in the rat depending on the region (Robaire 
and Hermo, 1988).  They span the depth of the epithlium from basement membrane 
to lumen, with a medial to basally located nucleus. In the initial segment they are tall 
columnar but cell height is reduced in each subsequent segment (Abou-Haila and 
Fain-Maurel, 1984). Principal cells are very active with respect to transport and 
secretion of small organic molecules, protein synthesis, and absorption of both fluid 
and particulate matter (Robaire and Viger, 1995). Narrow cells are found only in the 
initial segment and proximal caput epididymis, and have an apically located nucleus 
and a distinctive morphology with a narrow cell body that tapers further towards the 
basement membrane, but a thicker apical pole that may bulge into the lumen. Apical 
cells are also found in the initial segment and proximal caput epididymis, and appear 
morphologically similar to principal cells, but have an apically located nucleus.  
They have historically either been classified as a type of principal cell or narrow cell. 
However they do not share the ultra-structural features of the principal cells, or the 
carbonic anhydrase activity of the narrow cells, so currently are considered to be a 
distinct cell population (Adamali and Hermo, 1996). Both narrow and apical cells are 
thought to be involved in H+ secretion and bicarbonate reabsorbtion to maintain the 
luminal pH. Clear cells are found in the caput, corpus and cauda epididymis. Due to 
the presence of numerous apical structures including coated pits, vesicles, endosomes 
and lysosomes their function is thought to be primaly in endocytosis (Hermo et al., 
1988; Sun and Flickinger, 1979). Basal cells are found throughout the epididymis 
and constitute 15-20% of the epithelial population. The flat cell bodies containing 
nuclei are found along the basement membrane and contact the apical surface of the 
epithelium through narrow projections. Their function is thought to be in regulation 
of principal and clear cells by the release of paracrine factors, for example, 
expression of angiotensin type II receptor indicating a response to angiotensin (Shum 
et al., 2009). Halo cells are also found in all regions of the epididymis, and have a 
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distinct dense nucleus surrounded by a pale-staining cytoplasm. Halo cells are 
thought to function as intra-epithelial leukocytes (Serre and Robaire, 1999). 
 
1.6.2.2 Functions of the epididymis 
It is well defined that testicular spermatozoa that ve not passed through the 
epididymis are non-motile and unable to fertilise an oocyte in vivo. During transit, 
spermatozoa undergo morphological and functional changes including increased 
rigidity due to stiffening of flagellum and neck region (Yeung et al., 2002) 
movement of cytoplasmic droplet from sperm head to midpiece (Cooper and Yeung, 
2003) and  change in morphology of the acrosome (Olson et al., 2003). These 
characteristics are not acquired intrinsically but come about due to associations with 
the complex mixes of proteins and ions secreted and absorbed by the epididymal 
epithelium (Cornwall, 2009). Mouse knock-out models with defects in the proteins 
that mediate luminal protein and ion concentrations are often infertile due to defects 
in sperm morphology that lead to an inability to function in the female tract or 
fertilise an oocyte (Cooper et al., 2004). Each stage of spermatozoa maturation is 
thought to occur in a discrete region of the epididymis and is thought that epididymal 
septa act to constrain protein localisation to specific epididymal regions as well as 
providing structural support (Turner et al., 2003). This segment-specific expression 
of particular genes is illustrated in Figure 1-20.   
 




Figure 1-20: Diagram illustrating the specific regions of expression of epididymal 
gene products 
(Cornwall and Hann, 1995) 
 
1.6.3 Action of androgens in the efferent ducts and  epididymis 
Testosterone produced in the Leydig cells reaches t efferent ducts and epididymis 
by both transport through the seminiferous tubules to the rete, and in the systemic 
circulatory system.  
1.6.3.1 Expression of AR in the efferent ducts and epididymis 
Expression of AR in stromal mesenchymal cells during development is present from 
e13.5 and is vital for the stabilisation and early development of the Wolffian duct 
(section 1.3.2). Epithelial expression of AR begins around e16.5 in the efferent ducts 
and e19.5 in the epididymis (Cooke et al., 1991). In adult tissues, AR is present in the 
ciliated and non-ciliated cells of the efferent duct epithelium, the periductal smooth 
muscle cells and most other stromal cells in the eff r nt ducts of both the mouse (Zhou 
et al., 2002) and the rat (Oliveira et al., 2004). In most other non-rodent species studied 
to date including humans (Ungefroren et al., 1997), monkeys (Roselli et al., 1991) 
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and goats (Goyal et al., 1997) AR has limited or no expression in efferent duct 
epithelium. Post-natal mouse epididymides express AR in both the epithelial and 
stromal compartments of all regions in both the mouse (Zhou et al., 2002) and the rat 
(Yamashita, 2004). All epithelial cell types except halo cells have been reported to 
express AR. In the stroma, peri-tubular cells are generally AR+, with remaining 
stromal cells being a mix of AR+ and AR-.  
 
1.6.3.2 Effects of androgen withdrawal on the epidi dymis and efferent ducts 
In 1926, Benoit first reported that bilateral castrtion (orchidectomy) causes 
epididymides to regress, and concluded that a testicular factor must be important in 
epididymal maintenance. It was several years before testosterone was discovered. 
Many studies since have confirmed the trophic effects of testosterone on the 
epididymis and other male reproductive organs (Robaire et al., 2006).  
 
Castration causes a reduction in luminal diameter and epithelial height of the efferent 
ducts. Supplementation with exogenous testosterone did not cause a recovery in 
lumen diameter, but caused a partial recovery in the height of the epithelium 
(Oliveira et al., 2004). Castration decreases epididymal weight (Brooks, 1979) and 
elicits morphological changes in the principal cells of the epididymis including 
reduction of apical membrane stereocilia and cell organelles including endoplasmic 
reticulum, lysosomes and Golgi cisternae (Moore and Be ford, 1979b) and increased 
endocytosis (Moore and Bedford, 1979a). Epididymal lumen diameter and epithelial 
cell height are both decreased in castrated animals (Fawcett and Hoffer, 1979; 
Hamzeh and Robaire, 2009). These changes are mediated by a wave of apoptosis of 
principal cells of the epididymal epithelium that peaks in the initial segment on the 
first day of castration and then sequentially in the caput, corpus and cauda 
epididymis in the following days (Fan and Robaire, 1998). Castration also causes any 
spermatozoa left in the epididymis to lose mobility and ability to fertilise an egg  
(Dyson and Orgebin-Crist, 1973).  
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Replacement of testicular testosterone with exogenous testosterone can restore some, 
but not all of the weight of the epididymis (Brooks, 1979). Several subsequent 
studies have shown that exogenous testosterone given at the time of castration can 
rescue the changes associated with epididymal apoptosis and regression in all 
segments apart from the initial segment (Avram et al., 2004; Fan and Robaire, 1998; 
Fawcett and Hoffer, 1979; Hamzeh and Robaire, 2009) and preserve the fertilising 
ability of the epididymal sperm (Dyson and Orgebin-Crist, 1973). A similar pattern 
of initial segment degradation and apoptosis despit normal appearance of the 
remainder of the epididymis is seen when efferent ducts are ligated in non-castrated 
animals, preventing luminal fluid from reaching the epididymis but maintaining 
circulatory androgens (Abe and Takano, 1989; Avram et al., 2004; Fawcett and 
Hoffer, 1979; Turner and Riley, 1999). Conclusions of this work have been that 
circulatory testosterone is enough to maintain the structure and function of the caput, 
corpus and cauda epididymis, as well as the fertilising ability of spermatozoa (which 
is most probably an indirect effect on the spermatozoa via interactions with the 
epididymal epithelium), but the initial segment requires a lumicrine factor to 
maintain epithelial integrity. There is debate as to whether this factor is lumicrine 
testosterone or some other, as yet unidentified testicular factor (Fawcett and Hoffer, 
1979). Several microarray studies have been performed that have attempted to 
identify genes that mediate the action of testostern  in the epididymis, and their 
results have led to the discovery and characterisation of several androgen-controlled 
epididymis-specific genes (Chauvin and Griswold, 2004; Ezer and Robaire, 2003; 
Robaire et al., 2007; Sipila et al., 2006; Snyder et al., 2009; Turner et al., 2007). 
 
The epididymis can produce both DHT and estradiol (section 1.2) as it expresses 
both 5α-reductase (Robaire and Viger, 1995) and aromatase (Shayu and Rao, 2006). 
It has been postulated by some investigators that DHT is the principal androgen in 
the epididymis (Robaire and Henderson, 2006), but sperm from men with a 5α-
reductase type II mutation can result in pregnancy after intrauterine fertilisation 
(Katz et al., 1997) and 5α-reductase knock-out mice maintain fertility (Mahendroo et 
al., 2001) so testosterone appears to be the predominant androgen in ensuring normal 
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epididymal function. Estradiol is also important for the absorptive function of the 
epididymis as well as the efferent ducts (Joseph et al., 2010b). 
 
So far, no transgenic mice have been created to explor  the roles of AR in the 
function of the efferent ducts and epididymis. Withdrawal of androgens via 
castration has a significant effect on epididymal function, but it is difficult to prove 
whether androgens are acting via stromal AR, epithelial AR, or both to maintain the 
function and morphology of the epididymis. 
 
 
1.7 Hypothesis, objectives, rationale and experimen tal approach 
 
The action of androgens via their receptor AR is essential for the correct 
development and function of the male reproductive system. Studies using rodents 
with systemic ablation of androgen-action including mice with a systemic genetic 
ablation of AR (Tfm and ARKO) (Lyon and Hawkes, 1970; Yeh et al., 2002) or rats 
treated with the anti-androgen flutamide (Welsh et al., 2008; Welsh et al., 2006) have 
been very informative in gaining information on the function of androgens during 
development and function of the testis. But as adult spermatogenesis is incomplete, 
the testes of these animals are cryptorchid, and Wolffian duct-derived structures 
(epididymis, vas deferens and seminal vesicles) are absent, it is difficult to draw 
conclusions about the relative contributions of androgen action in specific cells to the 
overall androgen-dependent function and development of the male reproductive 
system. Models in which AR is genetically ablated in specific cell types have 
contributed to an exponential increase in our understanding  of its role in different 
organs of the body, but, perhaps unsurprisingly, no o e cell specific knockout has a 
phenotype that recapitulates every aspect of the global ablation models.   
 




The proposed hypothesis is that ablation of AR functio  in previously untargeted cell 
types of the male reproductive system, or in previously characterised cell types at 
different ages, will have significant and novel effects on reproductive development 




1.  To identify and empirically validate new Cre lines that will permit ablation of 
AR from previously untargeted cell types in the male reproductive system, or 
previously targeted cell types at different ages.  
 
2.  To ablate AR specifically in these cell types. 
 
3.  To use data generated from analysis of the resulting phenotypes to establish 
the role of AR in these cell types in male reproductive function.  
 
1.7.3 Rationale  
The key tool in this approach is the use of the transgenic Cre loxP system. Cre-loxP 
transgenic mice are appropriate models for elucidating the specific roles of 
androgens in different cell types, as the promoter that drives Cre can be selected to 
be active in a specific cell type, or at a specific age (Smith, 2011). Mouse lines with 
cell-specific knock-outs of AR in Sertoli cells (Chang et al., 2004; De Gendt et al., 
2004; Holdcraft and Braun, 2004), PTM cells (Welsh et al., 2009a; Zhang et al., 
2006), Leydig cells (Xu et al., 2007), germ cells (T ai et al., 2006), vascular smooth 
muscle (Welsh et al., 2010b), prostate epithelium (Simanainen et al., 2008; Wu et al., 
2007), seminal vesicle smooth muscle (Welsh et al., 2010a) and nervous system 
(Raskin et al., 2009) have been characterised, with varying success, proving that the 
Cre loxP system is an appropriate method for cell-specific AR ablation that has 
Chapter 1: Literature review          
 
66 
resulted in new insights into signalling of AR in several of the cell types of the testis 
and male reproductive tract.  
 
1.7.4 Experimental approach 
The first step is to identify novel Cre lines with the potential to express Cre in cell-
types of interest that have not previously been targeted for AR ablation. Empirical 
validation of the spatiotemporal expression pattern is essential. This will be 
undertaken using a fluorescent reporter gene system that will label cells in which the 
Cre is active. If validation proves that these Cre lin s target novel cell types, they 
will then be used to generate cell-specific ARKOs. Phenotypes of cell-specific 
ARKO lines will be analysed using physiological, histological, cellular and 
molecular techniques and compared to controls to deermine the pathophysiological 
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2. Materials and Methods 
2.1 Mouse line breeding 
2.1.1 Mouse husbandry and welfare 
Mice were bred and maintained in the BRF Little France Animal Facility, University 
of Edinburgh. Mice were kept in a 12 hour Light/Dark regime with humidity 
maintained at 55% and temperature between 20 and 25 °C. Food and water were 
available ad libitum. Mice were maintained under conditions specified in the 
Animals (Scientific Procedures) Act, 1986. All procedures were undertaken 
according to UK Home Office regulations, under project license 60/3544 held by 
Professor Philippa Saunders. Daily animal husbandry and setting up of timed 
matings was carried out under my direction by Mark Fisken, for which I am 
extremely grateful. 
 
2.1.2 Timed matings 
When embryos of a specific age were required, vaginal plug checks of breeding 
females were undertaken at 8 am each morning to allow accurate calculation of their 
stage of gestation. One male and one female mouse were paired together in cages in 
the afternoon, then the female examined for a post-c pulatory vaginal plug on 
subsequent mornings.  Since mice are expected to mae during the middle of their 
dark period (overnight), the day of discovery of the plug was designated e0.5.  
 
2.1.3 Breeding of Cre/ loxP transgenic lines 
 
The Cre/loxP system of conditional gene ablation is discussed in section 1.1.2. 
Several lines are used in this thesis.   
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2.1.3.1 AR flox , a Cre-conditional AR-ablation line 
Two separate groups have constructed a floxed AR line (henceforth referred to as 
ARflox) by homologous recombination of a transgene constructed to contain a loxP 
site in both intron 1 and intron 3 of the AR genomic sequence, flanking exon 2 (De 
Gendt et al., 2004; Yeh et al., 2002) (Figure 2-1). When a female homozygous ARflox 
mouse is mated to a male mouse with a single-inserton Cre transgene under the 
control of a cell-specific promoter, all of the male offspring will carry the ARflox 
transgene, as it is on the X chromosome and this is always maternally inherited.  Half 
of the male offspring will carry the Cre transgene and will undergo cell-specific 
recombination of AR. Upon the cell-specific action f Cre in these animals, the DNA 
between the two loxP sites is recombined and lost, resulting in genomic AR without 
exon 2. Exon 2 encodes the first zinc finger region of the AR DNA-binding domain, 
and its deletion causes a frame-shift and introduction of a premature stop codon 
resulting in premature termination of AR transcription (Hellwinkel et al., 1999).  
Because the loxP sites have been inserted into the introns of the genomic AR they do 
not interfere with AR transcription and translation in cells that do not express Cre. 
The ARflox line used in the experiments in this thesis was obtained from Karel de 
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Figure 2-1: Genetic ablation of AR action using the ARflox line 
(a) The ARflox transgene was constructed to contain a loxP site in both intron 1 and intron 3 
of the AR genomic sequence, flanking exon 2. (b) Upon the cell-specific action of Cre, the 
DNA between the two loxP sites is recombined and lost, resulting in genomic AR with 
ablation of exon 2. (3) This causes a frame-shift, introduction of a stop codon and premature 
termination of AR transcription.   
 
2.1.3.2 Rosa26YFP, a Cre-conditional fluorescent re porter line 
The Rosaβgeo26 (Rosa26) mouse strain was produced by random retroviral gene 
trapping in embryonic stem cells. The β-galactosidase gene carried by the gene trap 
was shown to be ubiquitously expressed in all tissue  (Friedrich and Soriano, 1991; 
Zambrowicz et al., 1997). The locus itself was mapped and found to produce two, 
non-coding transcripts. Mice homozygous for Rosa26 insertions are viable and 
fertile. Because of this, the locus has been exploited for the targeting of transgenes 
that are required to be ubiquitously expressed. To intr duce cell-specific control into 
genes expressed from this locus, a Rosa26 line was con tructed with a transgene 
consisting of the yellow fluorescent protein (YFP) gene downstream from a stop 
codon flanked by loxP sites (Srinivas et al., 2001) (Figure 2-2). When a female 
homozygous Rosa26YFP (R26YFP) mouse is mated to a male ouse with a single-
insertion Cre transgene under the control of a cell-specific promoter, all of the 
offspring will carry one copy of the transgene inherited from the mother. Half of the 
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offspring will carry the Cre transgene and will undergo cell specific expression of 
YFP. Upon the cell-specific action of Cre in these animals, the stop codon between 
the two loxP sites is recombined and lost, resulting in constitutive transcription of the 




Figure 2-2: Fluorescent reporter gene expression using the R26YFP line. 
(a) The R2YFP line consist of the YFP gene downstream from a stop codon flanked by loxP 
sites. (b) Upon the cell-specific action of Cre, the stop codon between the two loxP sites is 
recombined and lost, resulting in constitutive transcription and translation of the YFP 
transgene.  
 
2.1.3.3 FoxG1-ARKO and FoxG1-YFP 
The FoxG1-ARKO line used in this thesis is a congenic 129/SvEv mouse line 
carrying a knock-in of Cre Recombinase at one copy of the FoxG1 locus (Hebert and 
McConnell, 2000) resulting in hemizygosity of endogenous FoxG1. The line was 
obtained from Norah Spears, University of Edinburgh.  
 
FoxG1-ARKO mice used in this study were generated by mating FoxG1-Cre male 
mice to ARflox female mice (De Gendt et al., 2004). Genotype was determined by 
PCR of DNA purified from ear clips for the presence of Cre (section 2.6). The +/Cre, 
ARflox /y male offspring from these matings were termed ‘FoxG1-ARKO’ and the 
+/+, ARflox /y littermates were termed ‘control’. 
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FoxG1-YFP mice used in this study were generated by mating FoxG1-Cre male mice 
to R26YFP female mice (Srinivas et al., 2001). Genotype was determined by PCR of 
DNA purified from ear clips for the presence of Cre (s ction 2.6), or by viewing 
tissues under a fluorescent microscope with a YFP filter post-necroscopy. The +/Cre, 
+ /R26YFP male offspring from these matings were termed ‘FoxG1-YFP’. +/+, + 
/R26YFP littermates from these matings were termed ‘control’. 
 
2.1.3.4 Tie2-ARKO and Tie2-YFP 
The Tie2-Cre line used in this thesis is on a mixed (C57BL/6 x SJL) background. 
Founder mice were genetically modified to contain one r more copies of a transgene 
consisting of Cre downstream of the murine endothelial-specific receptor tyrosine 
kinase (Tie2) promoter inserted into a random locus in the genome. This Tie2-Cre 
line expresses Cre recombinase specifically in endothelial cells (Kisanuki et al., 
2001).  
 
Tie2-ARKO mice used in this study were generated by mating Tie2-Cre male mice 
to ARflox female mice. Genotype was determined by PCR of DNA purified from ear 
clips for the presence of Cre section 2.6). The +/Cre, ARflox /y male offspring from 
these matings were termed ‘Tie2-ARKO’ and the +/+, ARflox /y littermates were 
termed ‘control’. 
 
Tie2-YFP mice used in this study were generated by mating Tie2-Cre male mice to 
R26YFP female mice. Genotype was determined by PCR of DNA purified from ear 
clips for the presence of Cre (section 2.6), or by viewing tissues under a fluorescent 
microscope with a YFP filter post-necroscopy. The +/Cre, + /R26YFP male offspring 
from these matings express YFP in any cells that express Tie2-Cre and were termed 
‘Tie2-YFP’. +/+, + /R26YFP littermates from these matings were termed ‘control’. 
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2.1.3.5 Aqp2-ARKO and Aqp2-YFP 
The Aquaporin-2 Cre (Aqp2-Cre) mouse line used in this thesis is on a mixed 
(C57BL/6 x CBA) background. Founder mice were genetically modified to contain 
one or more copies of a transgene consisting of Cre downstream of 14 kb of human 
AQP2 5’-flanking region (including a TATA box and transcription initiation sites) 
inserted into a random locus in the genome. This Aqp2-Cre line expresses Cre 
recombinase in the principal cells of the renal collecting duct, post-meiotic germ 
cells and vas deferens epithelial cells (Nelson et al., 1998).  
 
Aqp2-ARKO mice used in this study were generated by mating Aqp2-Cre male mice 
to ARflox female mice. Genotype was determined by PCR of DNA purified from ear 
clips for the presence of Cre. The +/Cre, ARflox /y male offspring from these matings 
were termed ‘Aqp2-ARKO’ and the +/+, ARflox /y littermates were termed ‘control’. 
 
Aqp2-YFP mice used in this study were generated by mating Aqp2-Cre male mice to 
R26YFP female mice. Genotype was determined by PCR of DNA purified from ear 
clips for the presence of Cre (section 2.6), or by viewing tissues under a fluorescent 
microscope with a YFP filter post-necroscopy. The +/Cre, + /R26YFP male offspring 
from these matings were termed ‘Aqp2-YFP’. +/+, + /R26YFP littermates from these 
matings were termed ‘control’. 
 
2.1.3.6 AMH-YFP 
The AMH-Cre mouse line used in this thesis is on a mixed (C57BL/6 x SJL) 
background. Founder mice were genetically modified to contain one or more copies 
of a transgene consisting of bacteriophage Cre recombinase downstream of 3.6 kbp 
of the human anti-Müllerian hormone (AMH) promoter inserted into a random locus 
in the genome (Lecureuil et al., 2002). Sertoli cells from e15 of embryonic life 
express AMH, therefore Cre recombinase is also expressed in these cells, and can act 
to recombine DNA between two loxP sites. It has previously been used to selectively 
ablate AR in pre-natal Sertoli cells (De Gendt et al., 2004).  
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AMH-YFP mice used in this study were generated by mating AMH-Cre male mice 
to homozygous R26YFP female mice. Genotype was determin d by PCR of DNA 
purified from ear clips for the presence of Cre (section 2.6). The +/Cre, + /R26YFP 
male offspring from these matings expressed YFP in any cells that expressed AMH, 
and were termed ‘AMH-YFP’. +/+, + /R26YFP littermates from these matings were 
termed ‘Controls’. 
 
2.1.4 Evaluation of fertility 
To investigate fertility, males were each housed with an adult wild-type C57BL/6 
female for 4 days and the presence of a post-copulatory vaginal plug was recorded. 
This process was repeated with 3 subsequent wild-type CD1 female mice per male. 
Female mice were monitored for 25 days for litters to be born. Matings were scored 
as successful if one or more pups were born. Groups were compared with GraphPad 
Prism software (version 5; GraphPad Software Inc., San Diego, CA, USA) using a 
Chi squared test.  
 
2.2 Dissection and gross physiological measurements  
2.2.1 Culling of mice  
Postnatal mice were killed by inhalation of carbon dioxide in a rising concentration 
and subsequent cervical dislocation. Neonates were killed by decapitation. 
 
2.2.2 Gross physiological observations 
Each mouse was weighed and anogenital distance (AGD) was measured using digital 
callipers (Faithfull Tools, Kent, UK) as this represents a lifelong marker of normal 
testosterone action within the masculinisation programming window of development 
(Welsh et al., 2008). The mouse was examined externally to check for nipples, non-
scrotal testis and any evidence of penile hypospadias, which are all signs of disrupted 
testosterone action. 
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2.2.3 Serum hormone analysis 
To obtain serum for hormone analysis, a blood sample was taken from the mouse as 
soon as possible after cervical dislocation using a 1ml syringe (Becton Dickinson, 
UK) and 21 gauge needle (Becton Dickinson, UK) pre-treated with heparin to slowly 
remove blood from the left ventricle whilst the heart was still beating. The blood 
samples were then centrifuged at 10,000g for 10 minutes in a microcentrifuge, which 
separated the blood into serum (supernatant) and cellular (pellet) components. Sera 
were separated and stored at -20°C until assayed for testosterone and luteinising 
hormone (LH) as previously published (Corker and Davidson, 1978; McNeilly et al., 
2000). The within-assay and between-assay coefficients of variation were all less 
than 10%. Serum hormone assays were performed by Ian Swanston and Nancy 
Evans at the MRC-HRSU, for which I am extremely grateful. 
 
2.2.4 Recovery of tissues 
Individual organs were dissected as described in the following sections. Tissue was 
either snap-frozen for subsequent RNA analysis (section 2.7) or fixed in Bouin’s 
fixative (Clin-Tech, Guildford, UK) for subsequent embedding and histological 
analysis (section 2.3).  
2.2.4.1 Brain tissues and pituitary 
Brain tissues were removed first to minimise RNA degradation. The mouse was 
decapitated and all fur and skin removed from the skull. The skull was then cut from 
dorsal to ventral along the midline with a pair of sharp scissors, trying to avoid 
damage to the brain as much as possible. The anterior surface of the skull was then 
cut away. The brain was lifted out of the skull by pushing the dorsal side upwards 
with a blunt object, and the optic nerves cut from the posterior surface to allow the 
brain to be lifted out of the skull. After removal of the brain the pituitary could then 
be seen on the floor of the skull between the two large trigeminal nerves that run 
longitudinally along the bone. The pituitary is a 2 x 1 mm strip of pale tissue running 
crosswise between these two nerves, covered by a membrane. The pituitary was then 
frozen by direct contact with dry ice and stored at -80°C. The area of the brain 
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containing the hypothalamus was then dissected by taking a segment of the median 
eminence posterior to the optic chiasm about 4mm caudally and 2mm deep. This was 
frozen as before. The rest of the brain was cut into small pieces to aid freezing and 
frozen as before.  
2.2.4.2 Testis/epididymis/vas deferens 
The abdomen was moistened with 70% ethanol to wet the fur, then an incision made 
across the abdomen through the external skin and periton al membrane. The testis 
was pulled out from the scrotal sac through the abdomen using the attached fat pad 
then the testis, epididymis and a section of vas deferens were removed as a whole by 
cutting through the surrounding fat and cutting midway along the vas deferens. After 
removal, one testis/epididymis/vas deferens was fixed in Bouin’s fixative (Triangle 
Biomedical Sciences Ltd, Lancashire, UK) for 6 hours and then micro-dissected 
post-fixation, and the other testis/epididymis/vas deferens was micro-dissected, each 
part weighed and all parts frozen separately by direct contact with dry ice and stored 
at -80°C. 
2.2.4.3 Penis  
External fur and skin was removed and the penis was cut midway across the sigmoid 
flexure. The penis length was measured using digital callipers (Faithfull Tools, Kent, 
UK) and weighed then either fixed in Bouin’s fixative for 6 hours or frozen by direct 
contact with dry ice and stored at -80°C.  
2.2.4.4 Seminal vesicles (SV) 
The seminal vesicles and coagulating glands were cut at the junction with the 
mesentery just behind the bladder, taking care not to pierce the vesicles, weighed 
(intact, including seminal fluid) and either fixed in Bouin’s fixative for 6 hours or 
frozen.  
2.2.4.5 Ventral prostate (VP) 
The two lobes of the ventral prostate were cut from around the urethra, weighed, and 
either fixed in Bouin’s fixative for 6 hours or frozen. 
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2.2.4.6 SV/VP in pre-pubertal animals 
In mice culled at day 21 or younger, the SV are small, as testosterone has not yet 
reached a level high enough to induce proliferation of the SV epithelium. In these 
animals the bladder, urethra, prostate and SV were dissected out together and fixed in 
Bouin’s fixative for 6 hours. Because of variation in the point of dissection the 
tissues were not weighed.   
2.2.4.7 Adrenal gland and kidney 
The adrenal gland was removed by grasping the fat pad above the kidney and 
trimming the adrenal free of as much fat as possible. It was then weighed and either 
fixed in Bouin’s fixative for 6 hours or frozen. The remaining kidney was trimmed 
free of mesentery and vessels.  
2.2.4.8 Gravid uterus and embryos 
After culling of the pregnant dam by inhalation of carbon dioxide and subsequent 
cervical dislocation, the pregnant dam was positioned supine and the abdomen 
opened to allow removal of the intact uterus. Embryos were removed from their 
individual amniotic sacs and the umbilical cord cutprior to embryo immersion in ice-
cold PBS. Embryos were then either fixed whole in Bouin’s solution (up to e14.5) or 
subjected to fine dissection to remove gonads and ducts. Fine dissected tissues were 
then either processed by snap freezing or fixed in Bouin’s solution for one hour.  
2.2.4.9 Tissue weight analysis 
Values from at least 5 tissue weights for each group were averaged and plotted on a 
graph with the standard error of the mean (SEM). Groups were compared to each 
other in GraphPad Prism software (version 5; GraphPd Software Inc., San Diego, 
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2.3 Histology  
2.3.1 Fixing, embedding and sectioning 
After fixation for 6 hours in Bouin’s fixative, the tissues were placed into 70% 
ethanol where they were stored until processing. Automated processing of tissue was 
performed in a Leica TP1050 processor (Leica Microsystems, Milton Keynes, UK). 
Processed tissue was then embedded by hand in liquid paraffin wax and the cooled 
wax block was stored at room temperature until requi d. Processing and embedding 
was performed in-house by Mike Millar, Sheila MacPherson and Arantza Esnal, for 
which I am very grateful.  
Paraffin embedded tissues were sectioned at 5µm using a microtome (Leica, model 
RM 2135), floated on a water bath (Lamb RA, model E/65) set to 50 °C to smooth 
out any wrinkles, and mounted on electrostatically charged glass slides (BDH, cat 
no: 406/0179/00) to facilitate adherence of the sections. The slides where then dried 
overnight at 50 °C and allowed to cool to room temprature before staining using 
either a H&E stain to visualise tissue and cell morph logy (section 2.3.2) or an 
immunohistochemistry protocol to visualise localisation of a particular protein of 
interest (section 2.3.3).  
 
2.3.2 Haematoxylin and Eosin (H&E) staining. 
Gross histological analysis of tissues was performed on sections stained with 
haematoxylin and eosin. Slides were dewaxed by immersion in xylene (BDH) for 5 
minutes, then rehydrated by immersion in a series of decreasing concentrations of 
ethanol at 100%, 95% and 75% for 30 seconds each, were briefly washed and then 
immersed in Harris’s haematoxylin (section 2.9.1.1) for 5 minutes to stain nuclei 
blue. The slides were then washed in tap water, then 1% acid alcohol (to remove 
non-specific cytoplasmic staining, section 2.9.1.3), tap water, Scotts Tap Water (to 
allow the blue dye to develop, section 2.9.1.4), tap w ter, eosin (section 2.9.1.2), for 
30 seconds to stain cell cytoplasm pink), tap water, and then dehydrated by 
immersion in a series of increasing concentrations of ethanol at 70%, 80%, 95% and 
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100%. Finally slides were immersed in xylene for 5 minutes to clear, then mounted 
with a glass cover slip (VWR, UK) and Pertex (Cell Path, UK). 
 
2.3.3 Immunohistochemistry 
2.3.3.1 General principles 
Immunohistochemistry is the visualisation of a protein of interest in thin-sections of 
tissue by utilising an antibody to the protein of interest and a chromogenic or 
fluorescent detection system.  
 
A standard immunohistochemical protocol on tissues that have already been fixed, 
embedded and sectioned on to slides first involves th  process of antigen retrieval. 
Fixed tissues have undergone chemical processes that induce molecular cross-linking 
in order to preserve tissue integrity. Exposing fixed tissue to high temperature and 
pH change unmasks these antigens. The next step is blocking of any endogenous 
peroxidases using hydrogen peroxide and methanol. Many detection systems use 
peroxidase enzymes to catalyse a chromogenic or fluorescent reaction and if 
endogenous peroxide is not blocked this can result in background fluorescence or 
production of a non-specific chromogenic product. A non-specific antigen blocking 
step is also included using a serum from the same species that the secondary 
antibody used is raised in. This helps reduce non-specific binding of the antibodies. 
After the block the sections are incubated with a primary antibody against the antigen 
of interest, then a secondary antibody against the species your primary antibody is 
raised in. The secondary antibody is conjugated with a signal amplification system. 
Two commonly used ones are streptavidin/biotin for ch omogenic detection or 
peroxidase/tyramide for fluorescent detection. Here the protocols diverge. 
 
Chromogenic detection is the standard detection system to visualise one antigen at a 
time. It involves first incubating a secondary antibody in this case conjugated to 
biotin, a glycoprotein, then incubating with streptavidin conjugated horse-radish 
peroxidase (HRP) enzyme, then a substrate that is modified by the peroxidase to 
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produce a chromogenic product, in this case 3, 3’-diaminobenzene (DAB) which 
gives a brown product. The streptavidin/biotin step can be omitted by using a 
secondary antibody directly conjugated to HRP but inclusion of this step results in a 
larger amplification of the resulting colour and so a lower concentration of primary 
antibody is needed. 
 
Fluorescent detection can be used when two antigens n ed to be visualised at the 
same time, when the antigen is at a very low concentration (the amplification is 
generally larger and the detection method more sensitive), or when distribution of the 
antigen is in a very specific cellular location (for example cytoskeletal proteins). The 
protocol is identical up until the secondary antibody. For fluorescent detection this 
can be directly conjugated to a fluorophore if the antigen is abundant, or conjugated 
to HRP then used with the Tyramide signal amplification (TSA) system (Perkin 
Elmer, http://las.perkinelmer.com/tsa) if the antigen is present at low levels. When a 
TSA reagent is applied after a HRP-conjugated secondary antibody, HRP catalyses 
the production of free radicals from the tyramide. These free radicals covalently bond 
to electron-rich tyrosine and tryptophan residues of the antigens that the 
primary/secondary antibody complex has bound to. This provides a greater signal 
amplification than avidin/biotin methods. The tyramide is bound to a fluorophore 
which is used to fluorescently localise the signal. Fluorophores are excited and emit 
light at particular wavelengths when excited by a laser, so two or more fluorophores 
with different emission spectra can be used on the same section to visualise more 
than one antigen at the same time.  
 
Before visualisation of the antigen, the tissue sections are counter-stained with a 
DNA-binding dye. In chromogenic protocols this is usually haematoxylin, as used in 
an H and E stain, in fluorescent protocols a DNA binding fluorophore such as 
propidium iodide can be used. 
 
It is prudent to run negative controls when a new antibody or tissue is being 
investigated, to check for non-specific binding of the antibodies used at each stage. 
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Running the protocol with a negative control for each step involves substituting the 
diluted primary antibody, secondary antibody or amplification reagent for the diluent 
only. All other steps are processed as normal. Thismu t be carried out in each tissue 
of interest, as non-specific binding can differ betw en tissues. 
 
2.3.3.2 Standardised chromogenic (DAB) protocol  
Slides were dewaxed by immersion in two xylene baths for 5 minutes. They were 
then dehydrated by immersion in ethanol baths at 100%, 95% and 75% for 30 
seconds each, then washed in tap water. For antigen retrieval, slides were boiled for 5 
minutes in 0.01M citrate buffer pH 6.0 in a domestic pressure cooker (Clypso, Tefal), 
then left to stand for 20 minutes before cooling under cold water. To block 
endogenous peroxidase, slides were incubated in a solution of 30% w/v hydrogen 
peroxide (Fisher Scientific) diluted 1 in 10 in methanol (Fisher Scientific) for 30 
minutes at room temperature with mechanical agitation, then washed in tap water for 
5 minutes. Slides were wiped then the appropriate normal serum (NS)/TBS/BSA 
(section 2.9.3) was dropped on to the slides above the tissue sections. Using a plastic 
Pasteur pipette. Slides were then incubated for 30 minutes at room temperature in a 
humidified chamber. Excess blocking serum was carefully wiped from the slides 
before a solution of primary antibody diluted in appropriate blocking serum to an 
optimised concentration was pipetted onto the sections. The slides were incubated 
overnight (16 hours) in a humidified chamber at 4°C. Concentrations of primary 
antibodies are detailed in Table 2-1. The next day, slides were washed three times 
with TBS for 5 minutes with agitation to remove residual primary antibody. Excess 
buffer was carefully wiped from the slides before a biotinylated secondary antibody 
diluted 1:500 in appropriate NS/TBS/BSA was pipetted onto the sections. Slides 
were then incubated for 30 minutes at room temperature in the humidified chamber. 
Slides were then washed as before. Excess buffer was wiped from the slides before 
streptavidin-conjugated HRP reagent (Dako, UK) diluted 1:1000 in TBS was 
applied. Slides were incubated for 30 minutes at room temperature in a humidified 
chamber. After washing as before, antibody localisation was determined using DAB 
diluted in its supplied buffer (Vector, UK) just prio  to use according to 
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manufacturer’s instructions. Sections were incubated with DAB until staining was 
optimally detected in control sections: this varied depending on the antibody and 
target tissue. Slides were counterstained with haematoxylin, dehydrated and 
mounted, as detailed in H and E staining (section 2.3.2). Sections were visualised and 
photographs taken using a Provis AX70 (Olympus Optical, London, UK) fitted with 
a Canon DS6031 camera (Canon Europe, Amsterdam). 
 
Table 2-1: Details of antibodies used with DAB chromogenic detection 












AR Rabbit Santa Cruz 
# sc-816 
1:200 Goat GaRb* Strep-HRP, 
DAB 
CD45 Rabbit Abcam 
ab10558 
1:20 Goat GaRb* Strep-HRP, 
DAB 
ERα Mouse Novacastra 
#NCL-ER-
6F11 
1:500 Goat GaMb* Strep-HRP, 
DAB 
YFP/GFP Mouse Abcam 
# ab38689 
1:200 Goat GaMb* Strep-HRP, 
DAB 




2.3.3.3 Standardised fluorescent tyramide protocol (for single or double antibody 
staining)  
Slides were dewaxed by immersion in two xylene baths for 5 minutes each. They 
were then dehydrated by immersion in ethanol baths  100%, 95% and 75% for 30 
seconds each, then washed in tap water. For antigen retrieval, slides were boiled for 5 
minutes in 0.01M citrate buffer pH 6.0 in a domestic pressure cooker (Clypso, Tefal), 
then left to stand for 20 minutes before cooling under cold water. To block 
endogenous peroxidase, slides were incubated in a solution of 3% hydrogen peroxide 
in methanol for 30 minutes at room temperature with mechanical agitation, then 
washed in tap water for 5 minutes. Slides were wiped, then appropriate blocking 
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serum/PBS/BSA (section 2.9.3) was dropped on to the slides above the tissue 
sections. Using a plastic Pasteur pipette. Slides were then incubated for 30 minutes at 
room temperature in a humidified chamber. Excess blocking serum was carefully 
wiped from the slides before a solution of primary ntibody diluted in appropriate 
blocking serum to an optimised concentration was pipetted onto the sections. The 
slides were incubated overnight (16 hours) in a humidified chamber at 4°C. 
Concentrations of primary antibodies used are detailed in Table 2-2. The next day, 
slides were washed three times with PBS for 5 minutes with agitation to remove 
residual primary antibody. Excess buffer was carefully wiped from the slides before 
an appropriate peroxidase-conjugated secondary antibody diluted 1:200 in 
appropriate normal serum/TBS/BSA was pipetted onto the sections. Slides were then 
incubated for 30 minutes at room temperature in the humidified chamber. Slides 
were then washed as before. Excess buffer was wiped from the slides before TSA 
Fluorescein (Perkin Elmer, UK) diluted 1:50 in its own buffer (as manufacturer’s 
instructions) was applied. Slides were incubated for 10 minutes at room temperature 
in a humidified chamber. All subsequent steps were carried out limiting exposure to 
light as much as possible to avoid degradation of the fluorophore. At this stage, 
slides were washed and either counterstained if a single antibody was used, or the 
protocol repeated from the methanol/ hydrogen peroxide block stage with a second 
antibody if double-antibody colocalisation staining was required. The second 
antibody was detected as above but with TSA Cy5 (a TSA reagent that fluoresces at 
a different wavelength). 
 
To counterstain and mount, buffer was wiped from the slides before propidium 
iodide (Sigma, UK) diluted 1 in 1000 in PBS was applied as a nuclear counterstain. 
Slides were incubated for 10 minutes in a humidifie chamber, washing again, and 
mounted with Permafluor mounting medium (Thermo Scientific, UK) and a glass 
cover slip (VWR, UK). Fluorescent images were captured using a Zeiss LSM 510 
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Table 2-2: Details of antibodies used with single fluorescent tyramide detection 










AR Rabbit Santa Cruz 
# sc-816 
1:1000 Goat GaRp* Tyramide 
FoxG1 Rabbit Abcam  
#ab18259 
1:200 Goat GaRp* Tyramide 
YFP/GFP Mouse Abcam 
# ab38689 
1:400 Goat GaMp* Tyramide 
*Key: GaRp= goat anti-rabbit peroxidase conjugated (Dako, UK), GaMp= goat anti-mouse 
peroxidase conjugated (Dako, UK).  
 
 
Table 2-3: Details of antibodies used with double fluorescent tyramide detection 



































































































*Key: ChaRp= chicken anti-rabbit peroxidase conjugated (Santa Cruz, USA), ChaGp= 
chicken anti-goat peroxidase conjugated (Santa Cruz, USA), GaRp= goat anti-rabbit 
peroxidase conjugated (Dako, UK), GaMp= goat anti-mouse peroxidase conjugated (Dako, 
UK).   
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2.3.3.4 Automated immunohistochemistry for smooth m uscle actin (SMA) 
An automated immunostaining machine was utilised for antibodies with an optimised 
protocol. The Bond-max automated immunostaining machine (Leica Microsystems, 
UK) can run up to 30 slides at one time, and is based on a polymer rather than a 
streptavidin-based amplification system. For SMA, automated 
immunohistochemistry was performed using an α-SMA (Sigma A2547) primary 
antibody at 1:10,000 concentration and a Polymer Refine Detection kit according to 
the manufacturer’s instructions. Assistance with this machine was provided by 





In the context of these experiments, stereology refers to the quantification of length 
or counting of cells on 5µm sections of tissue using a microscope (Leitx DBRB), an 
automatic stage (Prior Pro-Scan automatic stage, Prior Scientific Instruments Ltd., 
Cambridge, UK) and computer software (Image-Pro Plus 6.2 software with a 
Stereology 5.0 plug-in (Media Cybernetics U.K., Berkshire, UK). This equipment is 
applied to the following problems with the assistance of Mike Millar and Marion 
Walker (MRC HRSU) for which I am extremely grateful.  
 
2.4.1 Quantification of AR ablation in epididymal c ells 
AR ablation was quantified in the epithelium of FoxG1-ARKO epididymis sections 
that had been immunostained for AR. Briefly, a slide from each epididymis showing 
a clear segment II was identified. The slide was examined with a x10 objective and 
the software used to isolate the area of interest (segment II) and divide it into a grid 
of squares corresponding to the field of view of the x63 objective. Each field of view 
was examined using the x63 objective and the ‘Count (NV)’ setting was used. The 
nuclei of all AR+ epithelial cells were identified by using a mouse click to place a 
marker above each nucleus as the software kept a tally. This was then repeated on the 
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same field of view for AR- epithelial cells.  This was repeated for each field of view 
in the grid, covering the whole area of interest. 
 
2.4.2 Quantification of epithelial cell height in A R+ and AR- cells of the 
epididymis 
Epithelial cell height was quantified in the epithelium of control and FoxG1-ARKO 
epididymis sections that had been immunostained for AR. Briefly, a slide from each 
epididymis showing a clear segment II was identified. The slide was examined with a 
x10 objective and the software used to isolate the area of interest (either segment I or 
segment II) and divide it into a grid of squares corresponding to the field of view of 
the x40 objective. Each square was examined using the x40 objective and the ‘no 
experiment’ setting was used. For each tubule cross-section present in the field of 
view, the height of every 5th epithelial cell was measured, starting at 12 o’clock and 
working clockwise. Cell height was defined as stretching from the basement 
membrane to the apical luminal cell surface. Each height measurement was 
designated from an AR+ or an AR- cell based on the staining of the cell nucleus.  
This was repeated for each tubule cross section in the field of view, then for each 
field of view in the grid, covering the whole area of interest.  
 
2.4.3 Quantification of epididymal lumen radius 
Lumen radius was quantified in the epithelium of contr l and FoxG1-ARKO 
epididymis sections that had been AR immunostained. Briefly, a slide from each 
epididymis showing a clear segment II was identified. The slide was examined with a 
x10 objective and the software used to isolate the area of interest (either segment I or 
segment II) and divide it into a grid of squares corresponding to the field of view of 
the x20 objective. Each square was examined using the x20 objective and the ‘no 
experiment’ setting was used. For each epididymal tubule cross-section present in the 
field of view, the software prompted the user to designate the centre of the lumen, 
before prompting the user to click at the apical epith lial membrane interface with 
the lumen on 6 random axes designated by the software. The software then 
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normalised these measurements to come up with an average lumen radius for each 
tubule cross-section. This was repeated for each tubule cross section in the field of 
view, then for each field of view in the grid, covering the whole area of interest.  
 
2.4.4 Quantification of seminiferous tubule radius and tubule lumen radius 
Seminiferous tubule and tubule lumen radii were quantified in the epithelium of 
control and FoxG1-ARKO testis sections that had been H&E stained. Briefly, a slide 
from each testis sectioned near the midline was examined with a x10 objective and 
the software used to divide it into a grid of squares corresponding to the field of view 
of the x20 objective. Each square was examined using the x20 objective and the 
‘Nucleator’ setting was used. When measuring the seminiferous tubule lumen radius: 
for each tubule cross-section present in the field of view the software prompted the 
user to designate the centre of the lumen, before prom ting the user to click at the 
apical epithelial membrane interface with the lumen on 6 random axes designated by 
the software. The software then normalised these measur ments to come up with an 
average lumen radius for each tubule cross-section. This was repeated for each tubule 
cross section in the field of view, then for each field of view in the grid, covering the 
whole area of interest. For entire seminiferous tubule radius a similar process was 
employed, but the axes originating from the centre of the tubule were clicked at the 
basement membrane of the tubule.  
2.4.5 Statistical analysis 
Values from at least 3 slides for each group (refer to individual experiments for 
numbers) were averaged and plotted on a graph with the standard error of the mean. 
Groups were compared to each other in GraphPad Prism software (version 5; 
GraphPad Software Inc., San Diego, CA, USA) using a 2-t iled unpaired t test. 
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2.5 Testis cell dissociation and fluorescence-activ ated cell sorting 
(FACS) 
 
The technique of fluorescence activated cell sorting is commonly used to separate 
cells in a single cell suspension by presence or absence of a fluorescent antibody 
bound to a cell surface marker. Because of this it is particularly suitable for 
separating populations of immune cells that are transported in blood or lymph and 
are defined by the cell surface proteins that they carry. In this case the technique of 
FACS is applied to the problem of sorting a population of cells in a solid organ (the 
testis) that are expressing a transgenic fluorescent protein (YFP). In order to sort 
cells expressing YFP in a testis from other cells that do not, the testis must first be 
dissociated into a single-cell suspension. FACS can then be used to isolate this 
single-cell suspension into YFP+ and YFP- cells. 
 
2.5.1 Testis cell dissociation  
The protocol used here is based on a previously published protocol for FACS of 
testicular cells (Deitch et al., 1986). Testes from a litter of mice were separated into 
fluorescent (AMH-YFP) and non-fluorescent (control) by examination under a 
dissecting scope fitted with a fluorescent filter. Each population was then processed 
as follows: the testes were washed in 70% ethanol to sterilise them, then washed 
twice in PBS (section 2.9.2.1) before removal of the unica albuginea of each testis 
using fine forceps. The remaining tubules were minced up into small pieces using 
small dissection scissors that had been sterilised with 70% ethanol. The minced testes 
were added to 5 ml of collagenase (section 2.9.4.1) in a flat-bottomed glass tube and 
incubated at 32°C in a shaking water bath for 15 minutes. After 15 minutes a 200 µl 
aliquot of DNase (section 2.9.4.2) was added to the testis suspension, and incubation 
continued for another 15 minutes. The suspension was then transferred to a 15ml 
Falcon tube and spun at 500g for 5 minutes. The pell t was resuspended and pelleted 
twice in PBS and then resuspended in 5 ml trypsin/DNase (section 2.9.4.3) in another 
flat-bottomed glass tube. The suspension was incubated for 5 minutes in a shaking 
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water bath at 32°C before being dispersed with a 1 ml pipette and filtered through a 
70 µm cell strainer (BD Biosciences, UK). The resulting cells were spun and washed 
twice with PBS as above. The pellet was resuspended in 1 ml PBS and filtered with a 
40 µm cell strainer (BD Biosciences, UK). Concentration f cells per ml was 
checked with a haemocytometer and the volume adjusted with PBS to give 5 x 106 
cells/ml. 
 
2.5.2 FACS  
Fluorescence-activated cell sorting (FACS: trademarked by Becton, Dickinson and 
Company www.bd.com) is a specialized type of flow cytometry for sorting a 
population of single cells into two or more sub-populations, based on the specific 
fluorescent characteristics of each cell. The FACS experiment in this thesis was 
performed on a BD FACS Calibur at the CALM facility, university of Edinburgh. I 
am extremely grateful to Fiona Rossi for calibrating the machine to my requirements.  
Briefly, the two testis cell suspensions (AMH-YFP and control) were taken 
immediately to the FACS machine after preparation (section 2.5.1). The control 
testes were used to calibrate the machine. The AMH-YFP testis cell suspension was 
then placed into the machine for sorting. Once inside the machine, the cell 
suspension is entrained in the centre of a narrow, apidly flowing stream of liquid. A 
vibrating mechanism causes the stream of cells to break into individual droplets. Just 
before the stream breaks into droplets, the flow passes through a fluorescence 
measuring station where the fluorescence of each cell is measured at the wavelength 
of interest. An electrical charging ring is placed just at the point where the stream 
breaks into droplets. A charge is placed on the ring based on the fluorescence 
intensity measurement of the cell passing through, w ich results in the droplet 
becoming charged with the opposite charge as it breaks from the stream. The charged 
droplets then fall through an electrostatic deflection system that diverts droplets into 
containers based upon their charge. The stream is then returned to neutral after the 
droplet breaks off. The two sorted populations were designated YFP+ and YFP-. 
RNA was extracted from both cell populations using the Qiagen RNeasy micro kit 
(section 2.7.1.3).  
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2.6 PCR genotyping  
To determine presence of Cre and the recombination s atus of  genomic Ar exon 2 in 
offspring of transgenic matings, DNA was prepared from ear punches or tail clips 
and subjected to a PCR assay containing primers for Cre and interleukin-2 (IL2) as 
an endogenous control (Welsh et al., 2009a), or Ar exon 2.  
2.6.1.1  Lysis of tissue from ear clips and tail ti ps 
First, a rough DNA preparation was obtained by placing either an ear punch in 25 µl 
TE-Tween (section 2.9.2.5) and 2 µl of 10 mg/ml proteinase K (‘PK’, Sigma), or 2 
mm of tail tip in 50 µl TE-Tween and 5 µl of 10 mg/l PK and heating to 55 °C for 
2 hours (to allow PK to digest proteins) then 95 °C for 7 minutes (to destroy PK 
activity). Samples were vortexed to mix the digested tissue then spun at 4000 rpm for 
5 minutes to pellet undigested tissue. 10 µl of supernatant was removed from the top 
of the tube then added to 90 µl of PCR-clean water. This dilution was used for any 
genotyping PCR reactions.  
2.6.1.2 PCR assay for Cre and IL2 
PCR was performed on this rough DNA preparation with the following protocol: 
10 µl of Biomix Red PCR buffer (Bioline) 0.2 µl of each of the Cre/IL-2 primers 
(Table 2-4), 7.2 µl of PCR-clean water (BDH, UK) and 2 µl of DNA were combined 
in a sterile, thin-walled 0.2 ml tube (Continental L b Products, Oxford, UK) and run 
on a PCR programme designed to amplify both the Cre and IL2 sequences (94 °C for 
3 minutes, followed by 35 cycles of 94 °C for 30 seconds, 57 °C for 30 seconds and 
72 °C for 30 seconds, followed by a final incubation at 72 °C for 5 minutes). 
Samples were run on an agarose gel [2% of agarose (Bioline) in 1x TAE buffer 
(section 2.9.2.3)] with a 100 base pair ladder (NEB) as a size reference. Expected 
product sizes were approximately 100 bp for Cre and 300 bp for IL-2. 
 
Table 2-4: PCR primers for Cre recombinase genotyping  
Name 5’ primer 3’ primer 
IL2  CTAGGCCACAGAATTGAAAGATCT GTAGGTGGAAATTCTAGCATCATCC 
Cre GCGGTCTGGCAGTAAAAACTATC GTGAAACAGCATTGCTGTCACTT 
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2.6.1.3 PCR assay for Ar exon 2 
PCR was performed for Ar exon 2 as described in section 2.6.1.2, but instead using 
the following programme: 94 °C for 3 minutes, followed by 35 cycles of 94 °C for 
45 seconds, 64 °C for 60 seconds and 72 °C for 60 seconds, followed by a final 
incubation at 72 °C for 5 minutes. Primers were 5’: GCTGATCATAGGCCTCTCTC  
and 3’: TGCCCTGAAAGCAGTCCTCT, designed to flank Ar genomic exon 2. 
Samples were run on a QIAxcel automated DNA fragment size analyser 
(http://www.qiagen.com/products/qiaxcelsystem.aspx). Expected product sizes were 
approximately 1.2 kb for ‘floxed’ genomic exon 2 and 0.6 kb for recombined 
genomic exon 2. 
 
 
2.7 RNA extraction and reverse transcription (RT) 
 
Extracting RNA from a tissue of interest allows gene expression transcriptome of the 
tissue to be explored. Commercial spin column kits such as the Qiagen RNeasy mini 
kit (Qiagen, UK) are based on the lysis of cells and subsequent binding of RNA to a 
spin column membrane. Once bound, the membrane is washed to purify the RNA, 
before the RNA is eluted from the membrane by ribonuclease (RNase) free water. 
RNases are ubiquitous RNA-degrading enzymes, and their effect on RNA quality 
was minimised by cleaning pipettes and surfaces that may come into contact with the 
tissue with a RNaseZAP (Ambion, UK), a RNase-denaturing product, and 
proceeding through an isolation protocol as quickly as possible after the cell-lysis 
step.  
 
Reverse transcription utilises the reverse transcriptase enzyme to make 
complementary (c)DNA using RNA as a template, along with random hexamer 
primers that bind throughout the RNA to allow complete RNA coverage. 
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2.7.1 RNA extraction from tissues  
2.7.1.1 Tissue lysis in preparation for RNA extract ion 
Tissues were either ground up into powder under liquid nitrogen then homogenised 
in RLT buffer (part of the Qiagen RNeasy kit) using a QiaShredder column (Qiagen, 
Crawley, UK) or lysed in RLT buffer using a Qiagen TissueLyser homogeniser 
(Qiagen, Crawley, UK). 
 
2.7.1.2 RNA extraction using Qiagen RNeasy mini kit  
RNA was isolated from frozen tissue pieces up to 30mg in weight by using the 
RNeasy mini extraction kit (Qiagen, Crawley, UK) according to the manufacturer’s 
instructions. The resulting RNA was eluted in two elutions of 30 µl of RNase-free 
water, the two aliquots were combined then quantified (section 2.7.1.4) and either 
reverse transcribed immediately (section 2.7.2) or st red at -80 °C until further use.  
2.7.1.3 RNA extraction using Qiagen RNeasy micro ki t 
To extract RNA from pieces of tissue smaller than 5mg, or up to 5x105 cells from 
FACS experiments, the Qiagen RNeasy micro kit (Qiagen, Crawley, UK) was used, 
according to manufacturer’s instructions. The binding membrane on the micro 
columns is smaller than the mini kit, and the resulting RNA is eluted in 15ul RNase-
free water to compensate for the smaller amount of starting tissue. Eluate was then 
quantified (section 2.7.1.4) and either reverse transcribed immediately (section 2.7.2) 
or stored at -80 °C until further use.  
 
2.7.1.4 Quantification of RNA using a Nanodrop spec trophotometer 
In order to correct for differences in amounts of RNA recovered from each sample, 
RNA concentration was quantified using a Nanodrop ND-1000 spectrophotometer 
(LabTech International, UK). 
 
Chapter 2: Materials and Methods        92 
 
2.7.2 Reverse transcription (RT) 
Random hexamer primed cDNA was prepared using the Applied Biosystems 
TaqMan reverse transcription kit (Applied Biosystems, Foster City, CA) according to 
manufacturer’s instructions. Briefly, 400 ng of RNA was made up to 9 µl with 
RNase-free water, 2 µl PCR buffer II, 4 µl magnesium chloride, 2 µl dNTPs, 1 µl 
RNase inhibitor, 1 µl of random hexamers and 1 µl of reverse transcriptase. The 
reagents were added together in a 0.2 ml sterile thin walled PCR tube (Continental 
Lab Products, Oxford, UK) and cycled in a thermo-cycler through the following 
programme: 25 °C for 20 minutes, 42 °C for 60 minutes and 95 °C for 5 minutes. 
The resulting cDNA was frozen at -20 °C until further use. 
 
2.8 Quantification of gene expression using RT-PCR or TaqMan® 
To determine whether cDNA prepared from tissues contained transcripts of a gene of 
interest, two approaches can be undertaken. RT-PCR, like PCR on genomic DNA, 
utilises two specifically designed oligonucleotide primers, DNA polymerase enzyme 
and dNTPs to make copies of the sequence of DNA between the two primers. 
However, RT-PCR uses cDNA rather than genomic DNA as a template, so is 
representative of the transcriptome of the tissue rather than the genome. RT-PCR is 
suitable for qualitative or semi-quantitative analysis of a gene of interest, but 
quantitative analysis requires quantitative (q)RT-PCR. TaqMan is a form of qRT-
PCR that incorporates a fluorogenic probe between th  two primers that is activated 
when cleaved during DNA replication to enable the dtection of a specific 
fluorescent product as it accumulates during the PCR process. 
 
2.8.1 RT-PCR 
For RT-PCR (where the reaction product is to be run on an agarose gel), the 
following protocol was used: 1 µl of cDNA was combined with 10 µl of Biomix Red 
PCR buffer (Bioline, UK), 0.2 µl of 20 µM 5’ and 3’primers appropriate to the assay 
(detailed in Table 2-5, designed using Primer3 online software, synthesised by 
Eurofins MWG Operon, UK) and 8.6 µl of PCR-clean water in a sterile 0.2 ml thin-
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walled tube (Continental Lab Products, Oxford, UK). Assays were run on a PCR 
machine using a programme of 94 °C for 3 minutes, followed by 35 cycles of 94 °C 
for 30 seconds, the appropriate pre-optimised anneali g temperature (see Table 2-5) 
for 30 seconds and 72 °C for 30 seconds, followed by a final incubation at 72 °C for 
5 minutes. Resulting products were run on an agarose gel (1% of agarose in 1x TAE 
buffer [section 2.9.2.3]) with a 100 base pair ladder (New England Biosciences, UK) 
as a size marker. 
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2.8.2 TaqMan®  qRT-PCR 
2.8.2.1 Primer and probe design 
Expression of specific transcripts was determined using the Mouse Universal Probe 
Library (‘UPL’, Roche, UK), a set of probes labelled with carboxyfluorescein (FAM) 
fluorophore, and specific forward and reverse primes designed for the gene of 
interest using the online software at www.roche-applied-
science.com/sis/rrpcr/upl/ezhome.html. Primers were ordered from Eurofins MWG 
Operon (UK). Validation of primer suitability for use with the ∆∆Ct method 
(discussed in section 2.8.2.3) was performed by running the assay detailed in section 
2.8.2.2 with a five-fold dilution series of a reference cDNA (either wild-type 
pituitary or wild-type epididymis, depending on the g ne to be assayed). ∆Ct should 
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Table 2-6: Details of TaqMan assays used in these studies 
Assay Ensembl  
Gene ID 














































2.8.2.2 TaqMan assay  
TaqMan reactions for each cDNA of interest were performed in duplicate. The 
expression level of the transcript of interest was related to an internal control (18s 
ribosomal RNA) with a probe labelled with VIC, a fluorophore that fluoresces at a 
different wavelength to the FAM labelled probe of the gene of interest, so levels of 
both the gene of interest and 18s control could be recorded after each cycle. Each 
plate included a ‘no template control’ that substituted water for cDNA template, and 
a positive ‘normaliser’ cDNA so assays performed on within and between plates 
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could be compared to each other (either wild-type pituitary cDNA or wild-type 
epididymis cDNA, depending on the assay).  
 
The reaction mix for a duplicate reaction was as follows:  
 
 Volume added 
2x Express Supermix (ABI) 16 µl 
5’ primer (20 µM) 0.32 µl 
3’ primer (20 µM) 0.32 µl 
Universal probe (10 µM) 0.32 µl 
18s (ABI, mix contains primers at 1.33 µM, probe at 5.3 µM) 0.24 µl 
cDNA 2 µl 
PCR-clean water (BDH) 13.2 µl 
 
This gave two duplicates of 15 µl (with 2 µl left over for error), which were 
aliquotted into a 96 well MicroAmp optical reaction plate (Applied Biosystems) 
sealed with an ABI prism optical adhesive cover (Applied Biosystems) and run on 
the default programme on the ABI prism with detection of both FAM and VIC. 
 
2.8.2.3 Analysing TaqMan results 
TaqMan PCR results were displayed as an amplification plot, which shows the 
amount of the fluorescent product generated during amplification: this is proportional 
to the amount of PCR product formed and thus the amount of target gene expressed 
in the target tissue. When analysing a TaqMan amplification plot three regions can 
be seen: the baseline, which indicates the basal fluorescence in the reaction plate, the 
exponential region where fluorescence is increasing exponentially associated with a 
corresponding increase of PCR product, and the platau region, where the reaction is 
no longer exponential due to limiting reagents. The ‘t reshold level’ is where the 
fluorescence that is generated during the reaction cr sses the threshold where it is 
significantly above background fluorescence. The Ct (threshold cycle) is the cycle 
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number at which this has occurred.  A lower Ct indicates that more of the transcript 
of interest was originally present in that sample.  
 
A relative quantification assay was used to analyse any changes in gene expression in 
a given sample, relative to another reference sample (such as an untreated control 
sample). Relative quantification was achieved using the comparative ∆∆Ct method 
(Schmittgen and Livak, 2008). For each sample, the ∆Ct was first calculated by 
subtracting the Ct for the internal positive control gene (in this case 18s rRNA) from 
the ∆Ct of the target gene. The two duplicates of each sample were then averaged 
and then compared to a reference sample. This was calculated by subtracting the ∆Ct 
for the reference sample from the ∆Ct for the target sample and was referred to as 
∆∆Ct. The formula 2-∆∆Ct gives the relative fold change of the target gene in that 
particular sample compared to the reference sample. Values from at least 3 samples 
for each group (specific age, genotype either control o  mutant) were averaged and 
plotted on a graph with the standard error of the mean. Groups were compared to 
each other in GraphPad Prism software (version 5; GraphPad Software Inc., San 
Diego, CA, USA) using a 2-tailed unpaired t test. 
 
2.9 Commonly used solutions 
 
Unless stated otherwise, all of the components of these solutions can be brought from 
Sigma-Aldrich, UK. Ultra-filtered water was provide by a Millipore water filter 
(Millipore, UK). 
2.9.1 H&E solutions 
2.9.1.1 Harris’s haematoxylin 
25 ml of 10% haematoxylin in absolute alcohol was added to 500 ml of 10% warm 
aluminium potassium sulphate solution. The solution was heated to boiling point and 
1.25 g of mercuric oxide (1.25g) was added slowly. The haematoxylin solution was 
Chapter 2: Materials and Methods        98 
 
plunged into ice to cool before filtering it into a staining dish. Finally, glacial acetic 
acid was added (4 ml per 100 ml haematoxylin).  
2.9.1.2 Eosin 
An aqueous eosin solution was made by dissolving 1% w/v eosin in water, and an 
alcohol solution was made by dissolving 1% w/v eosin in methylated spirit. The 
solutions were mixed at 1 part alcohol to 3 parts aqueous and filtered. 0.5 ml/L of 
formaldehyde was added to prevent bacterial growth.    
2.9.1.3 Acid alcohol 
1% concentrated hydrochloric acid was added to 70% ethanol.  
2.9.1.4 Scotts tap water 
0.2% w/v potassium hydrogen carbonate and 2% w/v magnesium sulphate were 
added to tap water.  
 
2.9.2 Buffers 
2.9.2.1 Phosphate-buffered saline (PBS) 
One PBS tablet (Medicago, Sweden) was added to each litre of ultra-filtered water. 
2.9.2.2 Tris-buffered saline (TBS) 
To make a 10x solution, 60.5 g of Trizma base, 87.6 g NaCl and 300 ml hydrochloric 
acid were made up to 10 L with ultra-filtered water. The solution was adjusted to pH 
7.4 and the stock solution was diluted to 1x with ul ra-filtered water before use.  
2.9.2.3 Tris-acetate-EDTA (TAE) 
To make a 50x solution, 242 g of Tris base, 57.1 ml glacial acetic acid (BDH, UK) 
and 100 ml 0.5M EDTA (section 2.9.2.4) were made up to 1 L with ultra-filtered 
water. The solution was adjusted to pH 8.5 and the s ock solution was diluted to 1x 
with ultra-filtered water before use.  
Chapter 2: Materials and Methods        99 
 
2.9.2.4 0.5M EDTA 
186.1 g EDTA was added to 800 ml of ultra-filtered water. The solution was adjusted 
to pH 8.0 with concentrated NaOH to allow the EDTA to dissolve then diluted to 1 L 
with ultra-filtered water. 
2.9.2.5 Tris-EDTA-Tween (TE-Tween) 
2.5 ml of Tris-HCl, 100 µl 0.5M EDTA (section 2.9.2.4) and 250 µl Tween were 
dissolved in 50 ml of distilled water.  
 
2.9.3 Normal sera 
Normal chicken and goat sera were obtained from Biosera, UK.  
2.9.3.1 Normal serum: phosphate-buffered saline: bo vine serum albumin (NS: PBS: 
BSA) 
NS from the animal of choice was diluted 1 in 4 with PBS (section 2.9.2.1) 
containing 5% BSA.  
2.9.3.2 Normal serum: tris-buffered saline: bovine serum albumin (NS: TBS: BSA) 
NS from the animal of choice was diluted 1 in 4 with TBS (section 2.9.2.2) 
containing 5% BSA. 
2.9.4 Tissue dissociation reagents 
2.9.4.1 Collagenase solution 
Collagenase A (Roche, UK) was reconstituted to a fin l concentration of 1mg/ml in 
PBS (2.9.2.1) 
2.9.4.2 DNase solution 
DNase I (Roche, UK) was reconstituted to a final concentration of 1 mg/ml in PBS 
(2.9.2.1). 
2.9.4.3 Trypsin/DNase solution 
Solution consisted of 50 µg/ml trypsin (Roche, UK), 40 µg/ml DNase I (Roche, UK) 
and 20 µg/ml EDTA reconstituted in PBS (2.9.2.1). 
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3. Generation and characterisation of novel testicu lar cell-
specific ARKO mice 
3.1 Introduction  
Testes of mice with total ablation of androgen receptor (ARKO) are well 
characterised (Yeh et al., 2002), as are those frommice with a cell-specific ablation 
of AR in the Sertoli (Chang et al., 2004; De Gendt et al., 2004), PTM (Welsh et al., 
2009a) and Leydig cells (Xu et al., 2007) (see Chapter 1). None of the cell-specific 
knock-outs has a phenotype as severe as the ubiquitous knock-out. This may be due 
to the additive effect of AR ablation in three cell types, or additional effects induced 
by the cryptorchidism of the total ARKO testis. However, two other cell types in the 
testis have been postulated to express androgen receptor: the germ cells and 
endothelial cells. It is generally accepted within the literature that germ cells of the 
adult testis do not express AR (O'Donnell et al., 2006) although some studies have 
demonstrated AR protein immunolocalisation in elongating spermatids of the adult 
testis (Vornberger et al., 1994). Whether or not ARis expressed in germ cells, 
evidence suggests that it is not necessary for normal spermatogenesis, as when 
spermatogonia from Tfm mice were transplanted into wild-type mice they proceeded 
through spermatogenesis normally (Johnston et al., 2001). Aquaporin-2 (Aqp2) is 
expressed by the post-meiotic germ cells of the testis (Nelson et al., 1998). Preceding 
these studies, an Aqp2-Cre line was available but had not yet been characterised in 
the testis. Mating of this line to the R26YFP reporter line would produce offspring 
that express YFP in cells where Cre is active, to confirm that expression of Aqp2-Cre 
mirrors that of endogenous Aqp2. Mating of the Aqp2-Cre line to the floxed 
androgen receptor (ARflox) line would produce offspring with ablation of AR in post-
meiotic germ cells. These mice can then be analysed to determine whether ablation 
of AR in these cells has an impact on spermatogenesis.  
 
Vascular endothelial cells line blood vessels in the testis and are also found in the 
testicular interstitium as lymphatic endothelial cels (Kerr et al., 2006). Androgen 
receptor signalling promotes proliferation and augments key angiogenic events in 
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cultured vascular endothelial cells (Cai et al., 2011; Sieveking et al., 2010), but there 
is some debate in the literature as to whether testicular endothelial cells express AR 
or not (Nakhla et al., 1984; Pelletier et al., 2000; Vornberger et al., 1994). The 
endothelial-specific receptor tyrosine kinase (Tie2)-Cre line expresses Cre 
recombinase specifically in endothelial cells (Kisanuki et al., 2001). Targeting of the 
Cre line in the testis has not been tested, so this will be also be investigated using 
Tie2-YFP mice before the testicular impact of ablating endothelial AR will be 
analysed in Tie2-ARKO mice. 
 
To study the effects of AR in Sertoli cells, it is advantageous to have a Sertoli cell 
line for in vitro experiments. It requires several days of seeding to isolate primary 
cultures of Sertoli cells free from contamination of germ and PTM cells (Buzzard et 
al., 2002), but Sertoli cells lose their expression of AR after a few days in culture 
(Sneddon et al., 2005). Immortalised Sertoli cells lines have been used as an 
alternative (Rahman and Huhtaniemi, 2004) but many of these lines also do not 
express AR, or aberrantly express mesenchymal cell-sp cific genes (Konrad et al., 
2005). The Cre-loxP system is mostly utilised to for conditional ablation of a gene of 
interest. However, as shown in the experiments in chapters 3 to 6 of this thesis, it can 
also be used to label a cell type of interest with a fluorescent protein. This is most 
often used to identify cells in which Cre is or has been active, but has the potential 
for novel uses. Mice with fluorescently labelled Sertoli cells can be generated by 
mating males from the AMH-Cre line to females carrying the R26R-YFP transgene 
(Srinivas et al., 2001). Fluorescence-activated cell sorting (FACS) is a type of flow 
cytometry that can be used to sort a heterogeneous mixture of cells into two or more 
populations based upon the specific light scattering a d fluorescent characteristics of 
each cell. FACS on a testicular cell suspension from the AMH-YFP line will 
therefore be investigated for the potential to assist in the isolation of a pure Sertoli 
cell population from the testis.  
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3.1.1 Aims 
The aims of this chapter are: 
• To investigate whether the endothelial and germ cells of the testis express 
androgen receptor, and what happens when AR is ablated in each of these 
two cell types. 
• To investigate whether the AMH-YFP line can be used to isolate a pure 






3.2.1 Use of a Tie2-Cre line to ablate AR from the endothelial cells of the 
testis 
3.2.1.1 Localisation of YFP in Tie2-YFP testes 
Immunostaining of thin sections of Tie2-YFP testes r vealed that YFP was localised 
to the endothelial cells of the testicular blood vessels of d100 Tie2-YFP testes, and 
also to a population of interstitial cells not associated with blood vessels (Figure 3-1, 
n=3 sections for both Tie2-YFP and controls).  YFP+ endothelial cells lining blood 
vessels and dispersed through the interstitium did not stain for AR. 
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Figure 3-1: YFP immunolocalisation in cross-sections of d100 Tie2-YFP testes  
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Figure 3-1: YFP immunolocalisation in cross-sections of d100 Tie2-YFP testes (figure 
on preceding page) 
(a, b) Endothelial cells of the interstitium of d100 Tie2-YFP testes stain for YFP, but do not 
stain for AR (solid arrowheads) whereas AR positive interstitial cells do not stain for YFP 
(solid arrows). (c, d) Endothelial cells of the blood vessels of d100 Tie2-YFP testes stain for 
YFP, but do not stain for AR (outline arrowheads) whereas AR positive blood vessel smooth 
muscle cells do not stain for YFP (outline arrows). (e) No YFP immunostaining is seen in 
testes of control littermates. (f) No-primary antibody control. Scale bars are 20µm. 
 
 
3.2.1.2 Analysing ablation of AR expression in the testis of a TIAR mouse line 
Tie2-ARKO mice did not differ significantly from controls in mean body weight, 
AGD and testicular weight (Table 3-1). d100 Tie2-ARKO testes d100 appeared 
histologically similar to controls with normal spermatogenesis (Figure 3-2). Mature 
spermatozoa were present in the cauda epididymides of d100 Tie2-ARKO mice, 
similar to controls. Testes of d100 Tie2-ARKO mice produced only wild-type full-
length Ar transcript, and not the shorter transcript that results from Cre recombinase-
mediated deletion of exon 2 (Figure 3-3). Recombinatio  of Ar exon 2 was shown to 
have occurred at the genomic level in Tie2-ARKO testes (Figure 3-4). 
 
Table 3-1: Mean body weight, AGD and testis weight of Tie2-ARKO compared to 
control.  
n=3 mice for both Tie2-ARKO and controls, P>0.05 
 Control Tie2-ARKO 
Body weight 24.2 g 25.0 g 
AGD 15.6 mm 15.5 mm 
Testicular weight 85.3 mg 86.2 mg 
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Figure 3-2: Histology of d100 control and Tie2-ARKO testes and cauda epididymides 
Histology of Tie2-ARKO testes and cauda epididymides is similar to controls at d100. Scale 





Figure 3-3: Presence of wild-type and/or Cre-recombined Ar transcript in d100 control 
and Tie2-ARKO testis 
RT-PCR on d100 control testis confirms all Ar transcripts are wild-type (upper band). d100 
Tie2-ARKO testis expresses only wild-type Ar transcripts. Total ARKO testis expresses only 
recombined AR (lower band).  
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Figure 3-4 Presence of wild-type and/or Cre-recombined genomic Ar exon 2 in d100 
control and Tie2-ARKO testis 
PCR on d100 control testis confirms that genomic Ar exon 2 is not recombined (upper band, 
approx. 1.2 kb). PCR on d100 Tie2-ARKO testis reveals that some genomic Ar exon 2 is 
recombined (lower band, approx. 0.6 kb), although most genomic AR exon 2 is not 
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3.2.2 Use of an Aqp2-Cre line to ablate AR from the  post-meiotic germ cells 
of the testis 
3.2.2.1 Localisation of YFP in Aqp2-YFP testes 
Whole mount visualisation of YFP fluorescence in unfixed seminiferous tubules 
demonstrated that YFP was localised in germ cells. When viewed at a plane at the 
base of the tubule, the YFP was localised to the outline of hexagonal-shaped Sertoli 
cells (Figure 3-5a). When viewed in a more central pl ne the YFP was localised in 
clusters of germ cells in the centre of the tubule (Figure 3-5b). When embedded in 
paraffin, sectioned and stained with a GFP/YFP antibody, YFP immunostaining was 
specific to the cytoplasm of post-meiotic germ cells at d100 (Figure 3-6, n=3 sections 
for both Aqp2-YFP and controls).  
   
Figure 3-5: YFP fluorescence localisation in whole seminiferous tubules of d100 Aqp2-
YFP testes  
(a) At the periphery of a seminiferous tubule, YFP is localised outside the characteristic 
hexagonal-shaped basal aspects of Sertoli cells (arrowhead). (b) In a more central plane of a 
seminiferous tubule, YFP is localised to the clusters of germ cells (arrow). Scale bars are 
50µm. 
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Figure 3-6: YFP immunolocalisation in cross-sections of d100 Aqp2-YFP testis  
YFP is localised to the post-meiotic germ cells of the testis (arrowheads). No YFP staining is 
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3.2.2.2 Analysing ablation of AR expression in the testis of an Aqp2-ARKO mouse line 
AR immunostaining in a wild-type d100 testis revealed that elongating spermatids 
stained for AR with the antibody used in these studies (Figure 3-7). Aqp2-ARKO 
mice did not appear to be grossly different to controls in mean body weight (25.0 g 
control, 26.2 g Aqp2-ARKO) AGD (14.8 mm control, 15.6 mm Aqp2-ARKO) and 
testicular weight (64.3 mg control, 69.3 mg Aqp2-ARKO). However, whilst it was 
apparent that there was no phenotypic difference, low n numbers prohibited 
statistical analysis of these observations (n=3 mice for Aqp2-ARKO and n=1 for 
control). Aqp2-ARKO testes at d100 appeared similar to controls with normal 
spermatogenesis (Figure 3-8). Mature spermatozoa were present in the cauda 
epididymides of d100 controls and Aqp2-ARKO mice (Figure 3-8). Testes of d100 
Aqp2-ARKO mice produced only wild-type full-length Ar transcript, and not the 
shorter transcript that results from Cre recombinase-mediated deletion of exon 2 
(Figure 3-9).  
 
 
                AR       DNA 
Figure 3-7: AR immunostaining in d100 control testis  
(a) Elongating spermatids of the testis show positive staining for androgen receptor (arrows). 
(b) No-primary control with no staining.  
 




Figure 3-8:  Histology of d100 control and Aqp2-ARKO testes and cauda epididymides 
Histology of Aqp2-ARKO testes and cauda epididymides is similar to controls at d100. Scale 
bars are 200µm. 
                                     
Figure 3-9: Presence of wild-type and/or Cre-recombined Ar transcript in d100 control 
and Aqp2-ARKO testis 
 RT-PCR on d100 control testis confirms all Ar transcripts are wild-type (upper band). d100 
Aqp2-ARKO testis expresses only wild-type Ar transcripts. Total ARKO testis expresses only 
recombined AR (lower band).  
Chapter 3: Generation and characterisation of novel testicular cell-specific ARKO mice                111   
 
3.2.3 Use of an AMH-Cre line to fluorescently label  the Sertoli cells of the 
testis for subsequent isolation by FACS 
3.2.3.1 Localisation of YFP in AMH-YFP testes 
Whole mount visualisation of YFP in unfixed seminiferous tubules demonstrated that 
YFP is localised in hexagonal shaped cells, characte istic of Sertoli cell morphology 
(Figure 3-10a). When viewed in a more central plane the YFP appeared to ‘project’ 
into the centre of the tubule (Figure 3-10b). When embedded in paraffin, sectioned 
and stained with a GFP/YFP antibody, YFP staining was specific to the nucleus and 




Figure 3-10: YFP localisation in whole seminiferous tubules of d100 AMH-YFP testes  
(a) At the periphery of a seminiferous tubule, YFP is localised to the characteristic 
hexagonal-shaped basal aspects of Sertoli cells (arrow). (b) In a more central plane of a 
seminiferous tubule, YFP is localised to the Sertoli cell cytoplasm projecting into the centre 
of the tubule (arrowhead). Scale bar is 100µm. 
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Figure 3-11: YFP localisation in cross-sections of seminiferous tubules of d100 AMH-
YFP testes  
No YFP staining is seen in testes of control littermates. Sertoli cells of AMH-YFP testes stain 
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3.2.3.2 Isolation of a population of cells by FACS 
AMH-YFP testes were distinguished from control littermates as they appeared to 
glow green under a dissecting microscope with a YFP-specific fluorescent filter, 
unlike control testes, which did not (Figure 3-12). Testes from two litters of mice, 
one at d15 and one at d21 were sorted into 4 groups, d15 AMH-YFP, d15 control, 
d22 AMH-YFP and d22 control based on their age and presence of YFP as 
established under a fluorescent scope.  
 
Figure 3-12: Distinguishing AMH-YFP testes from control testes using a dissecting 
microscope with fluorescent filter 
When viewed under a dissecting microscope fitted with a fluorescent filter, AMH-YFP testes 
glow green as a result of YFP expression, whereas control testes do not.  
 
Each group of testes was subjected to a combination of mechanical and enzymatic 
dissociation and subsequent sorting by FACS. Cells from both AMH-YFP and 
control testes were sorted into YFP+ and YFP- cell populations. 9.9 % of all events 
recorded by the FACS machine were classed as YFP+ cells using d15 AMH-YFP 
testes (Figure 3-13a), whereas 0% of all events were classed as YFP+ cells using d15 
control testes (Figure 3-13b). 3% of all events reco ded by the FACS machine were 
classed as YFP+ cells using d22 AMH-YFP testes (Figure 3-13c), whereas 0% of all 
events were classed as YFP+ cells using d22 control testes (Figure 3-13d). 
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Figure 3-13: Numbers of cells generated by FACS on AMH-YFP and control testes at 
d15 and d22 
The ‘singlet’ and ‘cells’ functions use size and shape algorithms to ensure only single whole 
cells are sorted. Fluorescence algorithms are then used to sort single whole cells into YFP+ 
and YFP- groups. 
 
Cells from YFP+ and YFP- cell populations of AMH-YFP testes at both d15 and d22 
were frozen and subjected to RNA extraction, reverse t anscription and PCR for 
testicular cell type markers. P27/kip localisation is specific to Sertoli cells in the 
testis (Figure 3-14a). RT-PCR revealed that Cdknb1 (the p27/kip transcript) was 
present in both the YFP+ and YFP- cell populations from both d15 and d22 testes, 
indicating that Sertoli cells were present in both YFP+ and YFP- cell populations 
from both ages (Figure 3-14b). Mouse Vasa homolog (MVH) localisation is specific 
to germ cells in the testis (Figure 3-15a). RT-PCR revealed that Ddx4 (the MVH 
transcript) was present in both YFP+ and YFP- cell populations from both d15 and 
d22 testes, although expression was weaker in d15 YFP+ population (Figure 3-15b). 
This indicated that germ cells were present in both YFP+ and YFP- cell populations 
from both ages, but potentially fewer were present in the d15 YFP sample. SMA 
localisation is specific to PTM and vascular smooth muscle cells in the testis (Figure 
3-16a). RT-PCR revealed that Acta2 (the SMA transcript) was present in both the 
YFP+ and YFP- cell populations from both d15 and d22 testes, although expression 
was much weaker in the YFP+ cell populations when compared to the YFP- cell 
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populations at both ages (Figure 3-16b). This indicated that PTM cells were present 
in YFP+ cell populations at a much lower level than in YFP- cell populations. 
3βHSD1 localisation is specific to Leydig cells in the testis (Figure 3-17a). RT-PCR 
revealed that Hsd13b (the 3βHSD1 transcript) was present in YFP- cell populations 
from both d15 and d22 testes but was not seen in YFP+ cell populations at either age 
(Figure 3-17b). This indicated that Leydig cells were only present in YFP- cell 
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Figure 3-14: Presence of Cdkn1b transcript in YFP+ and YFP- FACS samples 
(a) p27kip localisation is specific to Sertoli cells in the testis (b) Cdkn1b (the p27kip 





Figure 3-15: Presence of Ddx4 transcript in YFP+ and YFP- FACS samples  
(a) MVH localisation is specific to germ cells in the testis. (b) Ddx4 (the MVH transcript) was 
present in both YFP+ and YFP- cell populations from both d15 and d22 testes, although 
expression was weaker in d15 YFP+ population. 
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Figure 3-16: Presence of Acta2 transcript in YFP+ and YFP- FACS samples 
(a) SMA localisation is specific to PTM and vascular smooth muscle cells in the testis. (b) 
Acta2 (the SMA transcript) was present in both the YFP+ and YFP- cell populations from 
both d15 and d22 testes, although expression was much weaker in the YFP+ cell 
populations when compared to the YFP- cell populations at both ages. 
 
 
Figure 3-17: Presence of Hsd3b1 transcript in YFP+ and YFP- FACS samples 
(a) 3βHSD1 localisation is specific to Leydig cells in the testis (b) Hsd3b1 (the 3βHSD1 
transcript) was present in YFP- cell populations from both d15 and d22 testes but was not 
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3.3 Discussion 
The aims of this chapter were to characterise the expression of both post-meiotic 
germ cell and endothelial cell-specific Cre lines using fluorescent reporters and use 
them to ablate AR in these cell types, and also to investigate the possibility of using 
FACS to sort Sertoli cells from testes expressing a Sertoli cells-specific fluorescent 
reporter.  
 
The Tie2-Cre line was shown for the first time to be active in vascular and interstitial 
endothelial cells of the testis, based on the expression of a YFP reporter gene in 
Tie2-YFP mice. Vascular endothelial expression of the Tie2-Cre in several organs is 
well documented (Constien et al., 2001; Kisanuki et al., 2001), but its expression in 
both the vascular and interstitial endothelial cells is a novel finding. Based on these 
results, the Tie2-Cre line would be suitable for generating mice with testicular 
vascular and interstitial endothelial cell-specific ablation of a gene of interest by 
mating to a mouse line with a knock-in of a floxed version of that gene. Tie2-Cre 
was used to ablate AR in these cell types by mating to an ARflox line. Testes from 
Tie2-ARKO mice have a phenotype similar to testes from control littermates, with a 
normal testicular histology including complete spermatogenesis and the presence of 
morphologically mature spermatozoa in the cauda epididymis. There is no Cre-
recombined exon 2 band present in the RT-PCR of Tie2-ARKO testes. PCR on 
genomic DNA demonstrates that Cre has recombined Ar in the genome of the 
endothelial cells, but the endothelial cells do not express Ar so a recombined 
transcript is not seen. These results show that Tie2-Cre is effective at ablating the AR 
by recombination, but that the testicular endothelial cells do not express AR, which 
confirms reports in published literature (Vornberger et al., 1994). Since there is 
evidence in the literature that prostate vascular endothelial cells express AR (Godoy 
et al., 2008; Pelletier et al., 2000), then examinatio  of the prostates of the Tie2-
ARKO line could provide further information about the function of prostate vascular 
endothelial AR. As shown in Figure 3-1, vascular smooth muscle cells express AR, 
and when AR is ablated from this cell type using Cre-loxP, slight compensatory 
Leydig cell failure and a defect in testicular fluid exchange results, demonstrating 
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that  AR action in vascular smooth muscle cells may locally regulated microvascular 
blood flow within the testis (Welsh et. al, 2010b). 
 
The Aqp2-Cre line was shown for the first time to be active in post-meiotic germ 
cells based on the expression of a YFP reporter gene in Aqp2-YFP mice. This 
corroborates with the expression of endogenous Aqp2 (Nelson et al., 1998). Based on 
these results, the Aqp2-Cre line would be suitable for generating mice with post-
meiotic germ cell ablation of a gene of interest by mating to a mouse line with a 
knock-in of a floxed version of that gene. Aqp2-Cre was used to ablate AR in post-
meiotic germ cells by mating to an ARflox line. Testes from Aqp2-ARKO mice have a 
phenotype similar to testes from control littermates, with a normal testicular 
histology including complete spermatogenesis and the presence of morphologically 
mature spermatozoa in the cauda epididymis. There is no Cre-recombined exon 2 
band present in the RT-PCR of Aqp2-ARKO testes. Based on these results, either 
Cre has recombined AR in the genome of the post-meiotic germ cells, but they do 
not express AR so a recombined transcript is not seen, or post-meiotic germ cells do 
express AR but Cre ablation has not occurred at the genomic level which is why a 
recombined transcript is not seen. The way to definitively differentiate between these 
two possibilities would be to do a PCR across exon 2 of the genomic DNA rather 
than cDNA, as was performed on the Tie2-ARKO. In agreement with the hypothesis 
that germ cells do not express AR (O'Donnell et al., 2006), it is more likely that the 
Aqp2-Cre is effective at ablating the AR by recombinat on, but that post-meiotic 
germ cells do not express AR and that the elongatin spermatid staining seen both in 
some areas of the literature with the AR antibody used in this study is non-specific 
staining (Vornberger et al., 1994). 
 
Obtaining a fast, pure population of Sertoli cells by FAC-sorting cells from AMH-
YFP testes shows promise, but the protocol needs to be further refined to ensure high 
purity. Based on analysis of cell-specific marker expr ssion by RT-PCR, populations 
of YFP positive cells obtained from AMH-YFP testes have no Leydig cell 
contamination and very little PTM cell contamination at either d15 or d22. At both 
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ages, however, there is significant germ cell contamin tion. Experimentation with 
different protease enzymes and length and temperatur  of their digesting steps could 
potentially increase the dissociation of germ cells from Sertoli cells and therefore 
increase the purity of the cell population. Currently the protocol as it stands does not 
offer any advantages over other fast methods of isolat ng Sertoli cells. Mechanical 
dissociation and enzymatic digestion of neonatal rat testes followed by plating on D. 
stramonium lectin coated plates results in a population determined to be 95% Sertoli, 
4% PTM and 1% Leydig cell with no germ cell contaminat on (Scarpino et al., 
1998). However, a pure population of Sertoli cells is difficult to achieve when adult 
testes are used, and a combination of mechanical dissociation and enzymatic 
digestion on adult rat testes yields a population of cells that is determined to be 80% 
Sertoli cell, 10% germ cell and 10% PTM cell (Anway et al., 2003). It is likely that 
the germ cell contamination will be the most difficult to eliminate when attempting 
to isolate Sertoli cells from adult testes, due to the many diverse junction complexes 
that exist between the two cell types (Mruk and Cheng, 2004). If suitable Cre lines 
can be chosen then FACS isolation could be used to a greater effect for Leydig cell 
populations of the adult testis. As the cells are int rstitial then seminiferous tubules 
would not need to be mechanically dissociated and a mild enzymatic treatment of a 
decapsulated testis would potentially be enough to release interstitial cells into a 
single-cell suspension. The maturation of adult Leydig cells proceeds through several 
precursor stages, each of which expresses a specific transcriptome (Chen et al., 
2009a). Use of an appropriate Cre line could label on  of these populations and allow 
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4. Characterisation of the testicular phenotype of the FoxG1-
ARKO mouse 
4.1 Introduction 
The Cre/loxP transgenic system of cell-specific genetic ablation (section 1.1.2) has 
been an important tool in elucidating the action of androgen receptor (AR) within the 
male reproductive system. The Sertoli-cell androgen receptor knock-out (SCARKO) 
mouse line is a well-characterised model of cell-specific AR ablation using the Cre-
lox system (Chang et al., 2004; De Gendt et al., 2004). Cre is driven by the AMH 
promoter, specific to Sertoli cells in the male during embryonic life. ARflox mice are 
transgenically modified so that exon 2 of each copy f the Ar gene is flanked by loxP 
sites (De Gendt et al., 2004). Half of the male offspring from matings between 
AMH-Cre males and ARflox females are SCARKO mice. Two separate groups have 
characterised the SCARKO model and although both report the mice to be infertile, 
with an absence of post-meiotic spermatocytes and spermatids, there is conflicting 
evidence as to whether SCARKO mice have a change in serum hormone levels. 
However, the De Gendt group report that the seminal vesicle weight of the SCARKO 
is similar to the controls (De Gendt et al., 2004), and the Chang group report there 
was no difference in most of the genitourinary organs’ (Chang et al., 2004) between 
SCARKO and controls, suggesting that systemic testoster ne levels are unchanged.   
 
Expression of the AMH-Cre transgene in Sertoli cells occurs at e15 (Lecureuil et al., 
2002) before AR is widely expressed in Sertoli cells at d5 (Willems et al.). The 
SCARKO model recombines genomic AR before transcription and translation has 
begun in embryonic Sertoli cells. Hence, the Sertoli cells in SCARKO mice never 
express functional AR protein and spermatocytes arrest at the beginning of meiosis. 
This prevents the elucidation of the action of AR via Sertoli cells on post-meiotic 
spermatids. Rodent models with a systemic decrease in testosterone levels 
demonstrate several problems with round spermatid adhesion and spermiation 
(Holdcraft and Braun, 2004; O'Donnell et al., 1996; Saito et al., 2000), and it would 
be interesting to discover whether spermatid maturation and spermiation are 
Chapter 4: Characterisation of the testicular phenotype of the FoxG1-ARKO mouse                       122   
 
mediated by Sertoli cell AR signalling. This could be achieved with the generation of 
an ‘adult SCARKO’ where the Sertoli cell-specific promoter is activated after mature 
spermatozoa are produced and the testicular phenotype is analysed shortly 
afterwards, thus allowing the effect of Sertoli cell-specific AR ablation on post-
meiotic germ cells to be elucidated. 
 
Establishment and analysis of a conditional gene ablation model requires a well-
characterised Cre-line and thorough analysis of any resulting phenotype. In order to 
generate an adult SCARKO model, the Cre line used would have to be driven by a 
Sertoli-cell specific promoter so AR ablation would also be Sertoli-cell specific. It 
also needs to be expressed post-pubertally so Sertoli cells express AR for some time 
before it is ablated. Then, the Cre line should be fully tested using a fluorescent 
reporter to assess the penetrance of the Cre expression in the target cell population, 
as well as identifying the possibility of non-specific Cre expression in other cell 
types. The Cre line of interest can then be mated to the ARflox mouse line and the 
resulting ablation of AR assessed using cell and molecular biology techniques. 
Finally, if an infertility phenotype has resulted from the knock-out, differences 
between the knock-out and the control must be charaterised. Parameters to look at 
when assessing testis function and determining infert lity include serum and intra-
testicular hormone measurements, histological assessment of the testes and 
reproductive tract, and immunochemistry and quantittive RT-PCR for genes of 
interest that may be altered in the mutant line.  
 
Preliminary data from the Smith group had suggested that FoxG1-Cre would be a 
good Cre line to use to generate an adult SCARKO model. FoxG1 is primarily 
characterised in the development of the cerebral hemispheres (Xuan et al., 1995), but 
FoxG1 transcript has also previously been identified in the testis of humans, but not 
rodents (Obendorf et al., 2007). Despite this finding, preliminary 
immunohistochemistry on adult wild-type mouse testis howed FoxG1 was localised 
to all Sertoli cells. With preliminary expression data and the FoxG1-Cre line 
available for use, the aim was to utilise it to create an adult SCARKO line.  




• To analyse the pattern of expression of FoxG1 in the testis and determine its 
suitability for producing mice with an adult-onset Sertoli cell-specific knock-
out of AR 
• To generate ‘FoxG1-ARKO’ mice with an adult-onset Sertoli cell-specific 
knock-out of AR 
•  To analyse any resulting reproductive phenotype of these mice 
 
4.2 Results 
4.2.1 FoxG1 localisation in the embryonic and post- natal testis 
To assess the localisation of FoxG1 during development of the testes, 
immunohistochemistry using FoxG1 antibody was performed at several 
developmental time-points (Figure 4-1). FoxG1 protein was present in the testis from 
e12.5, but was not consistently present in one particular testicular cell type during 
development. At e12.5 to e13.5 FoxG1 protein was observed in the somatic cells of 
the developing testis cords. Localisation was then seen to switch to a sub-population 
of interstitial cells starting at e15.5 until d2. FoxG1+ interstitial cells were also 
3βHSD1+, demonstrating that they were fetal Leydig cells, but not all 3βHSD1+ 
cells were FoxG1+. One theory to explain this interesting staining pattern is that 
FoxG1 is transiently expressed in all fetal Leydig cells but not at the same time in all 
cells, another is that there is a sub-population of fetal Leydig cells that express 
FoxG1 and a sub-population that do not. By d12, FoxG1 was localised in the somatic 
cells of the seminiferous tubules, which at this age re morphologically identifiable 
as Sertoli cells. FoxG1 also continued to be localised to some interstitial cells. 
Expression was restricted to the nucleus rather than being both nuclear and 
cytoplasmic as it was in other cell types. FoxG1 continued to be localised in this 
pattern when assessed at d100. FoxG1 did not localise to the germ cells of the testis 
cords at any time-point observed.  
Chapter 4: Characterisation of the testicular phenotype of the FoxG1-ARKO mouse                       124   
 
 
Figure 4-1: FoxG1 expression in pre and post-natal wild-type mouse testis 
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Figure 4-1: FoxG1 expression in pre and post-natal wild-type mouse testis (figure on 
preceding page) 
(a): At e13.5 FoxG1 protein is localised to nucleus and cytoplasm of somatic cells of 
developing testis cords (solid arrowhead). FoxG1 does not localise to germ cells of testis 
cords (outline arrowhead). (b): By e15.5 FoxG1 staining is almost absent from testis cords 
(outlined in white and marked with an X), but staining is strong in nucleus and cytoplasm of a 
population of interstitial cells (arrow). This staining pattern is also seen at e17.5 and d2. (c): 
At e15.5 all FoxG1 positive cells stain positive for 3β HSD1 (solid arrow), but there is also a 
population of 3beta HSD1 positive cells that do not stain positive for FoxG1. (d): By d12, 
nucleus and cytoplasm of all Sertoli cells stain positive FoxG1 (solid arrowhead), and nuclei 
of some interstitial cells stain positive for FoxG1 (solid arrow). Germ cells do not stain for 






















Chapter 4: Characterisation of the testicular phenotype of the FoxG1-ARKO mouse                       126   
 
4.2.2 FoxG1-Cre stud males are fertile and do not d isplay a reproductive 
phenotype 
The FoxG1-Cre mouse line contains a knock-in of Crerecombinase at one of the 
FoxG1 loci, resulting in haploinsufficiency of FoxG1. Previous literature has stated 
that haploinsufficiency of another Fox gene, FoxA3 has resulted in a testicular 
phenotype (Behr et al., 2007). To confirm that the loss of one allele of FoxG1 did not 
induce a reproductive phenotype, reproductive tissue  were examined from aged 
males carrying the FoxG1-Cre transgene but no floxed AR. The testes of all FoxG1-
Cre males had no degeneration of the seminiferous epithelium and visually normal 
spermatogenesis, and were fertile with mature sperm in their cauda epididymis 
(Figure 4-2). That FoxG1-Cre males were used as studs to sire FoxG1-ARKO and 







Figure 4-2: Phenotype of FoxG1-Cre mice compared to FoxG1-ARKO and control. 
(a): d100 FoxG1-Cre mice have normal spermatogenesis (arrowhead) and no degeneration 
of the seminiferous epithelium. (b): d100 FoxG1-Cre mice have spermatozoa in the lumen of 
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4.2.3 Determining site of action of Cre recombinase  in FoxG1-Cre testes 
Testes from d100 FoxG1-YFP mice appeared fluorescent when viewed under a 
microscope with a YFP filter (Figure 4-3), with foci of YFP fluorescence in short 
lengths of tubules (Figure 4-3, arrow) as well as a fainter dispersed fluorescence 
throughout the tissue. To determine the localisation f this fluorescence, 
immunohistochemistry using a GFP/YFP antibody was performed on thin sections of 
FoxG1-YFP and control testes. This revealed that YFP expression in FoxG1-YFP 
testes was not localised to any one cell type (Figure 4-4). YFP was localised in some 
Sertoli cells, clusters of germ cells and some interstitial cells. Staining was 
heterogeneous and some tubule cross sections did not express YFP in any cell types. 
The pattern of YFP expression observed in these mic was not analogous to either 
endogenous FoxG1 expression (in which expression is seen in all Sertoli and some 
Leydig cells, see Figure 4-1), or YFP expression in an AMH-YFP mouse (in which 





Figure 4-3: d100 FoxG1-YFP and control testes viewed under a fluorescent filter 
FoxG1-YFP testes show foci of YFP fluorescence in short lengths of tubules (arrow) as well 
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Figure 4-4: Localisation of YFP in FoxG1-YFP testes compared to AMH-YFP testes 
(a) In d100 FoxG1-YFP testes, YFP is localised to some Sertoli cells (arrow) and also 
clusters of germ cells (outline arrowhead).  (b) YFP is localised to some Sertoli cells (arrow) 
and some interstitial cells (solid arrowhead). (c) Staining is heterogeneous and some tubule 
cross-sections do not express YFP in any cell types (asterisks) (d) Testes from control 
littermates do not stain for YFP. (e) AMH-YFP mice express YFP in all Sertoli cells of the 
testis (arrow).Scale bars are all 100µm. 
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4.2.4 Testis phenotype of FoxG1-ARKO mice 
FoxG1-ARKO mice were generated as described in materials and methods. As the 
original plan was to ablate AR in the adult testes, this was the first organ to be 
analysed. d100 testes were the first to be examined. Testes from d100 FoxG1-ARKO 
mice appeared visibly smaller than control testes during necroscopy, but all other 
reproductive tissues appeared similar to controls. Mean testis weight of FoxG1 mice 
was significantly reduced compared to controls at d100 (107.5 ± 3.9 mg control, 86.8 






Figure 4-5: Mean weight of testes from control and FoxG1-ARKO mice measured at 
selected post-natal ages 
Mean weights of testes from FoxG1-ARKO mice are not significantly different to controls at 
d11 and d16. At d21, d35, d50 and d100, FoxG1-ARKO mice have significantly smaller 
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When examined histologically, control testes appeared normal, with all stages of 
spermatogenesis present within a functioning seminiferous epithelium. By contrast, 
FoxG1-ARKO testes displayed tubules that had lost germ cells, appeared to have a 
lumen of increased diameter and the seminiferous epithelium of some tubules was 
almost completely atrophic (Figure 4-6). In control animals, the rete testis was 
normal and lacked spermatozoa as expected, compared to the FoxG1-ARKO rete 
which was distended and contained spermatozoa and pieces of sloughed 




Figure 4-6: Histology of testes from control and FoxG1-ARKO mice at d100 
At d100, all tubule cross-sections in the control appear to have a functioning seminiferous 
epithelium (arrowhead) and a lumen (asterisk). In the FoxG1-ARKO the tubule lumens 
appear bigger (asterisk), and although some areas of the seminiferous epithelium show 
normal spermatogenesis (arrowhead), others appear to be missing germ cells (arrow). In the 
control, the rete testis is small and empty of sperm (cross) compared to the FoxG1-ARKO 
rete which is distended and contains spermatozoa and pieces of sloughed seminiferous 
epithelium (cross).Scale bars are 200 µm. 
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Mean seminiferous tubule radius is significantly decreased in FoxG1-ARKO testes 
compared to control testes (106 µm control, 96 µm FoxG1-ARKO, P≤0.05, Figure 4-
7a) and mean lumen diameter is significantly increased (38 µm control, 51 µm 
FoxG1-ARKO, P≤0.001, Figure 4-7a).  
 
Figure 4-7: Radii of seminiferous tubule and tubule lumen cross-sections from d21 
and d100 control and FoxG1-ARKO testes 
(a) At d21, FoxG1-ARKO mean seminiferous tubule radius and mean tubule lumen radius 
are not significantly different to controls, but at d100 FoxG1-ARKO tubules have a 
significantly smaller mean radius than controls but a significantly larger mean lumen radius. 
Values are means of 5 samples for each group consisting of the mean of 100 tubule/lumen 
radii measured per sample ± SEM. (b) Graphs represented as scatter plots, so all tubule 
lumen/radius measurements for each of the 5 samples in each group can be observed. Error 
bars are standard deviations. Note that at d100 the spread of data is much larger in FoxG1-
ARKO tubule and lumen measurements. n=5 mice, ~100 tubule measurements from each. 
*P≤0.05, **P≤0.01. 
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This data demonstrates that seminiferous tubules ar not distended in the FoxG1-
ARKO as appears in histological section and in fact re smaller. This can be 
explained by the presence of completely atrophied tubules that no longer appear 
circular in cross section but are flattened due to the loss of tubule structure after 
atrophy. The increase in tubule lumen diameter could imply that the seminiferous 
tubules are distended but because the tubule diameter itself is not also increased it is 
more likely to be explained by a loss of germ cells from the seminiferous epithelium, 
perhaps by sloughing. The standard deviations of both individual tubule radius (12.8 
µm control, 19.8 µm FoxG1-ARKO) and lumen radius (10.7 µm control, 22.8 µm 
FoxG1-ARKO) measurements is larger for the FoxG1-ARKO data than the control 
data, implying that variation in FoxG1 ARKO tubules is greater (Figure 4-7b). This 
can be explained in tandem with the histological observations as normal, sloughed 
(normal tubule radius but larger lumen radius) and trophied (reduced tubule and 
lumen radius ‘collapsed’ appearance) tubule cross sections can all be seen in the 
same FoxG1-ARKO testis thin-sections. Similar to the SCARKO mouse phenotype, 
there is also a reduction in weight compared to controls, but the histology of the 
phenotype is very different. The SCARKO mouse has a post-meiotic germ cell block 
(De Gendt et al., 2004), whereas the FoxG1-ARKO has all stages of spermatogenesis 
present, but sloughing of the seminiferous epithelium. With the aim to document the 
progression of this phenotype, weighing and histological analysis was performed on 
the testes at the selected post-natal ages of d2, d11, d16, d21, d35.  
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Figure 4-8: Histology of testes from control and FoxG1-ARKO mice at selected post-
natal ages to d21 
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Figure 4-8: Histology of testes from control and FoxG1-ARKO mice at selected post-
natal ages to d21 (figure on preceding page) 
At d2 FoxG1-ARKO testes are morphologically similar to controls, with no seminiferous 
tubule lumens (outline arrows). At d11, some lumens are beginning to form in controls (solid 
arrows), but tubule lumens have not begun to develop in FoxG1-ARKO testes (outline 
arrows). At d16 nearly all tubules in control testes appear to have developed lumens (solid 
arrows), in the FoxG1-ARKO some tubules are beginning to develop cruciate lumens 
(arrowhead) whilst others are closed. At d21 seminiferous tubule lumens are patent in 
control and FoxG1-ARKO (solid arrows). Scale bars are 200µm. 
 
At d2 FoxG1-ARKO testes were histologically similar to controls (Figure 4-8). 
Testes at this age were too small to register an accur te weight reading on the 
balance used, so weights were not taken, but FoxG1-ARKO testes appeared grossly 
similar to controls.  
 
At d11, there was no significant difference in mean testis weight to controls (6.4 ± 
0.3 mg control, 6.7 ± 0.3 mg FoxG1-ARKO, P>0.05, Figure 4-5), but differences in 
histology had become apparent. Some seminiferous tubule lumens were beginning to 
form in controls (Figure 4-8, solid arrows), but tubule lumens had not begun to 
develop in FoxG1-ARKO testes. When quantified, the m an percentage of tubule 
cross-sections with a lumen was significantly lower (23% in control testes compared 
to 7% in FoxG1-ARKO testes, P≤0.01, Figure 4-9). 
 
At d16 mean testis weight is lower in FoxG1-ARKO compared to controls (13.7 ± 
0.8 mg control, 11.4 ± 0.7 mg FoxG1-ARKO, P>0.05, Figure 4-5). Though this 
difference is not significant, the P value is 0.0504 which is extremely close to being 
significant (P≤0.05).  When quantified, the mean percentage of tubule cross-sections 
with a lumen was again significantly lower (75% in control testes compared to 36% 
in FoxG1-ARKO testes, P≤0.05, Figure 4-9). Nearly all tubules in control testes 
appear to have developed lumens. Lumens that have formed in control seminiferous 
tubules are round, but those that have formed in FoxG1-ARKO seminiferous tubules 
were stellate (Figure 4-8).  
 




Figure 4-9: Mean percentage of seminiferous tubules lumens open in testis sections 
from d11, d16 and d21 control and FoxG1-ARKO testes 
At d11 and d16, the percentage of seminiferous tubule lumens open in sections of FoxG1-
ARKO testes is significantly lower than controls. At d21 the percentage of seminiferous 
tubule lumens open in sections of FoxG1-ARKO testes is not significantly different to 
controls. n=5 mice, ~100 tubule measurements from each. *P≤0.05, **P≤0.01. 
 
 
At d21 mean FoxG1-ARKO testis weight was significantly less than control testis 
weight (29.5 ± 1.6 mg control, 19.7 ± 1.8 mg FoxG1-ARKO, P≤0.01, Figure 4-5). 
The mean percentage of open FoxG1 tubule lumens was not significantly different to 
the control (87% in control testes compared to 71% in FoxG1-ARKO testes, P>0.5, 
Figure 4-9). FoxG1-ARKO seminiferous tubule radii (69.5 µm control, 67.5 µm 
FoxG1-ARKO, P>0.5, Figure 4-7) and lumen radii (22.3 µm controls, 18.5 µm 
FoxG1-ARKO, P>0.5, Figure 4-7) were not significantly different to controls, 
evidence that the apparent delay in lumen opening of the FoxG1-ARKO was 
resolved by d21. This is also apparent histologically, at d21 seminiferous tubule 
lumens are patent in control and FoxG1-ARKO (Figure 4-8). 
 
At d35 mean FoxG1-ARKO testis weight is significantly less than controls. (80.3 ± 
3.9 mg control, 65.8 ± 3.8 mg FoxG1-ARKO, P≤0.01, Figure 4-5). d35 control testes 
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had full spermatogenesis and patent seminiferous tubule lumens (Figure 4-10a). Of 
the seven d35 FoxG1-ARKO testes analysed, all appeared to have normal 
spermatogenesis, but three of these displayed a patent lumen akin to the control 
(Figure 4-10b), three had distended lumens that appeared larger than the control 
(Figure 4-10c) and one displayed evidence of the initiation of seminiferous epithelial 
sloughing (Figure 4-10d).  
 
 
Figure 4-10: Histology of testes from control and FoxG1-ARKO mice d35 
(a) d35 control testes have patent lumens (solid arrow). (b) An example of a d35 FoxG1-
ARKO testis with morphology similar to control and patent lumens (solid arrow). (c) An 
example of a d35 FoxG1-ARKO testis with distended lumens but without tubule atrophy 
(arrowhead). (d) An example of a d35 FoxG1-ARKO testis with seminiferous epithelial 
sloughing (outline arrow) as well as normal (solid arrow) and distended (arrowhead) lumens. 
Scale bars are 200µm. 
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4.2.5 Systemic androgen-dependent phenotype of FoxG 1-ARKO mice 
Disruption of androgen signalling has quantifiable effects on whole body hormone 
levels as well as the structure and function of other reproductive organs. To 
determine if a systemic change in androgen levels had occurred, specific 
physiological parameters were quantified. Testostern  is produced by the Leydig 
cells of the testis. As well as acting within the testis it is also released into blood 
vessels in the testis for transport around the body. Its production is promoted by LH, 
which is produced in the pituitary gland in response to a decrease in circulating 
testosterone levels (section 1.5). Serum testosterone and LH concentration was 
measured at several key ages. Testosterone concentratio s were not significantly 
different in FoxG1-ARKO males compared to controls (P>0.05) at d16, d21, d35 or 
d100 (Figure 4-11).  Due to difficulty obtaining sufficient serum from smaller 
animals, LH was measured at d35 and d100, but no significant difference was seen 
between control and FoxG1-ARKO animals at these ages (Figure 4-11). 
 
a             b 
    
Figure 4-11: Serum T and LH concentrations of control and FoxG1-ARKO mice 
measured at selected post-natal ages 
(a) Serum T concentration does not differ in FoxG1-ARKO mice compared to controls at d16, 
d21, d35 and d100. (b) Serum LH concentration does not differ in FoxG1-ARKO mice 
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Anogenital distance, seminal vesicle weight and body weight are all influenced by 
circulating androgen concentrations. Anogenital distance (AGD), the distance 
between the anus and base of the phallus, is greater in male mice than in female 
mice. A reduction in AGD is indicative of a decreas in exposure to androgens 
during the male programming window (Welsh et al., 2007), and total ARKO male 
mice have an AGD akin to females (Yeh et al., 2002).  AGD of FoxG1-ARKO males 
did not differ significantly compared to controls at d11, d16, d21, d35 and d100 
demonstrating that pre-natal androgen concentrations were normal (Figure 4-12).  
 
 
Figure 4-12: AGD of control and FoxG1-ARKO mice measured at selected post-natal 
ages 
AGD is not significantly different in FoxG1-ARKO mice compared to controls at d11, d16, 
d21, d35 and d100. n≥4 for each group. All values are means ± SEM. 
 
The seminal vesicles are Wolffian duct-derived structures. They are present in 
rudimentary form until puberty, when they begin to grow and produce seminal 
plasma, which contributes to the ejaculate. Seminal vesicles are dependent on 
androgen signalling for development and subsequent maintenance of their structure 
and function. When this is perturbed they are smaller and weigh less than controls 
(Simanainen et al., 2008; Welsh et al., 2010a). Weight of seminal vesicles of FoxG1-
ARKO males did not differ significantly compared to c ntrols at d11, d16, d21, d35 
and d100 implying that post-natal androgen levels were normal (Figure 4-13).  
 
Chapter 4: Characterisation of the testicular phenotype of the FoxG1-ARKO mouse                       139   
 
       
Figure 4-13: SV weight of control and FoxG1-ARKO mice measured at selected post-
natal ages 
SV weight does not significantly differ in FoxG1-ARKO mice compared to controls at d35 and 
d100. n≥5 for each group. All values are means ± SEM. 
 
 
Body-weight is androgen dependent, and was measured to check that there was no 
growth or metabolic effects of the knock-out. ARKO males weigh less than controls 
due to a reduction in weight of bone (Yeh et al., 2002) and muscle (MacLean et al., 
2008). Body weight of FoxG1-ARKO males did not differ significantly compared to 
controls at d11, d16, d21, d35 and d100 (Figure 4-14). Based on these observations, 
it was concluded that the testicular phenotype noted in the FoxG1-ARKO males was 
not due to a reduction in circulating testosterone lev ls. 
 
 
Figure 4-14: Body weight of control and FoxG1-ARKO mice measured at selected 
post-natal ages 
Body weight does not differ in FoxG1-ARKO mice compared to controls at d11, d16, d21, 
d35 and d100. n≥5 for each group. All values are means ± SEM. 
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4.2.6 Investigating fertility in FoxG1-ARKO mice 
Since the FoxG1-ARKO had a severe testicular phenotype, experiments were 
undertaken to investigate its fertility. Spermatozoa are stored in the cauda epididymis 
before entering the vas deferens prior to ejaculation. In d100 FoxG1-ARKO mice 
very few spermatozoa were present although proteinac ous material could be widely 
detected (Figure 4-15, asterisks). A few spermatozoa could be observed in the cauda 
epididymis (Figure 4-15, arrow).  
 
 
Figure 4-15: Histology of cauda epididymides from d100 control FoxG1-ARKO mice 
d100 control mice have densely-packed spermatozoa in the lumen of their cauda 
epididymides (cross). Cauda epididymides of d100 FoxG1-ARKOs contain proteinaceous 
material (asterisks) and a few sperm-heads (higher magnification, arrowhead) 
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FoxG1-ARKO males sired significantly fewer litters, (with just a single mating 
proving successful, representing 6% of total matings undertaken) than controls (83% 
of matings; χ2 P≤0.001, Figure 4-16). Furthermore, the sole FoxG1-ARKO male that 
did produce a litter failed to produce litters in three further matings. However, 
postcopulatory vaginal plugs were evident after FoxG1-ARKO males were paired 
with females overnight, implying that normal mating behaviour and ejaculation had 
occurred. Moreover, the frequency of plugs in females paired overnight with FoxG1-
ARKO males (50%) was no lower than in those paired with control males (33%). 
 
 
Figure 4-16: Fertility testing of d100 control and FoxG1-ARKO mice 
Significantly fewer matings between d100 FoxG1-ARKO males and wild-type females sire 

















Histological examination of the efferent ducts and rete testis junction of the d100 
FoxG1-ARKO revealed that spermatozoa have accumulated in the efferent ducts, 




Figure 4-17: Low magnification comparison of rete and efferent ducts of control and 
FoxG1-ARKO at d100 
The rete of the FoxG1-ARKO is distended with spermatozoa, unlike the rete of the control 
which is smaller and lacks spermatozoa (arrowheads). The efferent ducts of the FoxG1-
ARKO are distended with spermatozoa, unlike the efferent ducts of the controls which 
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4.2.7 Identifying the location of AR ablation in Fo xG1-ARKO testis 
To determine if the phenotype seen in the testis of FoxG1-ARKO mice was caused 
by ablation of AR in any of the testicular cell types, presence of wild-type AR in the 
testis was assessed at both the transcript and protein level. Presence of recombined 
and full-length Ar exon 2 in the testis as indicated by RT-PCR indicated that there 
was ablation of AR in a population of cells in the testis, but that ablation is not total 
(Figure 4-18). Percentage of cells ablated cannot be determined from an RT-PCR as 
it is not quantitative (see section 2.8). To determine the cell-types in which AR is 
ablated, immunohistochemistry for AR was performed both as 




Figure 4-18: Presence of wild-type and/or Cre-recombined Ar transcript in d100 
control and FoxG1-ARKO testis 
 RT-PCR on d100 control testes confirms all Ar transcripts are wild-type (upper band). d100 
FoxG1-ARKO testes express both full length and recombined (lower band) Ar transcripts. 
Total ARKO testis expresses only recombined AR. Gel is shown both underexposed (a) and 
overexposed (b) so the presence of all stated bands can be confirmed. 
 
Sertoli cells express AR from d5 (Willems et al., 2010). A single AR immuno 
revealed the presence of AR+ cells with Sertoli cell morphology in the testes of d100 
control and FoxG1-ARKO mice (Figure 4-19). AR was not identified in any 
intratubular cells at d2 in either control or FoxG1-ARKO testes. Double 
immunohistochemistry for AR with the Sertoli-cell specific markers Wilms’ tumour 
suppressor (WT1) or Cyclin-dependent kinase inhibitor 1B (p27/kip) was attempted 
to quantify any ablation but was unsuccessful in both cases. 
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Figure 4-19: Localisation of AR protein in testes from control and FoxG1-ARKO mice 
at d2 and d100  
Control testes at d2 stain positive for androgen receptor in both the PTM cells (solid arrows) 
and a population of the interstitial cells (solid arrowheads). Staining in FoxG1-ARKO testes is 
similar to the control. At this age Sertoli cells do not strongly express AR in either the control 
or FoxG1-ARKO testes (circled). There are also populations of interstitial cells with Leydig 
cell morphology that do not express AR in both the control and the FoxG1-ARKO (outline 
arrowhead).  At d100, AR staining is present in some interstitial cells with Leydig cell 
morphology in both the control and FoxG1-ARKO (outline arrow), all PTM cells in both 
control and FoxG1-ARKO (solid arrows) and is now strong in Sertoli cells in both control and 
FoxG1-ARKO (circled). Some cells with Leydig cell morphology in the FoxG1-ARKO do not 
express AR (outline arrowhead). Scale bars are 100 µm. 
 
Adult Leydig cells are thought to express AR from the precursor Leydig cell (PLC) 
stage (Chen et al., 2009a). Cells with definitive Leydig cell morphology can be seen 
to stain positive for AR from d21 in the mouse (Zhou et al., 2002). At early postnatal 
ages involuting AR-negative fetal Leydig cells may also be seen in the testis (Kerr 
and Knell, 1988), as well as AR-positive cells with a mesenchymal morphology 
(Willems et al., 2009). A single AR immuno revealed the presence of AR+ 
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interstitial cells at both d2 and d100 in both the control and FoxG1-ARKO (Figure 4-
19). To determine whether any ablation of AR had occurred in Leydig cells, double-
antibody immunohistochemistry of AR with 3βHSD1 (a Leydig cell-specific protein 
involved in steroidogenesis) was performed on d100 control and FoxG1-ARKO 
testes (Figure 4-20). In d100 controls, all 3betaHSD1+ cells were also AR+. In 
FoxG1-ARKO testes at d100, some 3betaHSD1+ cells were AR+ and some were 
AR-. This ablation was not quantified.  
 
 
Figure 4-20: Localisation of AR protein in Leydig cells of control and FoxG1-ARKO 
mice at d100 
(a and b): In d100 controls, all 3betaHSD1+ cells are also AR+ (arrowheads). (c): In FoxG1-
ARKO testes at d100, some 3betaHSD1+ cells are AR+ (arrowhead), but some are AR- 
(arrow) (d) High magnification of a group of AR+ 3betaHSD1+ interstitial cells (arrowhead) in 
a d100 FoxG1-ARKO testis (e) High magnification of a group of interstitial cells in a d100 
FoxG1-ARKO testis containing both AR+3betaHSD1+ cells (arrowhead) and AR- 
3betaHSD1+ cells (arrow). Scale bars for a and c are 100 µm, for b, d and e are 10 µm. 
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PTM cells express AR from at or before e16.5 in the mouse (Drews et al., 2001). A 
single AR immuno revealed the presence of AR+ peritubular cells in the testes of 
both d2 and d100 control and FoxG1 mice (Figure 4-19). To determine whether any 
ablation of AR had occurred in PTM cells, a double immuno of AR with SMA (a 
smooth muscle cell-specific protein) was performed on d100 control and FoxG1-
ARKO testes (Figure 4-21). All SMA+ cells are also AR+ in all testes examined for 
both control and FoxG1-ARKO testes at d100.  
 
 
Figure 4-21: Localisation of AR protein in PTM cells of control and FoxG1-ARKO mice 
at d100 
(a and b): In control testes at d100, all SMA+ cells are also AR+(arrows).  
(c and d): In FoxG1-ARKO testes at d100,  all SMA+ cells are also AR+. Scale bars for a and 
c are 100 µm, for b and d are 10 µm. 
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4.2.8 Identification of other sites of AR ablation in the FoxG1-ARKO mouse 
To determine whether ablation had occurred in any other tissues known to express 
AR, RT-PCR for Ar exon 2 was performed on tissues from d100 FoxG1-ARKO mice 
(Figure 4-22). Wild-type Ar transcript only was observed in the epididymis/efferent 
ducts and prostate, recombination of some, but not all Ar transcript was noted in 
testis, brain, penis, kidney, adrenal and seminal vesicle, and recombination of AR 





Figure 4-22: Presence of wild-type and/or Cre-recombined Ar transcript in a panel of 
tissues from d100 FoxG1-ARKO mice 
Expression of wild-type full-length Ar transcript (upper band) only is noted in control testis, as 
well as FoxG1-ARKO epididymis and ventral prostate. Some recombination of Ar exon 2, 
resulting in a truncated Ar transcript (lower band) is noted in FoxG1-ARKO testis, brain, 
penis, kidney, adrenal and seminal vesicles. The majority of Ar transcript in the FoxG1-
ARKO pituitary is recombined (lower band). All Ar transcript in the ARKO testis is 
recombined (lower band).  
 
 




The aims of this chapter were to characterise the expression of FoxG1 in the testis, 
determine the suitability of FoxG1-Cre for producing mice with an adult-onset 
Sertoli cell-specific knock-out of AR, and to generat  and analyse the phenotype of 
FoxG1-ARKO male mice. FoxG1-Cre was initially utilised to produce an ‘adult-
SCARKO’ ablation of AR in post-pubertal Sertoli cells based on 
immunohistochemistry confirming its expression in adult Sertoli cells. 
Immunohistochemistry on further ages demonstrated that endogenous FoxG1 is not 
present in fetal or neonatal Sertoli cells from e15.5 until d2, but is present in Sertoli 
cells from d12 onwards. Endogenous FoxG1 is also present in the somatic cells of 
the developing testicular cords at e12.5 and e13.5, in fetal Leydig cells from e15.5 
until d2, and is still seen in some interstitial cells at d12 and d100 (the nature of these 
interstitial cells could not be determined due to a lack of sufficient FoxG1 antibody 
for double immunohistochemistry experiments to be performed). The 
characterisation pattern of expression of FoxG1 in the testis is a novel result, 
previous literature has reported that it is present in the human but not rodent testes 
when examined by Northern blot, and cellular localisation has not previously been 
characterised (Obendorf et al., 2007). Full analysis of the expression pattern of 
FoxG1 at embryonic, perinatal and adult ages before a FoxG1-Cre was used to 
selectively ablate AR would have excluded it from being suitable for both Sertoli 
cell-specific gene ablation (as it is also expressed in fetal Leydig cells and interstitial 
cells of the adult) and adult-SCARKO generation (as it i  expressed from d12 and 
mature spermatozoa are not generated until between d30 and d35 in the mouse (Borg 
et al., 2010). However, by the time this immunohistochemical study had been 
performed, tissue from FoxG1-YFP and FoxG1-ARKO mice was already being 
analysed. 
 
FoxG1-Cre has been used to ablate ten different genes in the developing forebrain 
but has not been used in gene ablation studies in ti sues other than the brain (Arnold 
et al., 2006; Barrionuevo et al., 2008; Chen et al., 2006; Chen et al., 2009b; Fuccillo 
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et al., 2004; Gordon et al.; Hurd et al.; Hwang et al.; Pirvola et al., 2002; Wang et 
al.). Genetic background has previously been shown to affect the expression of 
FoxG1-Cre. 129SvJ embryos demonstrate a pattern of FoxG1-Cre action almost 
exclusively in the forebrain, whereas BALB/c embryos demonstrate Cre 
recombination in most tissues observed (Hebert and McConnell, 2000). Analysis of 
the expression pattern of YFP in FoxG1-YFP reporter mice revealed that FoxG1-Cre 
is not expressed in the same cell types as endogenous FoxG1 in the testis. Whereas 
endogenous FoxG1 is present in all adult Sertoli cells, YFP is only present in a few 
adult Sertoli cells, demonstrating that FoxG1-Cre has been active in these cells 
during their development. Endogenous FoxG1 is expressed in fetal Leydig cells and 
adult interstitial cells. YFP is present in some adult interstitial cells demonstrating 
that FoxG1-Cre has been active in these cells during their development. Since 
endogenous FoxG1 is present in both fetal Leydig cells and postnatal interstitial cells 
and it is not known if the interstitial cells are Lydig cells or mesenchymal cells, the 
activation of FoxG1-Cre could have happened at any age. It appears that Leydig cell 
FoxG1-Cre activation more accurately mirrors endogen us FoxG1 Leydig cell 
expression than the Sertoli cell FoxG1-Cre. Endogenus FoxG1 is not seen in germ 
cells at any age, but YFP expression is present in clones of germ cells, indicating that 
FoxG1-Cre has been active in these cells during their development. Ectopic Cre 
activity during gametogenesis has been recorded in some lines (including FoxG1-
Cre, also known as BF1-Cre) and has been hypothesised to occur when progenitor 
germ cells commit to terminal differentiation and enter gametogenesis, at which time 
the floxed allele may undergo Cre-mediated recombinatio  (Weng et al., 2008). The 
inconsistent expression pattern of FoxG1-Cre compared to FoxG1 is novel compared 
to its activity in the developing brain, where it faithfully reproduce the expression of 
endogenous FoxG1 (Hebert and McConnell, 2000). The diff rences in FoxG1-Cre 
expression in the testis could be due to a testis-specific promoter element within the 
FoxG1 gene that has been deleted in the FoxG1-Cre allele. The lack of a 
reproducible immunohistochemistry protocol for Cre m ans that its localisation can’t 
be determined and expression of YFP in FoxG1-YFP mice must be used. This has its 
limitations as the continuing YFP acts as a lineage tracer to label cells that have 
Chapter 4: Characterisation of the testicular phenotype of the FoxG1-ARKO mouse                       150   
 
expressed Cre at any point during their development, and also the daughter cells of 
cells where Cre is active. 
 
When the FoxG1-Cre line was mated to the ARflox line to generate a cell-specific 
knock-out of AR (FoxG1-ARKO), the ablation pattern of AR followed the same 
expression pattern of YFP in the FoxG1-YFP testis rather than the pattern of 
endogenous FoxG1 expression. Virtually no AR ablation was noted in Sertoli cells of 
FoxG1-ARKO mice, just as very few cells of the FoxG1-YFP mouse express YFP, 
despite ubiquitous expression of endogenous FoxG1 in adult Sertoli cells. There is 
evidence in the literature of studies where reporter gene expression and gene ablation 
lines show different localisation of Cre recombinaton; this is thought to be due to 
differences in recombination efficiency due to differing epigenetic modifications at 
the divergent genomic locations of l xP sites (Smith, 2011). However in this case the 
reporter gene and gene ablation lines show a similar pattern of recombination, but 
both are different from the endogenous gene expression. Since the FoxG1-Cre is a 
knock-in of Cre recombinase to one copy of the FoxG1 locus, removing the sequence 
downstream of the FoxG1 promoter, it is possible that e Cre is not expressed in the 
same spatio-temporal pattern as the endogenous FoxG1 due to loss of promoter or 
modifier sequences downstream of the ‘classical’ FoxG1 promoter that is thought to 
be driving expression. It is interesting to note that recent data from our lab suggests 
that the FoxG1 antibody our lab and other labs have used for immunohistochemistry 
may not be consistent between lot numbers: the most recent vial of antibody used 
stains germ cells specifically, and FoxG1 antibody from another company stains 
Leydig cells specifically. A transgenic line with a knock-in of β-galactosidase at the 
FoxG1 locus could be used to definitively determine th  localisation of endogenous 
FoxG1.  
 
FoxG1-ARKO mice also have a partial ablation of AR in the brain, kidney, penis, 
adrenal and seminal vesicle, as well as a near total abl tion of AR in the pituitary. 
These data lead to the conclusion that FoxG1-Cre is a Cre line with low specificity. 
Partial ablation of AR in the pituitary and brain of the FoxG1-ARKO is an 
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interesting result due to the role of the hypothalamus and pituitary in the control of 
testicular hormone production (see section 1.5). This will be investigated further in 
Chapter 5. 
 
Despite the lack of a complete ablation of AR in any o e testicular cell type, the 
phenotype of the FoxG1-ARKO testis is relatively sever , and does not have the 
same progression as any published cell-specific knock-outs of AR. The embryonic 
SCARKO exhibits a meiotic block that precludes formation of round or elongating 
spermatids (Chang et al., 2004; De Gendt et al., 2004). By contrast, the FoxG1-
ARKO undergoes normal spermatogenesis which is onlydisrupted by the onset of 
seminiferous epithelium sloughing from day 35. The peri-tubular myoid cell (PTM)-
ARKO mouse has testes with a reduction in numbers of all germ cell stages 
including the spermatogonia (Welsh et al., 2009a), but this phenotype is present from 
early in development and is not a degenerative change ssociated with seminiferous 
epithelial sloughing as in the FoxG1-ARKO. The published Leydig cell ARKO (Xu 
et al., 2007) has a block at the round spermatid stage whereas the FoxG1-ARKO has 
complete spermatogenesis up until the onset of seminiferous epithelial sloughing. It 
is important to note that the Leydig cell ARKO phenotype is complicated by the 
contribution of an ablation of AR in Sertoli cells, as the Cre line used in this paper 
(AMHR2-Cre) is present in both cell types (Jeyasuria et al., 2004). However, other 
experiments elucidating the effect of AR in Leydig cells have suggested that it works 
in tandem with LHR signalling to support pubertal maturation of PLCs to 
steroidogenically active ILCs (Hardy et al., 1990; Murphy et al., 1994). Since the 
FoxG1-ARKO has a similar serum testosterone level to the control it is unlikely that 
the partial ablation of AR in Leydig cells is having an effect on their maturation and 
therefore steroidogenic output. In conclusion, the FoxG1-ARKO does not have a 
phenotype analogous to any of the published cell-spcific knock-outs of AR. 
 
The FoxG1-Cre line has a knock-in of Cre downstream of the promoter of one of its 
two FoxG1 loci. This results in haploinsufficiency of FoxG1. Haploinsufficiency of 
another Fox gene (FoxA3), results in a severe testicular phenotype (Behr et al., 2007) 
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and FoxG1 has been noted to be an AR co-repressor (Obendorf et al., 2007), so 
haploinsufficiency of FoxG1 could potentially be interfering with normal testicular 
function. Despite this, FoxG1-Cre mice did not display a testicular phenotype or 
infertility; in fact they were used as efficient breeding studs to produce both FoxG1-
YFP and FoxG1-ARKO offspring. However, haploinsufficiency of FoxG1 in the 
FoxG1-Cre line has resulted in problems for groups sing FoxG1-Cre for brain-
specific ablation, as the FoxG1-Cre line itself displays a brain phenotype that 
complicates resulting phenotypic analysis of knock-ut lines (Eagleson et al., 2007).  
 
Phenotypes similar to the FoxG1-ARKO testis are seen in rodents with ligations or 
occlusions of the efferent ducts, epididymis or vasdeferens, resulting in fluid back-
pressure damage to the seminiferous epithelium of the testis (Anton, 2003; Flickinger 
et al., 1999; Hess and Nakai, 2000; Peng et al., 2010). When the efferent ducts of the 
FoxG1-ARKO were investigated they were found to contain a large number of 
spermatozoa, whereas the efferent ducts of control mice contained few spermatozoa. 
When considered along with the observation that FoxG1-ARKO contain very few 
spermatozoa in their cauda epididymis, the implication is that the spermatozoa are 
stalling in their transit upstream in the efferent ducts or caput epididymis. This will 
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5. Characterisation of the effects of AR ablation i n the 
FoxG1-ARKO pituitary  
 
5.1 Introduction 
FoxG1-ARKO mice have a near-total ablation of AR in the pituitary and a partial 
ablation in the brain (see section 4.2.8). FoxG1-Cre is expressed in the pharyngeal 
pouches (that give rise to the anterior pituitary) f om e9.5 (Hebert and McConnell, 
2000). The pituitary plays an important role in the HPG axis as the site of 
gonadotropin synthesis and release (see section 1.5). FoxG1-ARKO shows no 
change in serum testosterone or LH levels (see section 4.2.5). Testosterone is thought 
to act at the hypothalamus rather than the pituitary o modify the release of LH 
(Pitteloud et al., 2008; Tilbrook and Clarke, 2001). In Tfm mice, levels of serum LH 
and FSH are increased (Amador et al., 1986) due to a failure of testosterone to limit 
LH expression. Despite this, pituitaries of ARKO mice have apparently normal 
pituitary expression of LHβ and FSHβ at both the mRNA and protein levels 
(Miyamoto et al., 2007), but this was recorded qualitatively not quantitatively. Mice 
with cell-specific inactivation of AR in the nervous system (but not pituitary) also 
have increased testosterone and LH levels and a slight decline in the number of 
sperm present in the epididymis (Raskin et al., 2009). Their reduction in fertility is 
due to abnormal mating behaviours that lead to fewer matings and delayed 
ejaculation. Despite the partial ablation of AR in the brain of the FoxG1-ARKO 
male, its mating behaviour was normal as the frequency of post-copulatory plugs 
produced by FoxG1-ARKO males was no less than for control males (see section 
4.2.6). Since it appears that the levels of serum gonadotropins and sexual behaviour 
are not affected in FoxG1-ARKO mice, despite the total pituitary ablation of AR and 
partial brain ablation, pituitary hormone output other than gonadotropins could be the 
cause of the phenotype. 
 
As well as the gonadotropins which are vital for normal testicular function, the 
pituitary produces other endocrine hormones that have been noted to have potential 
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testicular effects, either via direct stimulation of their receptors in testicular cells, or 
via indirect effects on other target organs that have  subsequent testicular effect. 
Thyroid stimulating hormone (TSH) is produced by the anterior pituitary and 
consists of the common glycoprotein α subunit and the specific TSHβ subunit. It 
stimulates the thyroid gland to release the hormones thyroxine (T4) and 
triiodothyronine (T3). TSH receptor knock-out mice die within 1 week of weaning 
unless fed a diet supplemented with thyroid powder. However, diet-supplemented 
mice are fertile, suggesting that TSH does not have any direct testicular effects on 
male fertility (Marians et al., 2002). However, T3 is known to inhibit Sertoli cell 
proliferation and promote Leydig cell differentiation via receptors present in the 
testis, so it is likely that the absence of TSH stimulation of T3 would result in 
testicular effects (Wagner et al., 2008).  
 
Prolactin is produced by the anterior pituitary and is involved in lactogenesis in 
females.  Both prolactin (Steger et al., 1998) and prolactin receptor (Binart et al., 
2003) knock-out males are fertile (though prolactin knock-out males display reduced 
LH levels and weights of seminal vesicles and ventral prostate) suggesting that 
prolactin does not have any vital effects on male fertility. Pro-opiomelanocortin 
(POMC) is a precursor polypeptide hormone produced by the anterior pituitary that 
is post-translationally cleaved by prohormone convertas  enzymes to form 
adrenocorticotropin (ACTH), β-endorphin and α and β melanocyte stimulating 
hormones (MSH). POMC knock-out mice display obesity, defective adrenal 
development and altered pigmentation (Yaswen et al., 1999). ACTH has been shown 
to stimulate fetal Leydig cell function through the melanocortin type-2 receptor, 
however POMC-null mice have normal FLC development, so it is likely that FLCs, 
whilst responsive to ACTH, are not dependent on it (O'Shaughnessy et al., 2003). 
Investigation of the onset of AR deletion in the pituitary of FoxG1-ARKO mice and 
the levels of pituitary hormone transcripts produced ompared to the control would 
help elucidate the effects of AR in the mouse pituitary on levels of hormones it 
produces and any potential endocrine effects of these ormones on the testis.  
 




• To determine the onset of AR ablation in the pituitary of the FoxG1-ARKO.   
• To determine whether ablation of AR from the pituitary impacts upon 




5.2.1 Onset of activity of FoxG1-Cre in the forebra in and pituitary 
When e12.5 FoxG1-YFP embryos were examined under a dissecting scope fitted 
with a fluorescent filter, strong YFP expression could be detected in the developing 
forebrain and weaker YFP expression in the remainder of the embryo (Figure 5-1a). 
Localisation of YFP by immunohistochemistry was identified in Rathke’s pouch, the 
embryonic anlagen of the pituitary (Figure 5-2b, c). YFP was not observed in 
littermate control embryos either when viewed whole under a fluorescent filter or 
sectioned and stained with an antibody to YFP.  
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Figure 5-1: YFP expression in the forebrain and pituitary of e12.5 FoxG1-YFP embryos 
(a) Comparison of control and FoxG1-YFP e12.5 embryos when viewed under a 
fluorescent scope. YFP expression is particularly strong in the developing forebrain 
(arrow). (b and c)  YFP is present in the epithelium of Rathke’s pouch in an e12.5 
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5.2.2 Analysing ablation of AR in the pituitary of the FoxG1-ARKO 
To confirm and determine the onset and localisation of pituitary AR ablation, 
presence of full-length AR in the pituitary was assessed at both the transcript and 
protein level. Presence of recombined Ar exon 2 in the pituitary confirmed by RT-
PCR indicated that there was ablation of AR from the FoxG1-ARKO pituitary at d11 
(Figure 5-2). d11 was the earliest age that RNA extraction and RT-PCR was 
performed due to the difficulty obtaining a clean dissection of the pituitary from 
embryonic or neonatal mice. 
 
Figure 5-2: Presence of wild-type and/or Cre-recombined Ar transcript in d11 control 
and FoxG1-ARKO pituitary 
RT-PCR on d11 control pituitary confirms all Ar transcripts are wild-type (upper band). d11 
FoxG1-ARKO pituitaries express mostly a recombined (lower band) Ar transcripts. d11 total 




Immunohistochemistry for AR on d100 control and FoxG1-ARKO mice indicated 
that AR protein was completely absent from the FoxG1-ARKO pituitary at this age, 
whereas the control pituitary displayed AR staining i  a scattered sub-population of 
cells (Figure 5-3).  
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Figure 5-3: Immunohistochemistry for AR on d100 control and FoxG1-ARKO pituitary 
(a, b) d100 control pituitary shows immunostaining for AR in some cells (arrow) whereas 
other cells are AR negative (arrowhead). (c) d100 control pituitary with no primary antibody 
control does not show immunostaining for AR. (d, e) d100 FoxG1-ARKO pituitary does not 
show immunostaining for AR. Scale bars are 500 µm for a and d and 50 µm for b, c and e. 
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5.2.3 Morphology of the FoxG1-ARKO pituitary 
To determine whether ablation of AR was coincident with a change in morphology 
of the FoxG1-ARKO pituitary, H&E stained sections of d100 pituitary were 
examined (Figure 5-4).  Posterior, intermediate andterior lobes were present in 
both the d100 control and FoxG1-ARKO pituitaries. Pituitaries were too small to be 





Figure 5-4: H&E stain of d100 control and FoxG1-ARKO pituitaries 
Note that pituitary morphology is normal in both control and FoxG1-ARKO tissue, with 
posterior (p), intermediate (i) and anterior (a) lobes present. Scale bars are 100µm. 
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5.2.4 Levels of pituitary hormone transcripts in th e FoxG1-ARKO mouse 
To investigate the levels of pituitary hormone transcripts in the FoxG1-ARKO 
pituitary, TaqMan qRT-PCR was performed on d16, d21, d35 and d100 pituitary 
cDNA for the transcripts of Cga (glycoprotein hormone α-subunit, the common 
subunit for LH, FSH and TSH, Figure 5-5a), Lhb (LHβ transcript, Figure 5-5b), Fshb 
(FSHβ transcript, Figure 5-5c), Prl (prolactin transcript, Figure 5-5d), Tshb (TSHβ 
transcript, Figure 5-5e), and Pomc (POMC transcript, Figure 5-5f). Mean relative 
expression of these genes did not significantly differ between control and FoxG1-














Chapter 5: Characterisation of the effects of AR ablation in the FoxG1-ARKO pituitary                 161   
 
 
Figure 5-5: Expression levels of pituitary hormone transcripts in control and FoxG1-
ARKO mice pituitaries at selected post-natal ages 
(a) There is no significant difference in Cga transcript levels between control and FoxG1-
ARKO pituitaries at d16, d21, d35 or d100. (b) There is no significant difference in Lhb 
transcript levels between control and FoxG1-ARKO pituitaries at d16, d21, d35 or d100. (c) 
There is no significant difference in Fshb transcript levels between control and FoxG1-ARKO 
pituitaries at d16, d21, d35 or d100. (d) There is no significant difference in Prl transcript 
levels between control and FoxG1-ARKO pituitaries at d21, d35, d50 or d100. (e) There is no 
significant difference in Tshb transcript levels between control and FoxG1-ARKO pituitaries 
at d16, d21, d35 or d100. (f) There is no significant difference in Pomc transcript levels 
between control and FoxG1-ARKO pituitaries at d16, d21, d35 or d100. Values are mean ± 
SEM, n≥3 for each group. 
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5.3 Discussion 
The aims of this chapter were to determine the onset of AR ablation in the FoxG1-
ARKO pituitary, and to determine whether ablation of AR from the pituitary impacts 
upon hormone output. Androgen receptor mRNA has been shown to be expressed in 
the pituitary of e18.5 mouse embryos (Crocoll et al., 1998) but the HPG axis does 
not start to control testis function until after bith in the mouse (O'Shaughnessy et al., 
2009). FoxG1-Cre expression in the pituitary was present at e12.5. By d11 nearly all 
AR is ablated in the pituitary. Confirmation of onset at earlier ages was hampered by 
the difficulty of obtaining a clean dissection of pituitaries from embryonic and 
perinatal mice so exon 2 PCR could not be performed. AR immunohistochemistry 
confirmed that AR protein was absent from the d100 FoxG1-ARKO pituitary. 
 
As was noted in Chapter 4, FoxG1-ARKO mice do not have significantly different 
serum testosterone and LH levels to controls. As well as the gonadotropins which are 
vital for normal testicular function, the pituitary produces other endocrine hormones 
that have been noted to have potential testicular effects, but none have been shown to 
directly regulate male fertility (Binart et al., 2003; Marians et al., 2002; 
O'Shaughnessy et al., 2003; Steger et al., 1998). When pituitary hormone transcripts 
were examined at ages from d16 onwards there were no differences between levels in 
FoxG1-ARKO and controls, demonstrating that pituitary AR does not have a direct 
feedback effect on Cga, Lhb, Fshb, Prl, Tshb or Pomc transcript levels. However, it 
must be noted that concentrations of FSH, prolactin, ACTH or TSH proteins in the 
serum were not measured, and may differ between control and FoxG1-ARKO even if 
the transcript levels are not significantly different. The morphology of the FoxG1-
ARKO pituitary was normal, which is also reported for the pituitary morphology in 
the ARKO mouse (Miyamoto et al., 2007). Current theory is that AR acts on 
kisspeptin neurons, which regulate release of GnRH from AR-negative GnRH 
neurons into the anterior pituitary (Raskin et al.,2009). The expression of AR in 
pituitary gonadotrophs (Okada et al., 2003) despite its apparent redundancy in 
gonadotropin synthesis and release begs the question: what exactly is its role? 
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The FoxG1-ARKO mouse also demonstrated partial ablation of AR in the brain. As 
discussed above, site of action of AR feedback on the HPG axis is thought to be at 
the level of kisspeptin hormones in the hypothalamus. AR is also thought to act to 
promote male-specific sexual behaviour, and mice with ablation of neural AR show 
dysfunction in both the HPG axis regulation and sexual behaviour (Raskin et al., 
2009). Time and technical limitations prevented theanalysis of the sites of AR 
ablation in the brain, but since FoxG1-ARKO mice don t appear to have 
dysfunction in either HPG axis regulation or sexual behaviour it is unlikely that 
complete ablation of AR has occurred in the neural populations that control these 
function.  
 
Examination of the pituitary and hypothalamus-specific function of AR is 
complicated in FoxG1-ARKO mice by the lack of Cre specificity and therefore 
ablation of AR in multiple sites. More appropriate Cre lines to use to ablate AR 
would be ones that specifically target gonadotrophs, GnRH neurons or kisspeptin 
neurons. Gonadotroph-specific Cre lines include a glycoprotein α subunit-Cre 
controlled by doxycycline (Naik et al., 2006)  or a Cre knock in to the 3’ end of one 
copy of the Gnrhr gene (Wen et al., 2008). A random insertion GnRH-Cre line is 
available that active specifically in GnRH neurons whilst not interfering with GnRH 
production (Wolfe et al., 2008). Finally a Kisspeptin-Cre line is available with a Cre 
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6. Characterisation of the effects AR ablation in t he FoxG1-
ARKO epididymis  
 
6.1 Introduction 
As demonstrated in section 4.2.6, spermatozoa fail to transit the efferent ducts of the 
FoxG1-ARKO, which implies that the origin of the phenotype may be with 
dysfunction in the efferent ducts or downstream in the epididymis. Obstructive 
azoospermia (OA) is the absence of sperm in the ejaculate due to a post-testicular 
obstruction of the genital tract.  Four to six percent of infertile men have obstructive 
azoospermia (Anon, 2008). Some cases of OA have been linked to congenital 
bilateral absence of vas deferens due to mutations in the cystic fibrosis 
transmembrane conductance receptor (Lopez et al., 2010), but most cases of OA 
have no definitive cause.  
 
Several mouse models of OA exist. Mice with a knock- ut of LGR4/GPR48 fail to 
undergo proper epididymal convolution, and exhibit persistence of an 
undifferentiated epithelium in the epididymis resulting in OA (Mendive et al., 2006). 
Male mice with persistent Müllerian ducts develop spermatoceles (spermatozoal 
cysts in the reproductive tract) in the caput epididymis due to physical inhibition of 
the coiling and integrity of the epididymis by the aberrant Müllerian duct derived 
tissue (Tanwar et al., 2010). Mice with homozygous r heterozygous knock-outs of 
three of the bone morphogenetic protein (BMP) genes display obstructive 
azoospermia (Hu et al., 2004; Zhao et al., 2001). Other reported models of 
obstructive azoospermia implicate epithelial dysregulation of the efferent ducts and 
caput epididymis due to abnormal trans-epithelial fuid transport (Wong, 1990). One 
such example is the phenotype of mice with a knock-out of GPR64, an orphan GPCR 
located on the apical membrane of efferent ducts and stereocilia of epididymal caput 
principal cells (Kirchhoff et al., 2008). GPR64 knock-out mice display a similar 
stasis of spermatozoa in their efferent ducts, and incorrect fluid transport by the 
efferent ducts and epididymis is implicated (Davies t al., 2004). Obstructive 
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azoospermia also occurs in mice treated with the fungicides Benomyl or 
Carbendazim (Hess and Nakai, 2000; Nakai et al., 1992).  
 
The diverse causes of these OA models implies that the disorder can be caused by 
specific ablation of a particular gene but also by a failure in the correct 
morphological development of the epididymis leading to dysregulation of epididymal 
coiling and segmentation or epithelial function. Testicular dysfunction in the 
progression of the phenotype is also implicated in the case of chemical insult to the 
seminiferous epithelium, but this is thought to be in tandem with dysregulation 
occurring in the efferent ducts and epididymis, implying that these organs play the 
key role in OA development.  
 
RT-PCR targeting Ar exon 2 demonstrates that AR has not been ablated in the 
epididymis/efferent ducts of the FoxG1-ARKO mouse (ction 4.2.8), but this has 
not been confirmed by immunohistochemistry. Expression of FoxG1 or FoxG1-Cre 
has also not been documented in the efferent ducts or epididymis. Determination of 
the action of FoxG1-Cre in the efferent ducts and epididymis will assist in the 
elucidation of the cause of the phenotype in the FoxG1-ARKO, and whether it can be 
explained by the partial ablation of AR in the testis alone, or also has a contribution 
from ablation in the efferent ducts or epididymis.  
 
6.1.1 Aims 
• To characterise the expression of FoxG1-Cre in the eff rent ducts and 
epididymis, and determine if this has resulted in an ablation of AR in the 
FoxG1-ARKO efferent ducts or epididymis.  
• To characterise the OA phenotype and determine if it has been caused by 
dysfunction in the efferent ducts or epididymis. 
 
 




6.2.1 Spermatozoa progressively block the efferent ducts 
Characterisation of the progression of the FoxG1-ARKO efferent duct block was 
undertaken by histological examination of the efferent ducts at d11, d21 and d100 
(Figure 6-1). At d11, the efferent ducts of FoxG1-ARKO mice were 
indistinguishable from those in controls. In both cases, the efferent ducts appeared 
patent, with cellular debris within the lumen. At d21, an increase in the amount of 
cellular debris and proteinaceous exudate was observed in the efferent ducts of 
FoxG1-ARKO mice compared with that in controls. At d100, clusters of 
spermatozoa were evident in the efferent ducts of the FoxG1-ARKO and these 
appeared to have formed a physical ‘block’, preventing spermatozoa from passing 
through the lumen. Conversely, control efferent duct l mens did not contain obvious 
groups of cells/spermatozoa at d21 or d100. 
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Figure 6-1: Comparison of histology of efferent ducts at d11, d21 and d100  
 d11 control and FoxG1-ARKO efferent ducts are visibly similar, with cellular debris present 
in the lumens of both (arrowheads). Efferent ducts of d21 control and FoxG1-ARKOs also 
contain cellular debris (arrowheads) but d21 FoxG1-ARKO efferent ducts are beginning to 
accumulate eosinophilic proteinaceous material (arrow). d100 control efferent ducts have 
empty, patent lumens, unlike d100 FoxG1-ARKO efferent ducts which are distended and 
contain spermatozoa and cellular debris in their lumens (crosses). Scale bars are 100 µm. 
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6.2.2 Macroscopic comparison of FoxG1-ARKO and cont rol testis, efferent 
ducts and epididymis 
During dissection, it was noted that epididymides of F xG1-ARKO mice were 
smaller and a different shape to controls. When compared at d11 and d16, control 
and FoxG1-ARKO epididymides were morphologically similar (Figure 6-2). At d21 
the FoxG1-ARKO caput epididymis appeared to be smaller than that of the control. 
At d100, the whole epididymis of the FoxG1-ARKO was smaller than the control. 
The FoxG1-ARKO caput was narrower and flatter than that of the control and the 
efferent ducts appeared to connect to the epididymis at the top of the epididymal 
tunica rather than at the side as seen in the control. 
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Figure 6-2: Macroscopic comparison of testis, efferent ducts and epididymis of 
control and FoxG1-ARKO mice at d11, d16, d21 and d100 
At d11 and d16 FoxG1-ARKO testes (T), efferent ducts (arrowheads) and proximal 
epididymis are a similar size to controls. At d21 and d100 a decrease in the size of the 
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This apparent visual difference in size was also reflected in a difference in weight 
(Table 6-1, Figure 6-3). The mean post-fixation weight of FoxG1-ARKO efferent 
ducts and epididymis together (ED/epi) did not signif cantly differ from controls at 
d11 and d16. FoxG1-ARKO mean ED/epi weight was significantly smaller than 
controls at d21, d35 and d100. Reduction in weight could have been due to the lack 
of sperm in the epididymis, therefore the weights of epididymides from SCARKO 
mice were measured and compared to control littermates (the SCARKO does not 
have post-meiotic germ cells hence no spermatozoa in ep didymis, but with no 
epididymal ablation of AR). The weight of SCARKO ED/epi at d100 was not 
significantly different to their control littermates despite lacking spermatozoa, which 
implied that the difference in mean weight of the FoxG1-ARKO ED/epi to the 
control was not due solely to lack of spermatozoa. 
 
Table 6-1: Mean weights of control and FoxG1-ARKO epididymides (including efferent 
ducts) at d11, d16, d21 and d100 
*Key: Control-F = FoxG1-ARKO control littermates, Control-S= SCARKO littermates 
 
 d11 d16 d21 d35 d100 
Control-F* 2.2 mg 4.5 mg 8.1 mg 18.3 mg  47.4 mg  
FoxG1-ARKO 1.8 mg 3.7 mg, 4.5 mg 8.0 mg 25.5 mg 
P value P>0.05 P>0.05 P≤0.05 P≤0.001 P≤0.001 
 
Control-S* / / / / 38.2 mg  
SCARKO / / / / 34.1 mg 
P value  / / / / P>0.05 
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Figure 6-3: Mean weights of control and FoxG1-ARKO epididymides (including 
efferent ducts) at d11, d16, d21 and d100 
At d11 and d16, mean FoxG1-ARKO epididymis weight is not significantly different to mean 
control epididymis weight. At d21, d35 and d100 mean FoxG1-ARKO epididymis weight is 
significantly reduced compared to control. Mean d100 SCARKO epididymis weight is not 
significantly different to its corresponding littermate control. n≥5 for each group. All values 
are means ± SEM.*P≤0.05, ***P≤0.001. 
 
6.2.3 Gross and histological comparison of whole Fo xG1-ARKO and control 
epididymides 
FoxG1-ARKO epididymides were visibly smaller compared to controls when 
examined at d100 (Figure 6-4a). Histological examination, of longitudinal sections 
through the epididymis of FoxG1-ARKO and control animals revealed that the initial 
segment (IS) was absent from d100 FoxG1-ARKO epididym es (Figure 6-4b). The 
caput, corpus and cauda epididymis regions of the FoxG1-ARKO all appeared 
smaller both in gross and thin-section. 
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Figure 6-4: Gross and histological comparison of whole d100 control and FoxG1-
ARKO epididymides 
(a) Gross image of Bouin’s-fixed d100 control and FoxG1-ARKO epididymides: note that the 
FoxG1-ARKO epididymis appears smaller when compared to the control. (b) Histological 
analysis of d100 control and FoxG1-ARKO epididymides shows that the FoxG1-ARKO 
epididymis is missing the initial segment of the proximal caput (segment I) that is distinctly 
present in the control. Scale bars are 1 mm. 
 
6.2.4 FoxG1 protein localisation in wild-type effer ent ducts and epididymis 
Thin sections of d100 wild-type efferent ducts and epididymis were immunostained 
for FoxG1 protein to identify/establish where it was localised in these tissues (Figure 
6-5). FoxG1 was localised to the nucleus and cytoplasm of the ciliated cells of the 
efferent ducts, and to the nucleus and cytoplasm of sp radic cell groups of the 
epithelium of the caput segment III, corpus and cauda epididymis. It was not 
localised at all to the initial segment I, and was only localised to the nucleus of some 
apical cells of the caput segment II. FoxG1 protein was however localised to the 
proximal part of the epididymis at d2. 
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Figure 6-5: FoxG1 immunolocalisation in d100 wild-type efferent ducts and epididymis  
FoxG1 is present in the epithelium of d100 efferent ducts (a), caput segment III (d), corpus 
(e) and cauda (f) epididymis, as well as in tubules of the d2 proximal epididymis (g). FoxG1 
is not present in the epithelium of the d100 epididymal caput segment I (b) or segment II (c). 
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6.2.5 YFP protein localisation in FoxG1-YFP efferen t ducts and epididymides 
FoxG1-Cre stud males were mated to females carrying a Cre Recombinase inducible 
YFP reporter gene, to demonstrate Cre Recombinase functional expression. 
Immunohistochemistry for YFP in the efferent ducts and epididymis of d100 FoxG1-
YFP mice revealed that expression of YFP could be det cted in the proximal efferent 
duct and epididymal epithelium. This expression wasmo aic and was not detected in 
stromal cells. YFP is not expressed in the epithelium of distal efferent ducts of 
FoxG1-YFP mice. 
 
Figure 6-6: YFP immuno-localisation in d100 control and FoxG1-YFP epididymis and 
efferent ducts 
(a) YFP is present in the post-natal caput epididymis of FoxG1-YFP mice, but not in control 
littermates. (b) YFP expression is confined to the epithelium of the epididymis (arrow) and is 
not expressed in the stroma (asterisk). Inset: no-primary control showing interstitial non-
specific staining. (c) YFP is present in the epithelium of the post-natal proximal efferent ducts 
of FoxG1-YFP mice, but not in control littermates. (d) YFP is not expressed in the epithelium 
of distal efferent ducts of FoxG1-YFP mice (arrowhead) whereas it can be seen in the initial 
segment of the same mouse (arrow). Scale bars are 1 mm for a and 100 µm for b, c and d.  
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6.2.6 AR protein localisation in control and FoxG1- ARKO efferent ducts and 
epididymides 
AR immunostaining and quantification revealed that AR protein was not expressed 
in 37% of the principal epithelial cells of the proximal caput epididymis at d2 and 
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Figure 6-7: AR immuno-localisation in d2, d11, d21 and d100 control and FoxG1-ARKO 
proximal caput epididymis 
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Figure 6-7: AR immuno-localisation in d2, d11, d21 and d100 control and FoxG1-ARKO 
proximal caput epididymis (figure on preceding page) 
d11 control caput epididymal epithelium is low columnar and AR-positive (arrow). d11 
FoxG1-ARKO caput epididymal epithelium appears grossly similar to that in controls but with 
areas of epithelial AR ablation (arrowheads). d21 control caput epididymal epithelium has 
begun to increase in height where the initial segment (I) will develop, and is distinguishable 
from the proximal caput (II), conversely epididymal epithelium of the d21 FoxG1-ARKO 
remains low columnar. d100 control proximal epididymis is segmented with epithelium 
characteristic of the tall pseudo-stratified columnar epithelium of the IS (I) next to the lower 
columnar epithelium of the proximal caput (II). d100 FoxG1-ARKO proximal epididymis is 
disordered with no epithelial characteristics of the IS. AR-negative areas (arrowhead) of 
d100 FoxG1-ARKO epithelium are shorter, with more columnar cells (arrowhead), compared 
to AR-positive epithelial cells which are taller (arrow) and visibly similar to segment II rather 
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Ablation of AR was limited to principal cells whereas basal epithelial cells were all 
positive for AR in FoxG1-ARKO mice, as in controls (Figure 6-8). Small foci of AR 
ablation were occasionally noted in the remainder of the epididymis in FoxG1-
ARKO, but these were too irregular and few to merit quantification. All epididymal 




Figure 6-8: Histological comparison of the epithelium and lumen of segment II of d100 
control and FoxG1-ARKO 
d100 FoxG1-ARKO epididymides have a visible reduction in height of AR-negative 
compared to AR-positive epithelial cells. Basal cells in the proximal epididymal epithelium of 
the FoxG1-ARKO are AR-positive (arrows). The proximal epididymal lumen in the FoxG1-
ARKO is irregularly shaped compared to the circular lumen of controls (asterisks). Microvilli 
are present on the apical surface of AR-positive epithelial cells in d100 control and FoxG1-
ARKO (arrowheads) but are absent in AR-negative epithelial cells of the FoxG1-ARKO. 
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Immunostaining for AR protein in the efferent ducts demonstrated that neither 
control nor FoxG1-ARKO efferent duct epithelia displayed areas of ablation of AR 





Figure 6-9: AR immuno-localisation in d11, d21 and d100 control and FoxG1-ARKO 
efferent ducts 
Note that AR is expressed in all cells of the control and FoxG1-ARKO efferent duct 
epithelium at d11, d21 and d100 (arrows). 
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6.2.7 Development of control and FoxG1-ARKO epididy mides 
Control and FoxG1-ARKO caput epididymides were examined at d11, d21 and d100 
to determine if the initial segment failed to develop or developed and later regressed 
(Figure 6-7). At d11 the proximal caput epididymal epithelium in the FoxG1-ARKO 
appeared morphologically similar to that in controls. Mosaic loss of epithelial AR 
was already apparent in the d11 FoxG1-ARKO. At d21, differentiation of the caput 
epididymal epithelium was observed in controls; evid nce of this includes the 
development of a visibly distinguishable initial segment precursor, characterised by 
increasing epithelial cell height and lumen diameter. The initial segment precursor 
was not obvious in the FoxG1-ARKO at d21 and the AR-negative cells in the 
proximal caput epithelium did not display an increas  in height. At d100, control 
animals displayed a well developed IS characterised by tall pseudo-stratified 
columnar epithelia and large tubule lumen. Conversely, epithelial cells in the FoxG1-
ARKO segment immediately distal to the efferent ducts resembled those found in 
segment II, the proximal caput of the control; as a result, the single lobe of efferent 
ducts within the epididymal tunica of FoxG1- ARKO mice connected directly to 
segment II, the proximal caput.  
 
6.2.8 Epithelial cell morphology and lumen diameter  in segment II of d100 
control and FoxG1-ARKO epididymides 
On histological examination, AR-positive epithelial cells in the FoxG1-ARKO caput 
epididymis were visibly increased in height compared to AR-negative epithelial cells 
(Figure 6-8). This was confirmed when measurements of cell heights were taken 
(Table 6-2, Figure 6-10). Mean height of FoxG1-ARKO AR- epithelial cells in 
segment II was significantly reduced compared to AR+ epithelial cells in segment II 
at d11, d21 and d100. AR positive epithelial cells in FoxG1-ARKO mice did not 
differ significantly in height from the AR-positive epithelial cells in control 
epididymides at d11, d21 or d100.  
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Table 6-2: Comparison of mean heights of control epididymal segment II epithelium 
with both AR+ and AR- cells in the FoxG1-ARKO epididymal segment II epithelium 
 
 d11 d21 d100 
FoxG1-ARKO (AR+) 14.1 µm 17.3 µm 23.4 µm 
FoxG1-ARKO (AR-) 10.9 µm 10.5 µm, 13.4 µm 
P value (FoxG1-ARKO AR+ vs FoxG1-ARKO AR-) P≤0.001 P≤0.005 P≤0.005 
    
Control (AR+) 14.3 µm 20.3 µm 25.8 µm 
P value (control AR+ vs FoxG1-ARKO AR+) P>0.05 P>0.05 P>0.05 
 
 
         
Figure 6-10: Comparison of mean heights of control epididymal segment II epithelium 
with both AR+ and AR- cells in the FoxG1-ARKO epididymal segment II epithelium 
The height of AR-negative epithelial cells is significantly smaller than that of AR-positive 
epithelial cells within FoxG1-ARKO proximal caput epididymis at d11, d21 and d100. There 
was no significant difference between the AR-positive cells of the proximal caput epididymis 
in controls and FoxG1-ARKOs at any age examined. Values are means ± SEM, n= 3 mice 
for each group. (*** P≤0.001, ** P≤0.005). 
 
 
Upon histological examination, the mean lumen radius in the proximal caput region 
in d100 FoxG1-ARKO mice appeared smaller than those of the comparable segment 
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II region in d100 control mice. Quantification reveal d that at d11, mean epididymal 
lumen radius in segment II of FoxG1-ARKO mice was similar to that of the controls, 
but at d21 and d100 the FoxG1-ARKO lumen radius wassignificantly smaller than 
controls (Table 6-3, Figure 6-11). 
 
Table 6-3: Comparison of control and FoxG1-ARKO mean epididymal segment II 
lumen radius 
 
 d11 d21 d100 
Control  8.2 µm 15.1 µm 32.5 µm 
FoxG1-ARKO  8.2 µm 9.5 µm 17.3 µm 
P value  P>0.05 P≤0.001 P≤0.001 
 
 
                    
Figure 6-11: Comparison of control and FoxG1-ARKO mean epididymal segment II 
lumen radius  
 At d11 the caput epididymal lumen radius of FoxG1-ARKO mice is not significantly different 
to that of control mice. At d21 and d100 proximal caput epididymal lumen of FoxG1-ARKO 
mice is significantly smaller than that of control mice (*** P≤0.001). Values are means ± 
SEM, n= 3 mice for each group. 
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6.2.9 ERα protein localisation in segment II of control and FoxG1-ARKO 
epididymides 
ERα is thought to be a regulator of fluid absorption in the efferent ducts and 
proximal epididymis (Joseph et al., 2010a). To investigate whether the expression of 
ERα was affected by the disruption to the epididymal epithelium, thin sections of 
epididymis and efferent ducts from d100 FoxG1-ARKO mice were immunostained 
for ERα (Figure 6-12).  ERα staining in controls correlated with previously published 
literature (Zhou et al., 2002). ERα immunostaining was strong in the efferent duct 
epithelium of the control and FoxG1-ARKO. Only apical and narrow cells of the 
epithelium of segment I of the control stained positive for ERα, whereas the FoxG1-
ARKO did not develop a segment I so staining could not be assessed. Only apical 
and narrow cells of the epithelium of the control segment II stained positive for ERα, 
whereas all AR-ablated cells of the FoxG1-ARKO segmnt II stained strongly for 
ERα. In segment III of the control, all apical cells and some principal cells stained 
for ERα but all principal cells in the FoxG1-ARKO are ERα positive. 
 




Figure 6-12: ERα immunostaining in d100 control and FoxG1-ARKO efferent ducts and 
proximal epididymis  
ERα immunostaining is strong in the efferent duct epithelium of the control and FoxG1-
ARKO. Only apical and narrow cells of the epithelium of segment I of the control stain 
positive for ER, whereas the FoxG1-ARKO does not develop a segment I. Only apical and 
narrow cells of the epithelium of the control segment II stain positive for ERα, whereas all 
AR-ablated cells of the FoxG1-ARKO segment II stain strongly for ERα. In segment III of the 
control, all apical cells and some principal cells stain for ERα but all principal cells in the 
FoxG1-ARKO appear to stain for ERα. Key: ED = efferent ducts, I, II and III are segments I, 
II or III. Scale bars are 500 µm for main images and 50 µm for high magnification insets. 
 
 
6.2.10 SMA protein localisation in segment II of co ntrol and FoxG1-ARKO 
epididymides 
Dysregulation in the epithelial layer of hormone responsive tissues is known to affect 
the underlying stromal layer (Cunha et al., 1996), so to investigate whether the 
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smooth muscle interface between the stroma and epithelium was affected by the 
disruption to the epididymal epithelium, thin sections of epididymis from d11 and 
d100 FoxG1-ARKO mice were immunostained for SMA (Figure 6-13). At d11, 
SMA immunostaining was similar in control and FoxG1-ARKO epididymides, 
appearing as a strongly staining ring around the tubules. However, at d100 the 
smooth muscle layer of the FoxG1-ARKO epididymis was disorganised with 
evidence of disruption at specific foci.  
 
Figure 6-13: SMA staining in caput epididymides of d11 and d100 control and FoxG1-
ARKO mice 
At d11, SMA immunostaining appears as a thick layer around the outside of the tubule in 
both control and FoxG1-ARKO caput epididymides (arrows). At d100, SMA immunostaining 
is an unbroken thinner layer around the tubules in segment II of control epididymides (arrow) 
but staining is interrupted around the tubules in the caput region of FoxG1-ARKO 
(arrowhead). Inset: no-primary control non-specific interstitial staining (asterisks). Scale bars 
= 20µm. 
6.2.11 Levels of Gpr64 in FoxG1-ARKO epididymis 
Since the GPR64 knockout mouse has a similar phenotype to the FoxG1-ARKO 
(Davies et al., 2004), the levels of Gpr64 transcript in the control and the FoxG1-
ARKO were quantified using TaqMan qRT-PCR (Figure 6-14). Levels of Gpr64 
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transcript were lower that the control at d11, d16, d21 and d100, but the difference 
was only significant at d21.  
 
Figure 6-14: Expression levels of Gpr64 transcript in control and FoxG1-ARKO 
epididymides at selected post-natal ages 
Levels of Gpr64 transcript were lower that the control at d11, d16, d21 and d100, but the 
difference was only significant at d21.Values are mean ± SEM, n≥4 for each group. 
 
6.2.12 Effects of efferent duct block on FoxG1-ARKO  efferent ducts 
The efferent ducts of the FoxG1-ARKO do not have an ablation of AR. Despite this, 
the spermatozoal block occurs in the efferent ducts. The morphology and function of 
the efferent ducts was assessed to elucidate whether the dysfunction in the efferent 
ducts was contributing to the phenotype in the FoxG1-ARKO. Development of the 
efferent ducts of the FoxG1-ARKO has resulted in patent connection to the 
epididymis, as a low concentration of spermatozoa is st ll present in the cauda 
epididymis despite the block that has formed in the eff rent ducts (see section 4.2.6). 
The number of efferent ducts emerging from the testis was between three and five in 
both the FoxG1-ARKO and the control (Figure 6-15). Cilia present on the apical 
surface of some cells in the control efferent ducts were also noted in the FoxG1-
ARKO (Figure 6-16). 
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l 
Figure 6-15: Representative images of histology of d35 control and FoxG1-ARKO 
initial efferent ducts 
A transverse section of testis attached to epididymis close to the rete testis shows the 
number and form of efferent ducts that exit the rete testis. Both control (a, c) and FoxG1-




Figure 6-16: Presence of cilia in control and FoxG1-ARKO efferent ducts 
Cilia (arrows) are present on the apical surface of some cells in the control efferent ducts, 
and are also found in the FoxG1-ARKO. Scale bars are 20µm. 
6.2.13 Immunostaining for CD45 in control and FoxG1 -ARKO efferent ducts 
A common feature of efferent duct blockage is immune cell infiltration and 
phagocytosis of sperm by the epithelium (Hess and Nakai, 2000; Mendive et al., 
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2006; Nakai et al., 1992). Therefore immunostaining for CD45 (a pan-immune cell 
marker) was utilised to determine if inflammation was occurring in the efferent ducts 
as a consequence of the sperm block (Figure 6-17). The occasional cell was CD45+ 
in the efferent duct stroma of d100 controls. Conversely, the efferent ducts of d100 
FoxG1-ARKO mice displayed widespread CD45 immunostaining in stromal, 
epithelial and luminal compartments of the efferent ducts. Phagocytosis of stagnant 
sperm was apparent in the epithelia of some efferent duct cross-sections, as shown by 
dense accumulations of the characteristic ‘hooked’ spermatozoa heads inside CD45+ 




Figure 6-17: CD45 staining in control and FoxG1-ARKO efferent ducts 
Specific staining for CD45 can be seen in the occasional stromal cell in d100 control efferent 
ducts (solid arrowhead) but can be seen in stromal (solid arrowhead), epithelial (outline 
arrowhead) and luminal (cross) cells in the d100 FoxG1-ARKO efferent ducts. Higher 
magnification image shows phagocytosis of spermatozoa heads by the FoxG1-ARKO 
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6.3 Discussion 
The aims of this chapter were to characterise the expression of FoxG1-Cre in the 
efferent ducts and epididymis, and determine if this has resulted in an ablation of AR 
in the FoxG1-ARKO efferent ducts or epididymis, and to characterise the efferent 
duct block phenotype and determine if it has been caused by dysfunction in the 
efferent ducts or epididymis. Lack of ablation of Ar exon 2 in the epididymis (see 
section 4.2.8) implied that there was no ablation of AR protein in the epididymis. 
However, on immunohistochemical staining, FoxG1-ARKO mice were found to 
have a partial ablation of AR in the caput epithelium of the epididymis, with 67% of 
cells lacking AR at d100. This has also been noted in the seminal vesicles of the 
MHC-Cre ARKO mouse, which displays AR ablation at the protein level that is 
unable to be detected at the transcript level (Smith group, unpublished data). This 
observation could be due to the silencing of transcription of the Ar gene in a cell due 
to lack of functional AR protein or the loss of cell identity resulting in suppression of 
AR expression. A reduced level of mutant Ar transcript has previously been noted in 
gonadal fibroblasts from patients with CAIS (Hellwinkel et al., 1999).  
 
Ablation of AR in the caput epididymis was in a mosaic pattern similar to that seen 
for endogenous FoxG1 expression and FoxG1-Cre expression. It has been noted that 
several proteins present in the epididymal epithelium including sulphated 
glycoprotein 2 (Hermo et al., 1991), immobilin (Hermo et al., 1992) and cyclin D1 
(Darwanto et al., 2008) are expressed in this ‘checkerboard’ pattern with the 
potential explanation that the epididymal epithelium acts as a syncytium to control 
some functions and that only a percentage of the epithelial cells need to express the 
protein of interest for the epithelium as a whole t respond.   
 
FoxG1-Cre expression pattern in the epididymis generally followed the expression of 
endogenous FoxG1. Although endogenous FoxG1 appears to be present throughout 
the efferent duct epithelium, FoxG1-Cre is present in a mosaic pattern. Both FoxG1 
and FoxG1-Cre are present in a mosaic pattern throug out the distal caput, corpus 
and cauda epithelium, with no expression in mesenchymal tissues. However, at d100, 
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YFP is not seen in the initial segment or proximal caput (segment I or segment II) of 
the FoxG1-YFP epididymis. Since YFP is a lineage tracing marker it is probable that 
endogenous FoxG1 is expressed in segments I and II earlier than d100, but switches 
off before this age, whereas transgenic YFP activated by FoxG1-Cre persists. 
Expression of both endogenous FoxG1 and FoxG1-Cre is found in the efferent ducts, 
whereas ablation of AR does not occur in the efferent ducts. This could potentially be 
due to strain background effects (the FoxG1-Cre maybe active in the efferent ducts 
in the FoxG1-YFP background but not in the FoxG1-ARKO background) or AR 
ablation in the developing efferent ducts may have occurred earlier than the age first 
examined (d2) resulting in apoptosis of the ablated c lls and their failure to 
contribute to the adult efferent ducts. This could be determined by performing 
immunohistochemistry for AR on efferent ducts of prenatal FoxG1-ARKO mice. It is 
unlikely that any prenatal ablation of AR in the efferent ducts would contribute to the 
phenotype, as the efferent ducts appear to develop and function normally prior to and 
despite the formation of the efferent duct block. Since AR ablation is confirmed and 
persistent in the epithelium of the caput epididymis, it is likely that dysregulation in 
this region is the primary cause of the spermatozoa bl ck upstream in the efferent 
ducts.  
 
The epididymis in FoxG1-ARKO mice is grossly and histologically indistinguishable 
from that of controls at d2, despite AR ablation in 37% of caput epithelial cells. 
Normal epididymal development is known to be under th  control of androgens, as 
Wolffian duct-derived tissues are absent at birth in genetic models of ablation of AR 
function (He et al., 1991; Yeh et al., 2002) and the epididymis fails to coil in male 
rats treated prenatally with the AR antagonist flutamide (Welsh et al., 2006). 
However, prenatal androgen action is mediated by stromal AR in the WD, and 
epithelial androgen receptor is not detected until af er the WD has stabilised and 
begun to coil. These results are consistent with our bservation that neonatal 
development of the FoxG1-ARKO epididymis appears normal. Conversely, early 
post-natal maturation of the epididymis is compromised in FoxG1-ARKO mice. At 
d11, control and FoxG1-ARKO epididymides appear grossly similar with no 
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significant difference in weight, but histological bnormalities were already evident 
at this age. There is a significant difference in epithelial cell height between AR-
positive and AR-negative cells in FoxG1-ARKO epididymides at d11. Previously 
published literature suggested that the epididymal epithelium in mice exists in an 
undifferentiated state from d7 to d14 (Avram and Cooper, 2004), at which point a 
‘precursor’ epithelium arises. However our data suggests that the epithelium is 
already responsive to androgens at d11 and possibly even earlier, as AR-ablated and 
AR-positive cells at this age display different morphology. 
 
By adulthood, gross abnormalities can be identified in FoxG1-ARKO epididymides. 
At d100, FoxG1-ARKO mice lack the initial segment (IS, segment I) of the 
epididymis, so the proximal caput epididymis (segment II) is located immediately 
distal to the efferent ducts. Analysis of epididymal histology at d11, d21 and d100 
demonstrated that the IS was not absent because it had regressed, but rather that it 
had completely failed to develop in FoxG1-ARKO mice. By d21, the initial segment 
precursor is obvious in control mice, characterised by increasing epithelial cell height 
and lumen diameter. However, in the d21 FoxG1-ARKO epididymis, epithelial cells 
lacking AR failed to increase in height or develop stereocilia in the principal cells of 
the proximal caput, maintaining a similar morphology to that of the pre-differentiated 
epithelium at d11. Previously published studies have shown that IS development is 
under the control of a number of factors including circulating androgens, the product 
of the gene Cros and testicular lumicrine factors (Avram and Cooper, 2004). At day 
16, the epithelium of segment I (IS) is reported to become visually distinct from the 
remaining caput epithelium, whilst segment II (proximal caput) and III (distal caput) 
of the epididymis appear differentiated by day 21. Acute withdrawal of androgens 
following orchidectomy results in regression of segm nt I and de-differentiation of 
segments II and III to a ‘precursor’ state, suggesting that continuous androgen 
exposure is required to maintain a differentiated epididymal epithelium (Avram et 
al., 2004). Consistent with this, we conclude that in the absence of epithelial AR, the 
proximal epithelium of the caput is unable to undergo correct terminal 
differentiation, resulting in complete failure of development of the initial segment. 
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Since lumicrine factors from the testis are also thought to be needed for maintenance 
of the initial segment (Abe and Takano, 1989), the presence of an obstruction in the 
efferent ducts at later ages likely compounds this p enotype by preventing testicular 
lumicrine factors from passing into the epididymis. This requires further 
investigation.  
 
AR-negative epithelial cells within the remainder of the FoxG1-ARKO caput 
epididymis also fail to mature. This resulted in the persistence of areas of 
undifferentiated epithelium with reduced cell height compared to the AR-positive 
epithelial cells, and a decrease in lumen size at d11, 21 and d100 in the FoxG1-
ARKO caput. The striking difference in both epithelial cell height and morphology 
between AR-positive and AR-negative cells suggests that the impact of AR-
dependent signalling on epithelial cells is predominantly autocrine, not paracrine. 
Despite lumen diameter differences between the FoxG1-ARKO and control, AR-
positive FoxG1-ARKO epithelial cells in the remaining proximal caput of the 
FoxG1-ARKO did not significantly differ in height compared to cells in segment II 
of the ubiquitously AR-positive control epididymal epithelium. This suggests that 
AR-positive caput epithelium in the FoxG1-ARKO is comparable to segment II in 
the control. The initial segment is believed to develop from a different anlage to the 
rest of the epididymis, namely the mesonephric tubules, while the remaining caput 
develops from the Wolffian duct (Marshall et al., 1979). This divergent origin may 
explain the differential response of the two epididymal regions to AR ablation in 
FoxG1-ARKO mice, with epithelial AR signalling a fundamental requirement for 
development of the IS but not the caput; epithelial AR is however important in 
regulating epithelial cell function in the remainder of the caput. 
 
Previous models of epididymal androgen deprivation by orchidectomy reported 
apoptosis in the epididymal epithelium (Fan and Robaire, 1998; Takagi-Morishita et 
al., 2002). In contrast, the epithelium of FoxG1-ARKO mice did not display the 
characteristic histological signs of apoptosis. It is possible that epithelial cells in 
FoxG1-ARKO epididymides do not undergo apoptosis because AR has been ablated 
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from birth and the epithelia never develop correctly, whereas in previous studies 
androgen withdrawal took place after the differentiation of the epididymal epithelium 
(Fan and Robaire, 1998; Takagi-Morishita et al., 2002). This suggests that apoptosis 
either occurs in epithelial cells that have developd under the influence of androgens 
as a direct response to acute androgen withdrawal or that it is a secondary response to 
a reduction in androgens in the stromal compartment r sulting in a disruption in 
mesenchymal-epithelial signalling.  
 
The failure of the proximal epithelium of the FoxG1-ARKO epididymis to 
differentiate correctly results in an obstruction developing in the efferent ducts. From 
d21, FoxG1-ARKO efferent ducts begin to accumulate proteinaceous and cellular 
debris that would normally pass through the epididymis and be phagocytosed in the 
cauda in controls. When spermiation occurs at around d35 in the mouse, some 
FoxG1-ARKO mice had spermatozoa in the epididymis de pite having developed 
these histological changes in the efferent ducts. However, by d100 all FoxG1-ARKO 
epididymides examined were near azoospermic with spermatozoa stasis in the 
efferent ducts, suggesting that the phenotype was progressively degenerative. 
Previous reports suggest that the absence of an initial segment per se does not cause 
obstructive azoospermia. For example although the c-ros -/- mutant mouse fails to 
develop an initial segment, the spermatozoa progress straight from the efferent ducts 
to the distal caput of the epididymis (Sonnenberg-Riethmacher et al., 1996). 
Although spermatozoa from c-ros -/- male mice reach the cauda epididymis they 
have angulated tails and swollen heads due to problems with volume regulation 
(Yeung et al., 1999).  However the remaining caput epi helium in c-ros -/- mice 
developed and differentiated normally under the influence of androgens, suggesting 
obstructive azoospermia in FoxG1-ARKO mice is likely to result from persistence of 
an incorrectly differentiated epididymal epithelium rather than absence of an initial 
segment. A further morphological characteristic that m y have contributed to stasis 
of spermatozoa in the FoxG1-ARKO efferent ducts wasthe visibly smaller and more 
irregular lumen diameter of the FoxG1-ARKO caput epididymis. This could cause a 
‘bottleneck’ point for spermatozoa and testicular fluids, slowing down their transit 
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and resulting in accumulation upstream in the effernt ducts. This could result in a 
self-perpetuating stasis, leading to changes in the composition of testicular fluid and 
spermatozoa in the efferent ducts and further blockage. This view is supported both 
through our own observations and other published models of obstructive 
azoospermia. For example, mice with a knock-out of LGR4/GPR48 fail to undergo 
proper epididymal convolution, and exhibit persistence of an undifferentiated 
epithelium in the epididymis (Mendive et al., 2006). Other reported models of 
obstructive azoospermia implicate epithelial dysregulation of the efferent ducts and 
caput epididymis due to abnormal trans-epithelial fuid transport (Wong, 1990). One 
such example is the phenotype of mice with a knock-out of GPR64, an orphan GPCR 
located on the apical membrane of efferent ducts and stereocilia of epididymal caput 
principal cells (Kirchhoff et al., 2008). GPR64 knock-out mice display a similar 
stasis of spermatozoa in their efferent ducts, and incorrect fluid transport by the 
efferent ducts and epididymis is implicated (Davies et al., 2004). Androgens are 
known to control the height of epididymal stereocilia (Primiani et al., 2007) and the 
AR-ablated immature epithelium of the proximal epididymis of FoxG1-ARKO mice 
lacked stereocilia which are characteristic of mature epididymal epithelial cells of 
this region. It is therefore probable that the locaisation of many important fluid and 
solute transport proteins are compromised in the FoxG1-ARKO. ERα is expressed 
aberrantly and strongly by all cells of the epididymal epithelium in segments II and 
III of the FoxG1-ARKO, and increase in its expression may be causing a 
dysregulation of the fluid absorption function of the caput epididymis and 
contributing to the phenotype.  
 
To establish whether AR ablation in the caput epididymal epithelium impacts upon 
the surrounding stroma, SMA expression was investigated as a marker of epididymal 
smooth muscle cells (Welsh et al., 2006). At d11 the staining for SMA in FoxG1-
ARKO caput epididymides appeared similar to that in co trols. However, at day 100 
the smooth muscle layer of the FoxG1-ARKO epididymis was disorganised with 
evidence of disruption at specific foci, suggesting that smooth muscle function may 
be compromised in the FoxG1-ARKO epididymis and that this could be 
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compounding the problems with spermatozoa transport. This observation is likely to 
be an effect rather than a cause of the impaired development of the epithelium, since 
there is no observable difference in SMA staining in FoxG1-ARKO mice 
epididymides compared to controls at d11. Reciprocal homeostatic interaction 
between epithelium and smooth muscle in the adult prostate has been previously 
demonstrated (Cunha et al., 1996), so it is probable that disruption of epithelium in 
the epididymis also causes dysfunction in the surrounding smooth muscle layer, this 
requires further investigation.  
 
Previous studies have noted that the physical blockage of the efferent ducts by sperm 
stasis results in inflammation and phagocytosis by the ductal epithelium (Hess and 
Nakai, 2000; Nakai et al., 1992). This is also apparent in the FoxG1-ARKO model at 
d100, with more cells immunostaining CD45+ compared to controls. Of particular 
interest is the morphology and locations of the CD45+ cells, noted in the stroma, 
dispersed throughout the efferent duct epithelium and also interspersed with 
spermatozoa in the lumen of efferent duct cross-sections in the conus region of the 
efferent ducts. Foci of dense spermatozoa heads can also be noted inside epithelial 
cells that stain CD45+, showing that they are being phagocytosed by immune cells 
within the ductal epithelium. The presence of similar CD45+ cell syncytia has been 
noted in efferent duct block phenotype of the LGR4 knock-out mouse (Mendive et 
al., 2006).  
 
In conclusion, the mosaic ablation of AR in 67% of the cells of the caput epididymis 
is likely to be contributing to the phenotype of obstructive azoospermia through 
preventing maturation of the cells of the caput epididymal epithelium, reducing the 
lumen diameter of the epididymal tubule and interfering with fluid reabsorbtion in 
the caput epididymis.  
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7. General Discussion  
The action of androgens via their receptor AR is essential for the correct 
development and function of the male reproductive system. Studies using rodents 
with systemic ablation of androgen-action including mice with a systemic genetic 
ablation of AR (Tfm and ARKO) (Lyon and Hawkes, 1970; Yeh et al., 2002) or rats 
treated with the anti-androgen flutamide (Welsh et al., 2008; Welsh et al., 2006) have 
been very informative in gaining information on the function of androgens during 
development and function of the testis. But as adult spermatogenesis is incomplete, 
the testes of these animals are cryptorchid, and Wolffian duct-derived structures 
(epididymis, vas deferens and seminal vesicles) are absent, it is difficult to draw 
conclusions about the relative contributions of androgen action in specific cells to the 
overall androgen-dependent function and development of the male reproductive 
system. Models in which AR is genetically ablated in specific cell types have 
contributed to an exponential increase in our understanding  of its role in different 
organs of the body, but, perhaps unsurprisingly, no o e cell specific knockout has a 
phenotype that recapitulates every aspect of the global ablation models.   
 
This leads to the hypothesis of this thesis: that ablation of AR action in previously 
untargeted cell types of the male reproductive system, or in previously characterised 
cell types at different ages, will have significant and novel effects on reproductive 
development and function that have not been previously documented by current 
models of androgen disruption. This final chapter aims to pool together the 
conclusions derived by each results chapter and address the initial objectives in light 
of these results, as well as suggesting further dirctions for the research. 
 
The experimental approach used in this thesis, and in other cell-specific knock-out of 
AR was the transgenic Cre-loxP system. Cre-loxP transgenic mice are appropriate 
models for elucidating the specific roles of androgens in different cell types, as the 
promoter that drives Cre can be selected to be active in a specific cell type, or at a 
specific age (Smith, 2011). Mouse lines with cell-specific knock-outs of AR have 
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been generated for several different cell types in the testis and wider reproductive 
system (Chang et al., 2004; De Gendt et al., 2004; Holdcraft and Braun, 2004; 
Raskin et al., 2009; Simanainen et al., 2008; Tsai et al., 2006; Welsh et al., 2010a; 
Welsh et al., 2009a; Welsh et al., 2010b; Wu et al., 2007; Xu et al., 2007; Zhang et 
al., 2006) have been characterised, with varying success, proving that the Cre loxP 
system is an appropriate method for cell-specific AR ablation that has resulted in 
new insights into signalling of AR in several of the cell types of the testis and male 
reproductive tract.  
 
In this thesis, three lines expressing Cre Recombinase were used with the intention of 
ablating AR in the vascular endothelial cells, the post-meiotic germ cells and the 
adult Sertoli cells of the mouse. Although the latter aim was not fully realised the 
experiments had the serendipitous result of AR ablation in the pituitary and caput 
epididymal epithelium, both of which were cell types in which the effect of AR had 
not previously been examined by cell specific ablation.  
 
7.1 The importance of empirical validation of Cre l ines 
It is important to note that, regardless of where it is supposed to function, the utility 
of a Cre line should be decided upon only following empirical validation of its 
spatiotemporal expression pattern, which can be achieved by using reporter genes 
such as β-galactosidase or fluorescent proteins to label the cells in which it is 
expressed or functioning. The expression of a transge e driven by a cell-specific 
promoter may not mirror the expression of the endogen us gene driven by the 
promoter, demonstrated by the discrepancy between th  expression of endogenous 
FoxG1 and the FoxG1-Cre transgene in these studies, so it is important that the site 
of ablation of a gene of interest is not automatically ssumed from the expression 
pattern of the gene downstream of the endogenous promoter that is driving Cre. 
Reasons for this include the ablation of any transcription enhancer or repressor sites 
internal to the ORF of the gene that is replaced by Cre so the transgenic promoter 
may no longer behave like the endogenous promoter (Smith, 2011). 
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The R26YFP reporter line activated by Cre expression is used to good effect in these 
studies to identify where the Cre is going to be active: the ablation of AR in the 
FoxG1-ARKO is an example of this. However, some caveats are attached. Since 
reporter genes and the floxed gene of interest are at different loci and may be in 
different strains, it cannot be assumed that Cre recombinase is going to have the 
same affect in both a reporter gene and a floxed gene of interest. Reasons for this 
may be the silencing of chromatin at different loci that prevents Cre recombinase 
from accessing the DNA, or the presence of modifier sequences in the vicinity of the 
loci.  
 
Empirical validation using a fluorescent reporter line determined that two of the three 
Cre lines (Tie2-Cre and Aqp2-Cre) used in this thesis for cell-specific ablation of AR 
were suitable for the cell-type they were predicted to be active in. Tie2-Cre was used 
to target endothelial cells, a cell type which is not widely thought to express AR the 
testis (Pelletier et al., 2000; Vornberger et al., 1994), although the literature contains 
some disagreement. Through validation of the Tie2-Cre line using a fluorescent 
reporter that labelled Tie2-Cre positive cells, it was shown that both the vascular and 
interstitial endothelial cells of the testis do not express AR, but that Tie2-Cre 
appeared to specifically target testicular endothelial cells, a novel finding. To 
confirm that loss of AR from testicular endothelial cells was indeed dispensable for 
normal function of the testis, the Tie2-Cre line was used to genetically ablate AR in 
endothelial cells, and this was shown to have no effect on spermatogenesis and 
morphologically mature spermatozoa were found in the cauda epididymis. No 
truncated Ar transcript was recorded in the testis of the Tie2-ARKO, confirming the 
general consensus in the literature that AR is not expressed by endothelial cells. 
Aqp2-Cre was used to target post-meiotic germ cells, another cell type which is 
generally agreed to lack AR (O'Donnell et al., 2006), although again the literature 
contains some disagreement (Vornberger et al., 1994) and the AR antibody used in 
these studies was found to stain elongating spermatids. Validation of the Aqp2-Cre 
line using a fluorescent reporter confirmed that it was suitable for targeting genes in 
post-meiotic germ cells. Although the original paper that set out to characterise 
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Aqp2-Cre expression in the testis could confirm that endogenous Aqp2 was present 
in post-meiotic germ cells, attempts to tag Cre with a herpes simplex virus (HSV) 
glycoprotein epitope tag and discover its localisation by immunostaining with an 
antibody against the tag failed in the testis due to high background levels (Nelson et 
al., 1998). Localisation of YFP to the post-meiotic germ cells of the Aqp2-YFP testis 
is therefore the first demonstration of the suitability of Aqp2-Cre for targeting this 
cell type, validating it for the purpose of genetic ablation of AR. To confirm that loss 
of AR from post-meiotic germ cells was indeed dispensable for normal function of 
the testis Aqp2-Cre was used to genetically ablate AR in this cell type. Ablation had 
no effect on spermatogenesis and morphologically mature spermatozoa were found 
in the cauda epididymis. No truncated Ar transcript was recorded in the testis of the 
Aqp2-ARKO, confirming the literature consensus that AR is not expressed by post-
meiotic germ cells. 
 
FoxG1-Cre was the third Cre line used for cell-specific AR ablation in this thesis, 
and although validation using a FoxG1-YFP reporter did not determine that the Cre 
was suitable for its originally intended use in generating an adult SCARKO model, it 
assisted in determining where the FoxG1-Cre was in fact active and therefore 
promoting focus on its action in the pituitary and epididymis. A preliminary study 
that had shown FoxG1 to be expressed in adult but not embryonic Sertoli cells 
suggested that FoxG1-Cre, a line previously used for ablation in the developing 
telencephalon (Hebert and McConnell, 2000), would be a suitable Cre line to use to 
generate an ablation of AR in adult post-pubertal Sertoli cells. However FoxG1-Cre 
expression did not mirror endogenous FoxG1 expression and was not active in the 
majority of adult Sertoli cells, so was determined to be unsuitable to generate an 
adult SCARKO. Despite this, observation of dissected whole organs of FoxG1-YFP 
mice under a microscope with a fluorescent filter, and immunostaining of tissues for 
YFP helped confirm that the FoxG1-Cre was active in the pituitary and epididymis 
and that AR ablation should be explored in these organs.   
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7.2 The phenotype of the FoxG1-ARKO   
The aim of using FoxG1-Cre to ablate AR in post-pubertal Sertoli cells was 
hampered by the failure of the Cre line to mirror endogenous FoxG1 in the testes. 
The FoxG1-Cre did not target all Sertoli cells but instead targeted a mosaic of germ 
cells, Leydig cells and a small number of Sertoli cells. Despite this, when FoxG1-
ARKO mice were generated, they had a severe age-depn nt phenotype in which 
failure of spermatozoa to transit the efferent ducts leading to atrophy of the 
seminiferous epithelium due to a build up of pressure. Further investigation revealed 
that the FoxG1-ARKO line had a partial ablation of AR in several reproductive 
organs, including the epididymis and a total ablation of AR in the pituitary. The 
contribution of ablation in different organs to the observed phenotype was 
investigated.  
 
The ablation of AR in the testis appeared to be confined to approximately 20% of 
Leydig cells and occasional Sertoli cells, but the phenotype of the FoxG1-ARKO 
was unlike the phenotype of previously published cell-specific knock-outs. The 
Leydig cell ARKO paper published by Xu et al. (2007) has a block at the round 
spermatid stage whereas the FoxG1-ARKO has complete spermatogenesis up until 
the onset of seminiferous epithelial sloughing. The Leydig cell ARKO phenotype is 
complicated by the contribution of an ablation of AR in Sertoli cells, as the Cre line 
used in this paper (AMHR2-Cre) is present in both cell types (Jeyasuria et al., 2004). 
Other experiments elucidating the effect of AR in Leydig cells have suggested that it 
works in tandem with LHR signalling to support pubertal maturation of PLCs to 
steroidogenically active ILCs (Hardy et al., 1990; Murphy et al., 1994). Since the 
FoxG1-ARKO has a similar serum testosterone level to the control it is unlikely that 
the partial ablation of AR in Leydig cells is having an effect on their steroidogenic 
output. The FoxG1-ARKO also has a very different phenotype to the published 
embryonic SCARKO, which exhibits a meiotic block that precludes formation of 
round or elongating spermatids (Chang et al., 2004; De Gendt et al., 2004). By 
contrast, the FoxG1-ARKO undergoes normal spermatogenesis which is only 
disrupted by the onset of seminiferous epithelium sloughing from day 35. The peri-
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tubular myoid cell (PTM)-ARKO mouse has testes with a reduction in numbers of all 
germ cell stages including the spermatogonia (Welsh et al., 2009a), but this 
phenotype is present from early in development and is not a degenerative change 
associated with seminiferous epithelial sloughing as is the FoxG1-ARKO.  
 
The total ablation of AR in the pituitary gland did not have an effect on LH serum 
hormone levels or the levels of any other pituitary hormone transcript measured so 
was unlikely to be impacting on the function of the testis or excurrent duct system. 
The focus of the analysis of the FoxG1-ARKO phenotype was the ablation in the 
caput epithelium of the epididymis, as it was immediately downstream of the block 
that was forming in the efferent ducts. Acute withdrawal of androgens following 
orchidectomy has previously been observed to result in apoptosis of epididymal 
epithelial principal cells (Fan and Robaire, 1998; Takagi-Morishita et al., 2002)  and 
de-differentiation of the caput epididymal epithelium to a ‘precursor’ state (Avram et 
al., 2004), demonstrating that androgens are important for maintenance of epithelial 
cell identity. Although action of androgens in Wolffian duct stabilisation and early 
development is known to be mediated by stromal AR (rchambeault et al., 2009), it 
was not known if maintenance of the epididymis in adults was due to stromal or 
epithelial AR (or a combination of the two). 
 
In the FoxG1-ARKO, ablation of AR in the caput epididymal epithelium resulted in 
the failure of the epithelium to mature. The initial segment did not develop, and the 
remaining caput epithelium had a reduction in luminal diameter, cell height and 
development of apical stereocilia. These results were a novel demonstration of the 
vital effects of epididymal epithelial AR in promoting differentiation and terminal 
maturation of this cell type. The result of these eff cts would be likely to cause the 
efferent duct block, as an epididymal phenotype is apparent from d11 but the efferent 
duct block does not begin to develop until later ages. Also, obstructive azoospermia 
is also seen in other mouse models with perturbation of the epididymal epithelium or 
epididymal development and morphology (Davies et al., 2004; Mendive et al., 2006; 
Tanwar et al., 2010; Zhao et al., 2001). The phenotype seen appears to be a 
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concentration of sperm in the efferent ducts, unlike the ERα ablation mouse model 
which exhibits efferent duct distension due to malabsorbtion of fluid in the efferent 
ducts (Lee et al., 2000) and infertility due to aberrant sperm morphology (Joseph et 
al., 2010a). 
 
The testicular phenotype seen in FoxG1-ARKO mice is most probably a secondary 
effect due to the efferent duct block, rather than the primary cause of the block in the 
first place, though it is likely that the two events are perpetuating each other. The 
development of a physical block in the efferent ducts induced both gross and 
histological changes in the testis of the FoxG1-ARKO from d35. Stereological 
quantification revealed a reduction in tubule diameter with an increase in lumen 
diameter at d100 consistent with atrophy of the seminiferous tubules and sloughing 
of the seminiferous epithelium in FoxG1-ARKO testes. This late-stage testicular 
phenotype is similar to that found following acute efferent duct blockage (Anton, 
2003; Flickinger et al., 1999; Hess and Nakai, 2000; Peng et al., 2010) and suggests 
that the degeneration seen in the testis is a consequence of the efferent duct block. 
However, the transient increase in testis weight predicted from this model was not 
observed in the FoxG1-ARKO model. This may be due to the observed epithelial 
phagocytosis relieving fluid pressure and accumulation of sperm to some extent. 
Further to this, the FoxG1-ARKO model represents a ‘chronic treatment’ with a 
progressively worsening phenotype in a developing system rather than an ‘acute 
treatment’ whose impacts are widespread and immediate (e.g. efferent duct ligation 
or chemical insult). 
 
However, the predicted sequence of events (epididymal dysfunction causes efferent 
duct block causes testicular disruption) does not preclude the contribution of a 
testicular phenotype to the generation of the effernt duct block in the first place. 
There is a delay in lumen opening of the FoxG1-ARKO testis compared to controls 
that is resolved by d21. The reason behind this was not fully investigated.  It could 
potentially be the consequence of AR ablation in testis, a consequence of the early 
stages of the epididymal phenotype or a result of the FoxG1 haploinsufficiency. 
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Though adult FoxG1-Cre stud males at the end of their br eding life had normal 
spermatogenesis with no evidence of the phenotype that FoxG1-ARKO mice display, 
earlier ages were not investigated for any potential effect of the haploinsufficiency 
on testicular phenotype. Even if testicular effects from either the FoxG1 
haploinsufficiency or ablation of AR in a few Leydig and Sertoli cells were causing 
germ cell sloughing this would probably not be enough to block efferent ducts 
without a coincident dysfunction in the epididymis. Several models of germ cell 
sloughing demonstrate that the sloughed cells pass through the efferent ducts and 
epididymis as mature spermatozoa would, and are noted in the cauda, where they are 
phagocytosed. Despite these observations, widespread sloughing of germ cells is not 
seen in the FoxG1-ARKO until after the seminiferous epithelium degradation occurs, 
so it is unlikely to be contributing to the initial progression of the efferent duct block. 
Although a few sloughed immature germ cells have accumulated in the efferent ducts 
when observed at d21, epididymal ablation of AR has already caused a phenotype in 
the epididymal epithelium from d11 implying that the initial stages of the block are 
likely to be already due to epididymal dysfunction. Another contribution to the early 
stages of the efferent duct block could be the reduction in testicular luminal fluid that 
would occur with a delay in the opening of the seminiferous tubule lumen. Since 
lumen opening is due to fluid produced by the Sertoli cells, which is dependent on 
AR signalling, it could be postulated that ablation of AR in Sertoli cells is causing 
this. Analysis of any ablation of AR in Sertoli cells has been one of the main 
problems encountered in this thesis, as a double immunostaining protocol for AR and 
a Sertoli-cell marker was consistently unsuccessful, despite several attempts at 
optimisation with several different antibodies used as Sertoli cell markers (p27/kip, 
WT1 and β-tubulin were all attempted, with limited success). However, 
immunohistochemistry with an AR antibody alone combined with identification of 
Sertoli cells by their distinctive morphology demonstrated that very few, if any 
Sertoli cells had AR ablation, although  this was further compounded by the 
fluctuation of the intensity of AR immunostaining at different stages of the 
spermatogenic cycle (Zhou et al., 2002). It could be possible that the partial ablation 
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of AR in the Leydig cell population causes a delay in lumen opening by limiting a 
trophic factor that stimulates the Sertoli cells.  
 
The FoxG1-ARKO mouse has utility as a novel model of obstructive azoospermia 
(OA). OA is the absence of sperm in the ejaculate due to a post-testicular obstruction 
of the genital tract. Four to six percent of infertil  men have obstructive azoospermia 
(Anon, 2008). Some cases of OA have been linked to congenital bilateral absence of 
vas deferens due to mutations in the cystic fibrosis transmembrane conductance 
receptor (Lopez et al., 2010), but most cases of OA have no definitive cause. The 
FoxG1-ARKO model introduces the idea that OA results from epithelial 
dysregulation in the epididymis. Since cell-specific gene ablation of AR is extremely 
unlikely to occur in humans, a possible cause could be a mutation in an epididymis-
specific gene controlled by AR signalling, or another developmental problem that 
has lead to incorrect maturation of the epididymal epithelium, or epithelial 
degeneration with age.  
 
7.3 Future perspectives 
Several of the results in this thesis would benefit from further exploration.  The 
morphology of the caput epididymal epithelium was clearly affected in the FoxG1-
ARKO mice, and this in itself is likely to contribute to the efferent duct spermatozoal 
block by narrowing the lumen diameter of the epididymal tubule. But the aberrant 
expression of ERα noted in the caput epididymal epithelium implies that there may 
also be dysregulation in absorption of testicular fuid in the epididymis that may be 
contributing to the block. There is abundant speculation in the literature about an 
optimal  ‘balance’ between androgens and estrogens that affects spermatogenesis, but 
balance between expression of their equivalent receptors in certain tissues could be 
contributing to this. Since the FoxG1-ARKO and the ERα knockout have ‘opposite’ 
phenotypes and aberrant ERα expression is implicated in the phenotype of the 
FoxG1-ARKO, it would be interesting to treat FoxG1-ARKO and control mice with 
an ERα inhibitor such as ICI 182,780 (Lee et al., 2000) and see whether this 
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positively or negatively impacts on the phenotype. The expression of Gpr64 (a novel 
receptor whose systemic ablation caused a phenotype similar to that seen in the 
FoxG1-ARKO (Davies et al., 2004)) was decreased in FoxG1-ARKO epididymides 
compared to controls at d21. Performing a microarray on epididymis tissue at an age 
between d21 and d35 could identify genes that are diff rentially regulated between 
the FoxG1-ARKO and controls and that may contribute to the obstructive 
azoospermia phenotype. Studies of gene expression in the FoxG1-ARKO mouse 
could prove useful for identifying downstream pathways and molecules for potential 
therapeutics for obstructive azoospermia. The epididym s is also being investigated 
as a site for potential novel post-testicular contraceptives (Sipila et al., 2009; Turner 
et al., 2006), and although the phenotype generated by the FoxG1-ARKO would be 
an undesirable side-effect of any novel male contraceptive, any information 
generated about the epididymis and its response to changes in gene expression could 
help pinpoint proteins that are potential contraceptiv  targets. 
 
Another aspect of the FoxG1-ARKO that was under-explored is the presence of a 
partial brain ablation of androgen receptor. Due to time and tissue constraints the 
location of this ablation was not established. Complete neural ablation of AR in 
males (Raskin et al., 2009) is linked to problems with both mating behaviour (due to 
AR ablation in the medial amygdala, lateral septum, bed nucleus of stria terminalis 
and medial preoptic area) and the HPG axis (due to AR ablation in the kisspeptin 
neurons of the hypothalamus). Since FoxG1-ARKO mice d d not demonstrate either 
of these problems it is unlikely that the ablation seen is in either of these areas, but 
pinpointing the localisation of the ablation in these mice may help draw a map of the 
regions of the brain that have redundant AR expression. Growth hormone (GH) is a 
pituitary hormone that was not investigated in these studies. GH receptor knock-out 
(GHR-KO) mice have a delayed puberty (Keene et al., 2002), with conflicting 
reports of either a slight decrease (Chandrashekar et l., 1999) or no decrease (Zhou 
et al., 1997) in fertility.  However GHR-KO mice are approximately half the weight 
of their wild-type controls (Keene et al., 2002); and a decrease in body weight is not 
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seen in the FoxG1-ARKO implying that GH expression is unlikely to be altered in 
this model.  
 
The Tie2-ARKO also presents interesting opportunities for further investigation. In 
this model the endothelial AR is ablated throughout the body, not just in the testis. 
Evidence suggests that AR is causally involved in the homeostasis of human prostate 
endothelial cells (Godoy et al., 2008), suggesting that the observation of the prostates 
of Tie2-ARKO mice could yield some interesting result .   
 
The use of a FoxG1-Cre line to ablate AR did not result in an ‘adult SCARKO’, so 
the generation of this line has still not been achieved. Potential suitable Cre lines are 
difficult to select for this task because most Sertoli cell-specific genes are induced 
either embryonically or at the advent of puberty, rather than after the first full round 
of spermatogenesis has occurred (Ojeda and Skinner, 2006). A potential way of 
circumnavigating this problem is to use a Cre line that is dependent on a ligand such 
as tamoxifen, interferon or tetracycline for activaion (Garcia and Mills, 2002), but 
also under the control of a Sertoli-cell specific promoter, so would not be expressed 
in Sertoli cells until the animals were treated with the ligand of choice. Furthermore, 
preliminary investigations in the Lee Smith group are underway to assess the 
suitability of using a lentiviral vector carrying a Sertoli cell-specific Cre, to be 
injected into the efferent ducts of an ARflox mouse. Lentiviral vectors injected into 
seminiferous tubules are preferentially taken up by the Sertoli cells (Ikawa et al., 
2002), and so Cre expression should be specific to these cells. 
 
7.4 General thesis conclusions 
The original hypothesis of this thesis was that ablation of AR action in previously 
untargeted cell types of the male reproductive system, or in previously characterised 
cell types at different ages, will have significant and novel effects on reproductive 
development and function that have not been previously documented by current 
models of androgen disruption. This hypothesis has been proven with the FoxG1-
ARKO, which has resulted in the following novel observations: 
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• AR signalling in the caput epididymal epithelium of the mouse is vital for 
normal differentiation of the epithelium, including the development of the 
initial segment.  
• Disruption of AR signalling the caput epididymal epithelium of the mouse 
contributes to a novel model of obstructive azoospermia in which most 
spermatozoa do not transit the efferent ducts. 
• AR signalling in the pituitary is not required for normal regulation of serum 
LH and testosterone, or for regulation of other pituitary endocrine hormone 
transcripts in the mouse. 
 
Other novel, previously unreported observations through the course of this thesis 
have been:  
• FoxG1 is present in the fetal Leydig cells and post-pubertal Sertoli cells of 
the mouse testis. Previously, FoxG1 had been shown t  be expressed in the 
human but not mouse testis, and localisation had not been determined 
(Obendorf et al., 2007). 
• Tie2-Cre is an appropriate line to use to ablate a g ne of interest in both the 
vascular and interstitial endothelial cells of the estis. 
• Ablation of endothelial AR has no effect on normal spermatogenesis in the 
mouse.  
• Ablation of AR in post-meiotic germ cells has no effect on normal 
spermatogenesis in the mouse.  
 
The FoxG1-ARKO has also demonstrated that the Cre/loxP system is a useful tool 
for cell-specific genetic ablation, but careful empirical validation must be performed 
to determine the site of action of the Cre line used in studies. However, because we 
conducted detailed empirical analysis we were able to xploit this line extremely 
successfully to provide significant novel findings relevant to male reproductive 
health. Although it was not the original intention f the study to target the epididymis 
or pituitary in the FoxG1-ARKO, the targeting of both provided novel results. 
Analysis of the epididymal phenotype of the FoxG1-ARKO has been published in a 
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recent paper (O'Hara et al., 2011). This manuscript was published back-to-back with 
another group who independently targeted AR in the caput epididymis from d25 
using an RNase10-Cre line, resulting in a similar phenotype of obstructive 
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